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Abstract 
2 
There  is  a  growing  awareness  of  the  potential  health  benefit  of  a  diet  rich  in  fruits 
and  vegetables  and  nutritional  guidelines  indicate  that  an  increase  in  the  consumption  of 
these  foods  may  decrease  the  risk  of  developing  coronary  heart  disease  (CHD)  and 
certain  cancers.  These  properties  may  be  ascribed  to  the  presence  of  antioxidants  and 
recent  attention  in  this  regard  has  focused  on  phenolic  and  polyphenolic  compounds. 
These  compounds  are  present  in  a  wide  variety  of  commonly  consumed  foods  and 
beverages  in  the  diet  and  red  wines  are  an  especially  abundant  source  derived  from 
grape  seeds,  skins  and  vine  stems.  The  objectives  of  the  studies  presented  in  this  thesis 
were  to  identify  and  quantify  the  major  phenolic  components  of  red  wine  and  to  assess 
the  contribution  of  individual  compounds  to  the  total  antioxidant  activity.  Further  aims 
were  to  investigate  the  influence  of  a  moderate  and  regular  consumption  of  red  wine  on 
the  antioxidant  status  and  on  indices  of  oxidative  stress  associated  with  CHD  in  healthy 
volunteers,  and  to  investigate  the  absorption,  metabolism,  sequestration  in  body  tissues 
and  excretion  of  the  monomeric  and  polymeric  flavan-3-ols  in  rats  following  ingestion 
of  a  grape  seed  extract  (GSE). 
Red  wines  were  analysed  for  their  phenolic  content  and  antioxidant  activity  using  a 
range  of  complementary  techniques  including  HPLC-tandem  mass  spectrometry, 
preparative  HPLC  and  HPLC  with  an  on-line  antioxidant  detection  system.  HPLC-MS2 
revealed  the  presence  of  a  number  of  flavonoids  and  phenolic  compounds  of  which  19 
were  identified,  with  gallic  acid,  the  flavan-3-ols  and  anthocyanins  being  the  most 
abundant.  Preparative  HPLC  was  used  in  an  effort  to  isolate  the  antioxidant  components 
in  red  wine  and  60  aliquots  were  collected.  Each  wine  fraction  was  analysed  for  total 
phenolics,  catechins  and  anthocyanins,  while  antioxidant  activity  was  determined  by 
electron  spin  resonance  spectroscopy  (ESR).  The  preparative  HPLC  step  did  not 
completely  separate  the  compounds  in  red  wine,  nonetheless  increasing  antioxidant 
activity  was  highly  and  significantly  associated  with  total  phenolics  (r  =  0.816,  P< 
0.001)  and  total  catechins  (r  =  0.591,  P<0.01);  but  there  was  no  correlation  with  total 
anthocyanins  (r  =  0.188,  p=0.151).  HPLC  with  an  on-line  antioxidant  detection  system 
was  subsequently  used  to  separate  and  identify  red  wine  phenolics.  The  findings  from 
this  study  indicate  that  gallic  acid,  (+)-catechin,  (-)-epicatechin,  and  procyanidin  dimers Catherine  Tsang,  2004  3 
B1  and  B2  were  the  major  in  vitro  antioxidants  identified  in  red  wine.  Collectively  the 
flavan-3-ols  contributed  >  50  %  of  the  total  antioxidant  capacity  of  each  wine,  while 
gallic  acid  contributed  between  23-44  %.  The  flavonols  and  anthocyanins  were  minor 
antioxidant  components  in  red  wines.  By  combining  HPLC,  MS2  and  on-line 
assessment  of  antioxidant  activity,  the  major  phenolic  compounds  present  in  red  wine 
were  identified,  together  with  their  direct  contribution  to  the  total  antioxidant  activity. 
A  randomised,  controlled  study  was  performed  with  20  free-living  healthy 
volunteers  in  an  effort  to  determine  the  effects  of  a  daily  moderate  consumption  of  red 
wine  on  the  antioxidant  status  and  indices  of  lipid  peroxidation  and  oxidative  stress 
associated  with  CHD.  Subjects  in  the  red  wine  group  consumed  375  mL/d  of  an 
antioxidant-rich  red  wine  for  two  weeks.  The  total  concentrations  of  phenolics  were 
measured  and  individual  phenolics  in  the  wine  and  plasma  were  analysed  by  HPLC- 
MS2.  The  antioxidant  capacity  of  plasma  was  assessed  with  ESR  and  homocysteine  and 
fasting  plasma  lipids  were  also  determined.  The  production  of  conjugated  dienes  and 
thiobarbituric  acid  reactive  substances  (TBARS)  were  measured  in  copper  oxidised  low- 
density  lipoprotein  (LDL).  Plasma  total  phenolic  concentrations  were  highly  and 
significantly  increased  by  4.4  µM  GAE  after  2-weeks  of  daily  red  wine  consumption  (P 
<  0.001)  that  was  associated  with  a  non-significant  increase  in  the  plasma  antioxidant 
activity.  Trace  levels  of  four  metabolites,  namely  (+)-catechin  glucuronide,  (-)- 
epicatechin  glucuronide,  methyl-catechin  glucuronide  and  methyl-epicatechin 
glucuronide  were  detected  in  plasma  of  the  red  wine  group.  These  flavan-3-ol 
metabolites  were  not  detected  in  plasma  of  the  control  group.  Moreover,  the  maximum 
concentration  of  conjugated  dienes  and  TBARS  in  copper-oxidised  LDL  were 
significantly  reduced  (P  <  0.05)  and  HDL  cholesterol  concentrations  were  significantly 
higher  (P  <  0.05)  following  red  wine  consumption.  None  of  these  parameters  were 
observed  in  the  control  group.  The  findings  from  this  investigation  suggest  that  some 
phenolics  appear  to  be  directly  absorbed  into  the  bloodstream  from  the  gastrointestinal 
(GI)  tract  following  a  daily  moderate  consumption  of  red  wine,  and  are  able  to  exert 
some  protective  effects  such  as  raising  HDL  cholesterol  concentrations  and  enhancing 
the  resistance  of  LDL  to  withstand  oxidative  modification. Catherine  Tsang,  2004  4 
The  absorption,  metabolism  and  excretion  of  flavan-3-ols  and  procyanidins  were 
investigated  in  rats  following  the  ingestion  of  a  single  acute  dose  of  a  tannin-rich  grape 
seed  extract  (GSE).  The  liver,  kidney,  brain  and  GI  tract  together  with  plasma,  urine  and 
faeces  were  collected  at  several  time  points  up  to  24  h  after  ingestion  of  the  GSE  and 
the  flavan-3-ol  contents  were  analysed  by  reversed  phased  HPLC  with  tandem  mass 
spectrometry  and  diode  array  detection.  In  this  study,  small  amounts  of  the  GSE  flavan- 
3-ols  moved  out  of  the  stomach  and  into  the  duodenum/jejunum,  and  to  a  greater  extent 
the  ileum  1h  after  ingestion  and  in  the  caecum  after  2h  with  relatively  small  amounts 
being  detected  in  the  colon  after  3  h.  The  GI  tract  contained  principally  the  parent  GSE 
flavan-3-ols  and  procyanidins,  however  trace  amounts  of  four  metabolites,  namely  (+)- 
catechin  glucuronide,  (-)-epicatechin  glucuronide,  methyl-(+)-catechin  glucuronide  and 
methyl-(-)-epicatechin  glucuronide,  were  detected  in  the  duodenum/jejunum  and  ileum. 
In  contrast  to  the  GI  tract,  plasma  contained  exclusively  flavan-3-ol  metabolites  in 
detectable  quantities  which  reached  a  peak  plasma  concentration  3h  after  GSE 
ingestion;  (+)-catechin  glucuronide  (36.0  ±  2.5  µmoles/L)  and  (-)-epicatechin 
glucuronide  (34.4  ±  0.2  µmoles/L)  and  in  small  amounts  methyl-(+)-catechin 
glucuronide  (19  ±  0.3  µmoles/L)  and  methyl-(-)-epicatechin  glucuronide  (11.4  ±  0.7  µ 
moles/L).  All  four  metabolites  were  also  detected  in  the  liver  and  kidneys.  They  were 
also  detected  in  urine  along  with  (+)-catechin  sulphate,  (-)-epicatechin  sulphate,  methyl- 
(+)-catechin  sulphate  and  methyl-(-)-epicatechin  sulphate.  In  addition,  urine  also 
contained  in  low  amounts  the  procyanidin  dimers  B1,  B2,  B3  and  B4  as  well  as  the  trimer 
C2  and  an  unknown  GSE  trimer.  The  levels  of  (+)-catechin  and  (-)-epicatechin 
metabolites  excreted  in  urine  relative  to  the  quantity  of  the  monomers  ingested  were  27 
and  36  %,  respectively,  after  24  h.  The  findings  from  this  investigation  indicate  that 
monomeric  together  with  smaller  amounts  of  oligomeric  and  polymeric  flavan-3-ols  can 
be  directly  absorbed  into  the  bloodstream.  The  monomers  are  metabolised  forming 
glucuronidated,  sulphated  and  methylated  derivatives.  Moreover,  this  study  provides 
further,  albeit  indirect,  evidence  that  the  procyanidin  oligomers  in  the  GSE  were  not 
depolymerised  in  the  GI  tract  releasing  monomeric  flavan-3-ols  to  any  extent  after 
ingestion. Catherine  Tsang,  2004  5 
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v/v  volume/volume 
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Aims  of  Study 
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Red  wine  (Vitis  vinifera)  provides  a  rich  source  of  phenolic  and  polyphenolic 
compounds  derived  from  grape  seeds,  skins  and  vine  stems.  Recent  evidence  has 
suggested  that  a  moderate  consumption  of  red  wine  may  protect  against  the 
development  of  CHD.  Phenolics  act  as  potent  antioxidants  in  vitro  however  the 
contribution  of  individual  components  in  red  wine,  their  protective  effects  in  vivo  and 
their  absorption  and  metabolism  have  yet  to  be  addressed. 
This  study  set  out  to  achieve  the  following  aims: 
1.  To  identify  and  quantify  the  major  phenolic  contributors  to  the  in  vitro  antioxidant 
capacity  of  red  wine. 
2.  To  investigate  the  influence  of  a  moderate  daily  consumption  of  red  wine  on  the 
antioxidant  status  and  on  indices  of  oxidative  stress  associated  with  CHD  in  healthy 
volunteers. 
3.  To  determine  the  absorption,  metabolism,  excretion  and  distribution  of  a  grape  seed 
extract  rich  in  (+)-catechin  and  procyanidins  in  a  rat  model  system. Catherine  Tsang,  2004 
Chapter  1  Introduction 
1.1  Diet  and  Health 
14 
A  diet  rich  in  fruits  and  vegetables  has  long  been  recognised  to  protect  against 
chronic  diseases  including  cardiovascular  disease  (CHD  and  stroke)  and  certain  cancers 
(WHO,  2003),  and  current  dietary  guidelines  recommend  a  daily  intake  of  at  least  5 
portions  (400  g).  Although  the  protection  afforded  by  fruits  and  vegetables  can  be  partly 
explained  by  associated  lifestyle  factors  including  abstinence  from  smoking  and 
increased  physical  activity  (Lampe,  1999),  specific  dietary  constituents  are  considered 
to  be  important  to  health. 
Phenolic  and  polyphenolic  compounds  are  secondary  metabolites  widespread  in  the 
plant  kingdom  and  form  an  integral  part  of  the  human  diet  with  fruits,  vegetables,  tea 
and  red  wine  providing  an  especially  abundant  source.  During  the  past  decade,  interest 
has  arisen  in  these  compounds  as  there  is  some  evidence  to  suggest  that  an  increased 
consumption  of  phenolic  rich  foods/beverages  may  help  prevent  disease.  Polyphenols 
are  reducing  agents  and  their  potential  health-related  properties  have  been  ascribed  to 
their  powerful  antioxidant  abilities,  which  may  protect  the  body  from  damaging 
oxidation  reactions,  caused  by  `free  radicals'  (Kanner  et  al.,  1994). 
1.2  Free  radicals,  Oxidative  stress  &  chronic  disease 
It  is  becoming  increasingly  evident  that  wide  ranges  of  chronic  diseases  have 
oxidation  events  as  a  major  component  of  their  pathophysiology  and  has  been 
implicated  in  the  aetiology  of  a  number  of  degenerative  diseases  including  cancer, 
atherosclerosis  and  chronic  inflammatory  diseases  (Beckman  &  Ames,  1998).  Harman 
first  proposed  the  `free  radical  theory  of  ageing',  which  stated  that  free  radicals 
produced  during  metabolism  and  other  biological  reactions  cause  cumulative  cell 
damage  leading  to  ageing  and  eventual  death  (Harman,  1956).  This  theory  has  since 
been  transformed  into  a  more  general  premise  which  highlights  that  an  over-production 
of  reactive  oxygen  species  (ROS)  during  normal  metabolic  processes,  or  a  loss  of  the Catherine  Tsang,  2004  15 
protective  mechanisms  that  reduce  the  ability  to  withstand  oxidative  challenge  is 
intricately  connected  to  ageing  and  lifespan  (Beckman  &  Ames,  1998). 
1.2.1  Source  of  free  radicals 
Free  radicals  are  fundamental  to  any  biochemical  process  and  represent  an  essential  part 
of  aerobic  life.  They  are  characterised  as  having  one  or  more  unpaired  electrons  and  are 
therefore  capable  of  reacting  with  electron  donors  to  equilibrate  its  charge  (Rice-Evans, 
2001).  Endogenously  free  radicals  are  generated  as  by-products  through  electron 
transport  chains  during  normal  aerobic  metabolism  (Halliwell,  1996),  peroxisomes  and 
the  cytochrome  P-450  system  (Wiseman  et  al.,  1997).  They  are  essential  for  the 
regulation  of  normal  metabolic  processes  and  immune  function  including  cell  growth, 
energy  production,  phagaocytosis  and  the  synthesis  of  nucleic  acids,  hormones  and 
proteins.  Free  radicals  are  also  generated  exogenously  through  cigarette  smoke, 
products  of  ionising  UV  radiation,  environmental  pollutants,  lipid  oxidation  products  in 
foods  and  excessive  intakes  of  iron  (Halliwell  et  al.,  1992;  Kubow,  1993)  (Table  1.1). 
Free  radicals  can  be  classified  into  oxygen,  nitrogen,  carbon  and  sulphur  based 
molecules  and  include  hydroxyl  radical  (OH-),  superoxide  anion  (02'-),  singlet  oxygen 
(102)  and  hydrogen  peroxide  (H202).  The  hydroxyl  radical  is  the  most  reactive  of  the 
oxygen  centred  radicals  and  will  react  with  the  first  available  bio-molecule  they 
encounter.  Other  free  radicals  include  the  2  gaseous  radicals  nitric  oxide  (NO-)  and 
nitrogen  dioxide  (NO2-),  and  the  carbon  centred  radicals  (R")  of  organic  compounds; 
alkoxyl  (RO")  and  peroxyl  (ROO")  formed  during  the  peroxidation  of  lipids.  While  the 
sulphur  based  radicals  (RS-)  and  (RS-SR'-)  are  involved  in  cellular  function. 
Table  1.1  Endogenous  and  exogenous  sources  of  free  radicals. 
Source  Mechanism 
Endogenous 
Mitochondrial  electron  transport  Leakage  of  superoxide  due  to  inefficient  reduction  of 
Transition  metal  ions 
Inflammation 
Enzymes  e.  g.  Xanthine  Oxidase 
oxygen 
Copper  and  iron  facilitate  hydroxyl  radical  formation 
Free  radicals  released  by  activated  phagocytes 
Release  superoxide  during  reperfusion  of  ischemic 
tissues 
Exogenous 
Drug  metabolism  Free  radical  intermediates  created  during  metabolism 
Cigarette  smoke  Gas  phase  rich  in  free  radicals 
Radiation  X-rays,  UV  light Catherine  Tsang,  2004  16 
1.2.2  Free  radical  reactions  in  biological  systems 
All  of  the  major  macromolecules  found  within  the  body  are  susceptible  to  oxidative 
modification  by  free  radicals,  including  lipids,  DNA  and  protein.  Lipid  peroxidation  is 
probably  the  most  extensively  investigated  free-radical  induced  process  (Moore  & 
Roberts,  1998).  The  lipid  component  of  biological  membranes  is  highly  susceptible  to 
oxidation  and  may  undergo  a  rapid  and  destructive  chain  peroxidation  process  (Karten 
et  al.,  1988).  Lipid  peroxidation  is  initiated  by  free  radical  attack  on  a  double  bond 
associated  with  a  PUFA  resulting  in  the  abstraction  of  a  H+  atom  from  a  methylene 
(CH2)  group,  the  rate  of  which  determines  the  rate  of  initiation.  The  OH-  radical  is 
particularly  effective  in  initiating  lipid  peroxidation  (Morrisey  et  al.,  1994).  The 
formation  of  the  lipid  radical  is  then  accompanied  by  molecular  re-arrangement  that 
results  in  stabalisation  of  the  unstable  carbon  radical  into  a  conjugated  diene.  The 
conjugated  diene  reacts  very  quickly  with  molecular  oxygen,  and  the  peroxyl  radical 
thus  formed  is  a  crucial  intermediate.  Peroxyl  radicals  can  combine  with  each  other  or 
they  can  attack  membrane  proteins,  however  they  are  also  capable  of  abstracting  H+ 
from  adjacent  fatty  acid  side  chains  in  membranes  and  so  propagate  the  chain  reaction 
of  lipid  peroxidation.  Lipid  hydroperoxides  can  undergo  further  oxidation  via  its 
interaction  with  transition  metals  including  copper  and  iron,  yielding  a  complex  mixture 
of  secondary  degradation  products  including  hydrocarbon  gases  (ethane  and  pentane) 
and  aldehydes  (malonaldehyde  and  4-hydroxynonenal)  (Fig.  1.1).  Proteins  and  nucleic 
acids  seem  to  be  less  susceptible  than  lipids  to  free  radical  attack,  in  that  there  seems  to 
be  less  possibility  in  the  formation  of  rapidly  progressing  chain  reactions.  Nonetheless, 
DNA  can  undergo  a  series  of  reactions  with  ROS  leading  to  DNA  strand  breaks  (double 
and  single)  and  base  modifications  which  may  result  in  genetic  mutations,  cell  death, 
damage  to  DNA  repair  enzymes  and  chromosomal  re-arrangements  (Halliwell  & 
Arouma,  1991).  Moreover,  amino  acyl  constituents  crucial  for  the  function  of  proteins 
are  especially  vulnerable  to  radical  damage.  The  consequences  of  such  damage  may  be 
aggregation,  cross-linking  or  protein  degradation  and  fragmentation,  depending  on  the 
nature  of  the  protein  component  and  the  attacking  free  radical  species  involved  leading 
to  altered  enzyme  activity,  membrane  and  cellular  function  (Wolff  et  al.,  1986). Catherine  Tsang,  2004 
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Figure  1.1  Basic  reaction  sequence  of  lipid  peroxidation  (Young  &  McEneny,  2001). Catherine  Tsang,  2004 
1.2.3  Antioxidant  defence  mechanisms 
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A  number  of  antioxidant  defence  mechanisms  and  repair  systems  exist  in  the  body  to 
protect  against  the  damage  and  reduce  the  adverse  effects  of  free  radicals  (Table  1.2). 
This  complex  network  involves  mechanisms  that  reduce  the  initial  formation  of  oxygen 
centred  radicals  of  organic  compounds  (peroxyl  and  alkoxyl  radicals);  scavenge  free 
radicals,  break  chain-reactions  and  repair  systems  for  damage  (Yu,  1994).  Intracellular 
antioxidant  enzymes  include  superoxide  dismutase,  which  removes  superoxide  radicals 
by  accelerating  the  formation  of  hydrogen  peroxide;  glutathione  peroxidase,  converts 
hydrogen  peroxide  to  water,  and  catalase,  which  breaks  down  hydrogen  peroxide 
(Morton  et  al.,  2000).  Non-enzymatic  antioxidants  act  mainly  as  scavengers  in  oxidative 
chain  reactions.  They  can  be  divided  into  lipid  phase  chain  breaking  antioxidants  such 
as  tocopherols  and  aqueous  phase  chain  breaking  antioxidants  such  as  ascorbate. 
Several  extracellular  antioxidants  such  as  proteins  (transferrin,  lactoferrin,  albumin  and 
caeruloplasmin)  and  urate  prevent  free  radical  reactions  in  the  body  by  sequestering 
transition  metals,  thus  reducing  the  occurrence  of  fenton-like  reactions  (Khan  &  Kasha, 
1994). 
Table  1.2  Enzymatic  and  non-enzymatic  physiological  antioxidants. 
Antioxidant  Properties 
Enzymatic 
SOD  removes  02--  by  accelerating  formation  of  H202. 
GSH  removes  H202  and  organic  hydroperoxide 
CAT  removes  H202 
Non-enzymatic 
vitamin  C  free  radical  scavenger;  recycles  vitamin  E 
vitamin  E  major  chain-breaking  antioxidant  in  cell  membrane 
glutathione  multiple  roles  in  cellular  antioxidant  defence 
uric  acid  scavenger  of  OH  radicals 
a-lipoic  acid  recycles  vitamin  C;  effective  glutathione  substitute 
carotenoids  scavenger  of  ROS;  singlet  oxygen  quencher 
bilirubin  extracellular  antioxidant 
ubiquinones  reduced  form  are  efficient  antioxidants 
metal  ions:  e.  g.  transferrin  chelate  metals  ions  responsible  for  fenton  reactions 
NO  free  radical  scavenger;  inhibitor  of  lipid  peroxidation 
Adapted  from  Fang  et  al.  (2002).  SOD-superoxide  dismutase;  GSH-glutathione 
peroxidase;  CAT-catalase;  NO-nitric  oxide;  ROS-reactive  oxygen  species. Catherine  Tsang,  2004  19 
1.2.4  Antioxidant  activity  of  polyphenols 
Although  the  body  has  a  number  of  endogenous  defences,  antioxidants  from  dietary 
sources  also  have  an  important  role  to  play  in  quenching  free  radicals  and  in  preventing 
damage.  In  addition  to  the  common  dietary  antioxidants;  vitamins  C  and  E,  phenolics 
and  polyphenolics  are  purported  to  act  as  potent  antioxidants  in  biological  systems  in 
vitro.  The  protective  effects  have  been  ascribed  to  their  capacity  to  transfer  electrons  to 
free  radicals,  chelate  metal  catalysts  (Ferrali  et  al.,  1997),  activate  antioxidant  enzymes 
(Elliot  et  al.,  1992)  and  inhibit  oxidases  (Cos  et  al.,  1998).  Scavenging  free  radicals  can 
prevent  the  oxidation  of  biological  matrices,  and  chelating  metal  ions  such  as  copper 
and  iron,  can  reduce  the  initiation  of  chain  reactions  in  fatty  acids  present  in  LDL. 
Phenolics  are  also  involved  in  the  regeneratation  of  vitamin  C  and  E  when  they 
accept/donate  an  unpaired  electron  or  H+  from  a  free  radical.  The  antioxidant  activities 
of  polyphenols  are  closely  related  to  their  structure  and  a  number  of  important  structural 
determinants  have  been  identified.  The  common  flavonoids,  myricetin,  quercetin,  rutin 
and  gallic  acid  have  been  shown  to  exert  greater  antioxidant  capacities  than  the 
conventional  antioxidant  vitamin  a-tocopherol.  This  is  due  to  the  number  of  hydroxyl 
groups  which  enable  the  compound  to  donate  H+  and  delocalise  the  resulting  free 
electron.  In  general  the  greater  the  number  of  hydroxyl  groups  on  a  structure,  the  greater 
the  antioxidant  activity  (Salah  et  al.,  1995).  Studies  have  shown  that  quercetin  is  a 
potent  antioxidant  due  to  the  number  and  distribution  of  its  hydroxyl  groups  (Rice- 
Evans  et  al.,  1995),  in  addition  to  (+)-catechin  (Teissedre  et  al.,  1996).  Particular 
combinations  are  found  to  offer  greater  activity.  Bors  et  al.  (1990)  proposed  the 
following  structural  determinants  for  effective  radical  scavenging  properties  of 
flavonoids:  (1)  The  O-dihydroxy  (catechol)  structure  in  the  B-ring.  This  is  an  obvious 
radical  target  site  for  all  flavonoids  with  a  saturated  2,3-double  bond.  (2)  The  2,3-double 
bond  in  conjugation  with  a  4-oxo  function,  which  is  responsible  for  electron 
delocalisation  from  the  B-ring.  (3)  The  additional  presence  of  both  3'  and  5'  hydroxyl 
groups  for  maximum  radical  scavenging  potential  and  strong  radical  absorption. 
Moreover,  the  ability  of  flavonoids  to  donate  electrons  and  stop  chain  reactions  is 
attributed  to  the  phenolic  hydroxyls  with  activity  increasing  with  the  number  of  -OH 
groups  in  the  A  and  B  rings,  particularly  the  3',  4'-OH  of  the  ring  B  and  the  meta Catherine  Tsang,  2004  20 
arrangement  of  -OH  groups  at  the  5'  and  7'  positions  of  ring  A  are  reported  to  further 
increase  the  antioxidant  activity  of  a  compound  (Frankel,  1999). 
1.2.5  Methods  to  determine  antioxidant  activity 
A  number  of  techniques  have  been  developed  to  measure  the  activity  of  an  antioxidant. 
Some  techniques  are  based  on  a  chemical  reaction,  while  others  make  use  of  a 
biological  response.  Some  of  the  most  common  methods  used  to  assess  the  antioxidant 
capacity  of  phenolic  rich  foods  and  beverages  are  electron  spin  resonance  (ESR),  trolox 
equivalent  antioxidant  activity  (TEAC),  chemiluminescence,  2,2  azobis  (2 
amionopropane)  hydrochloride  (AAPH)  and  2,2-diphenyl-l-picrylhydrazyl  radical 
(DPPH),  while  the  ferric  reducing  antioxidant  potential  (FRAP)  assay  is  most 
commonly  used  for  the  assessment  of  plasma  antioxidant  activity. 
1.2.5.1  Electron  spin  resonance  spectroscopy 
ESR  spectroscopy  is  unique  in  that  it  is  only  sensitive  to  transitions  involving  unpaired 
electrons,  whereby  the  decay  of  radical  resonance  of  either  a  water-soluble  or  organic- 
soluble  radical  is  examined  over  time.  This  enables  the  kinetics  and  the  stochiometry  of 
the  donation  of  the  H+  from  the  antioxidant  to  the  radical  to  be  determined  (Duthie, 
1999).  Unlike  many  other  antioxidant  assays  this  method  can  be  used  with  turbid  or 
coloured  samples  such  as  red  wine  (Gardner  et  al.,  1999).  The  application  of  this 
approach  has  been  tested  in  parallel  with  the  common  FRAP  assay  in  the  analysis  of  red 
wines  (Burns  et  al.,  2000).  Although  two  different  methods  were  used  to  assess  the 
antioxidant  capacity  the  results  obtained  were  highly  correlated. 
1.2.5.2  TEAC  -  trolox  equivalent  antioxidant  activity 
The  TEAC  assay  is  based  on  the  oxidation-induced  decolourisation  of  radical  cation 
ABTS  (2,2'-azinobis-3-ethylbenzothiazoline-6-sulphonic  acid),  and  determines  the 
ability  of  hydrophilic  H+  donating  antioxidants  to  scavenge  the  ABTS+  radical 
compared  with  Trolox  (a  water  soluble  analogue  of  vitamin  E)  (Miller  et  al.,  1993).  The 
ABTS+  radical  is  not  found  naturally  in  the  body  and  is  strong  compared  with  other Catherine  Tsang,  2004  21 
oxidising  species.  As  the  activity  of  an  antioxidant  compound  depends  on  the  free 
radical  used  this  technique  offers  little  information  about  the  biological  reactions  of  the 
antioxidants.  This  method  overcomes  some  of  the  difficulties  associated  with  other 
inhibition  assays;  although  stringent  control  of  reaction  conditions  and  time  is  critical  in 
obtaining  reproducible  results.  This  method  gives  a  non-linear  dose  response,  is 
insensitive  to  small  changes  in  individual  antioxidants  when  used  in  complex  samples 
such  as  plasma,  and  antioxidant  stoichiometric  factors  vary  with  test  conditions 
(Schofield  et  al.,  1996). 
1.2.5.3  AAPH  method 
The  ability  of  compounds  to  trap  peroxyl  radicals  is  assessed  using  the  2,2'-azobis(2- 
amidinopropane)  dihydrochloride  (AAPH)  assay.  A  steady  stream  of  peroxyl  radicals  is 
initiated  by  the  addition  of  the  azo  compound.  The  decrease  in  absorbance/fluorescence 
of  a  reactive  compound  is  quantified  in  the  presence  of  a  radical  scavenger  (Ghiselli  et 
al.,  1998). 
1.2.5.4  DPPH  method 
The  radical  scavenging  effect  of  1,1  -diphenyl-2-picryl-hydrazyl  (DPPH)  involves  the 
quenching  of  the  absorbance  of  a  compound  due  to  the  scavenging  of  radicals  by  an 
antioxidant.  This  method  can  be  extended  to  examine  the  kinetics  of  the  radical 
scavenging  by  following  the  reaction  over  time  rather  than  just  at  a  fixed  time  point. 
This  method  has  been  used  to  determine  the  antioxidant  activity  of  wines  and  phenolic 
compounds  (Fauconneau  et  al.,  1997). 
1.2.5.5  Chemiluminescence 
The  principal  of  this  method  is  based  on  the  oxidation  of  luminol  by  hydrogen  peroxide 
in  a  reaction  catalysed  by  horseradish  peroxidase.  Under  normal  circumstances  this 
reaction  produces  low  intensity  light  emission  however  in  the  presence  of  antioxidants 
light  emission  is  diminished.  The  length  of  time  of  light  quenching  is  related  to  the Catherine  Tsang,  2004  22 
amount  of  the  antioxidant  present.  This  approach  has  been  used  to  determine  the 
antioxidant  capacity  of  plasma  and  phenolic  compounds  (Whitehead  et  al.,  1992). 
1.2.5.6  FRAP  assay 
The  FRAP  assay  is  simple,  inexpensive  and  robust  and  provides  an  index  of  antioxidant 
activity  (Benzie  &  Strain,  1996).  It  describes  the  ability  of  a  compound  to  reduce  Fe  3+ 
to  Fee+.  This  reduction  is  accompanied  by  the  formation  of  a  blue  colour  in  the  presence 
of  a  ferric-tripyridyltriazine  (Fe3+-TPTZ)  complex.  The  dose-response  is  linear  over  a 
wide  range,  stoichiometric  factors  of  antioxidants  are  constant  in  pure  solution,  aqueous 
mixtures  and  in  complex  mixtures  such  as  plasma,  and  therefore  is  suitable  for  the 
analysis  of  a  range  of  biological  fluids  and  extracts  of  foods/beverages.  FRAP  values 
are  similar  to  those  obtained  using  other  types  of  antioxidant  techniques  including 
chemiluminescence  (Whitehead  et  al.,  1992),  TRAP  (Lissi  et  al.,  1995)  and  ESR,  as 
described  previously. 
1.3  Chemistry  and  Classification  of  Phenolics 
Plants  synthesise  a  vast  and  diverse  range  of  secondary  metabolites,  the  majority 
of  which  do  not  appear  to  be  involved  in  essential  processes  of  plant  physiology.  Their 
production  in  plant  tissues  is  influenced  by  a  wide  range  of  environmental  factors  in 
response  to  stress,  including  exposure  to  UV  radiation,  attack  by  fungi  or  bacteria  and 
disease  (Landry  et  al.,  1995).  As  a  consequence  a  number  of  physiological  and 
ecological  functions  have  been  described  in  plants  including  plant  defense,  chemical 
signalling,  protection  against  UV  radiation,  regulation  of  hormones,  organogenesis,  in 
addition  to  contributing  to  their  colour  and  flavour  (Vogt  et  al.,  1994;  Bravo,  1998).  In 
humans  they  have  been  reported  to  exhibit  a  wide  range  of  biological  effects  including 
anti-bacterial,  anti-viral,  anti-inflammatory  and  anti-allergic  properties  (Cook  & 
Samman,  1996).  Phenolics  are  characterised  by  having  an  aromatic  ring  bearing  one  or 
more  hydroxyl  (OH)  substituents,  and  range  from  simple  low  molecular  weight,  single 
aromatic  compounds  to  the  large  highly  polymerised  and  complex  tannins.  They  occur 
predominantly  as  conjugates  with  sugars,  glucuronic  or  galacturonic  acids,  other 
phenols  or,  less  frequently,  to  aromatic  carbon  atoms  (Bravo,  1998).  Modifications  in Catherine  Tsang,  2004  23 
their  basic  structure  such  as  oxidation,  hydroxylation,  glycosylation  and  methylation  has 
led  to  a  wide  range  of  phenolic  substances  with  over  8000  structures  reported  to  date 
(Strack,  1997).  Phenolics  can  be  classified  according  to  the  number  and  arrangement  of 
their  carbon  atoms  and  can  be  classified  into  two  major  groups,  the  flavonoids  and  the 
non-flavonoids.  The  majority  of  phenolics  are  synthesised  from  carbohydrates  via  the 
shikimate  and  phenylpropanoid  pathways  (Fig.  1.2). 
1.3.1  Flavonoids 
Flavonoids  comprise  one  of  the  largest  and  most  widely  dispersed  groups  of 
secondary  plant  metabolites  (Kuhnau,  1976)  with  over  6000  flavonoids  indentified  to 
date  (Harbone  &  Williams,  2000).  Flavonoids  mainly  exist  in  plants  as  glycosides, 
while  aglycones  (lacking  sugar  moieties)  occur  less  frequently.  Their  common  structure 
is  that  of  diphenylpropanes  which  has  15  carbon  atoms  arranged  in  three  rings  (C6-C3- 
C6)  consisting  of  two  benzene  rings  (A  &  B),  which  are  connected  by  an  oxygen 
containing  pyrane  ring  (C)  (Figure  1.3). 
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Flavonoids  are  formed  from  the  combination  of  derivatives  synthesized  from 
phenylalanine  (via  the  shikimic  acid  pathway)  and  acetic  acid;  the  'A'  ring  is  formed 
from  three  acetate  units  (via  the  malonic  acid  pathway)  and  the  'B'  ring  with  the  3- 
carbon  bridge  is  constructed  of  a  phenylpropane  unit  via  the  shikimic  acid  pathway.  The 
first  step  involves  the  formation  of  phenylalanine  from  phenylpyruvate.  Phenylalanine 
is  transformed  to  trans-cinnamic  acid,  which  is  then  hydrolyzed  to  p-coumaric  acid  (C- 
9).  The  C-9  acids  condense  with  three  C-2  (malonyl-coA)  units  to  form  a  C-15 
chalcone.  Subsequent  ring  closure  and  hydration  give  rise  to  such  compounds  as  the  3- 
hydroxyflavonoids  (catechins)  and  3,4-diolflavonoids  (flavonols)  (Dixon  &  Steele, 
1999).  The  various  classes  of  flavonoids  differ  in  the  level  of  oxidation  and  pattern  of 
substitution  of  the  C  ring  and  as  such  are  subdivided  according  to  their  chemical 
structures  into  six  classes:  flavanones,  flavones,  flavonols,  isoflavonoids,  anthocyanins, 
and  flavan-3-ols.  Flavonoids  are  present  in  most  edible  fruits  and  vegetables,  and  are 
found  in  a  wide  range  of  beverages  including  tea  and  red  wine.  The  main  dietary 
flavonoids  and  their  sources  are  shown  in  Table  1.3. 
1.3.1.1  Flavonols 
Flavonols  are  mainly  represented  by  myricetin,  quercetin,  kaempferol  and  isorhamnetin. 
Conjugation  occurs  most  commonly  at  the  3-position  of  the  C  ring  although  5,7,4',  3' 
and  5'  substitutions  also  occur  (Herrman,  1976).  Flavonols  are  commonly  found  in  a 
wide  range  of  fruits,  vegetables  and  beverages  with  the  most  common  flavonol  in  the 
diet  being  quercetin. 
Quercetin  is  present  in  various  fruits  and  vegetables,  including  tea  and  red  wine  but  the 
highest  concentrations  are  found  in  onions  (Hertog  et  al.,  1992).  Quercetin  is  present  in 
plants  in  many  different  glycosidic  forms  (Kühnau  1976)  with  quercetin-3-rutinoside, 
also  called  quercetin-3-rhamnoglucoside  or  rutin,  being  one  of  the  most  widespread 
forms.  Other  flavonols  in  the  diet  include  kaempferol  (broccoli),  myricetin  (berries)  and 
isorhamnetin  (onion). Catherine  Tsang,  2004 
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Anthocyanidins,  an  extended  conjugation  made  up  of  the  aglycone  of  the  glycoside 
anthocyanins,  are  a  group  of  water-soluble  compounds  responsible  for  most  floral,  fruit 
and  leaf  pigmentation  in  nature  (Clifford,  2000a).  The  most  common  naturally 
occurring  anthocyanins  are  3-O-glycosides.  Structurally  anthocyanins  consist  of  an 
anthocyanidin  bound  to  one  or  more  sugar  moieties,  and  with  a  sugar  always  present  at 
the  C3  position  and  frequently  on  carbons  7,3'  and  5'.  They  can  also  form  conjugates 
with  hydroxycinnamates  and  organic  acids  such  as  malic  acid  and  acetic  acid. 
Anthocyanins  are  responsible  for  the  red,  blue  or  violet  colour  of  edible  fruits  including 
grapes,  plums  and  berries,  with  levels  increasing  during  fruit  maturation  (Peterson  & 
Dwyer,  1998).  The  most  common  anthocyanidins  include  pelargonidin,  cyanidin, 
delphinidin  and  malvidin  (Ktihnau,  1976). 
1.3.1.3  Flavan-3-ols 
Flavan-3-ols  range  from  the  simple  monomers  (+)-catechin  and  its  isomer  (-)- 
epicatechin,  to  the  oligomeric  and  polymeric  proanthocyanidins,  also  known  as 
condensed  tannins.  In  addition  to  forming  complexes  with  other  flavan-3-ols,  they  are 
hydroxylated  to  form  the  gallocatechins,  and  also  undergo  esterification  with  gallic  acid. 
Furthermore,  methylation,  prenylation  and  O-glycosylation  reactions  have  all  been 
reported  (Porter,  1992).  (+)-Catechin  and  (-)-epicatechin  are  found  in  various  fruits  and 
vegetables  such  as  apples,  pears,  grapes  and  peaches  (Arts  et  al.,  2000a),  with  the 
highest  concentrations  of  catechins  found  in  tea  and  red  wine  (Arts  et  al.,  2000b). 
1.3.1.4  Flavones 
Flavones  are  structurally  similar  to  the  flavonols,  however  they  lack  oxygenation  at 
position  C3.  A  variety  of  substitutions  is  possible  providing  a  wide  array  of  natural  and 
synthetic  compounds;  these  include  hydroxylation,  methylation,  0-  and  C-alkylation 
and  0  and  C-glycosylation.  Most  flavones  occur  as  7-0-glycosides  (Bohm,  1998). Catherine  Tsang,  2004  27 
Flavone  distribution  appears  to  be  limited  to  only  a  few  plant  families,  with  the  main 
flavones  in  the  diet  being  apigenin  and  luteolin.  They  have  been  identified  in  celery 
(apigenin),  sweet  red  pepper  (luteolin),  parsley  and  other  herbs  (Hertog  et  al.,  1992). 
1.3.1.5  Flavanones 
Flavanones  are  mainly  represented  by  taxifolin,  naringenin  and  hesperitin.  Flavanones 
are  characterized  by  the  absence  of  the  C2-C3  double  bond  and  the  presence  of  a  chiral 
center  at  C2.  The  flavanone  structure  is  highly  reactive  and  they  have  been  reported  to 
undergo  hydroxylation,  glycosylation  and  O-methylation  reactions.  The  main  dietary 
source  of  flavonones  is  citrus  fruit  and  the  most  commonly  consumed  is  hesperitin  from 
oranges  (Rousseff  et  al.,  1987).  Naringenin  is  found  in  tomatoes  and  tomato-based 
products.  Fresh  tomatoes,  especially  tomato  skin,  also  contain  naringenin  chalcone, 
which  is  converted  to  naringenin  during  processing  to  tomato  ketchup  (Krause  & 
Galensa,  1992). 
1.3.1.6  Isoflavanones 
Isoflavonoids  are  characterised  by  having  the  B  ring  attached  at  the  C3  of  the 
phenylchromane  structure.  Isoflavonoids  are  derived  from  the  biosynthetic  pathway  and 
can  be  converted  into  a  wide  range  of  different  isoflavonoids  including  isoflavones, 
isoflavanones  and  isoflavonols  (Harbone,  1993).  Isoflavones  are  mainly  represented  by 
daidzen  and  genistein.  The  main  dietary  source  is  soybeans  and  soy  products,  with  soy 
containing  -1  mg  of  genistein  and  daidzen  per  gram  of  dry  bean  and  much  lower 
concentrations  are  present  in  other  legumes  (Mazur,  1998;  Liggins  et  al.,  2000).  These 
compounds  have  received  much  attention  due  to  their  putative  role  in  the  prevention  of 
breast  cancer  and  osteoporosis  (Tapiero  et  al.,  2002). Catherine  Tsang,  2004 
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Flavonoid'  Food  source  Content  of  aglycone 
(mg/kg) 
Flavonol 
Quercetin-3,4'-glucoside 
Quercetin-3-rhamnoglucoside  (rutin) 
Quercetin-3  -galacto  side 
Myricetin 
Kaempferol 
Flavone 
Luteolin-7-apiosylglucoside 
Apigenin 
Flavanone 
Hesperitin-7-rhamnoglucoside  (hesperidin) 
Naringenin-7-rhamnoglucoside  (naringin) 
onion 
black  tea 
blackcurrant 
apple 
green  beans 
kale 
sweet  red  pepper 
celery 
orange 
grapefruit 
280-4901 
10-252 
443 
21-721 
301 
210-4701 
15-391 
15-601 
116-2014 
68-3024 
Flavan-3-ols 
(+)-catechin 
(-)-epicatechin 
procyanidins 
Anthocyanins 
Cyanidin-3  -glucoside 
Cyanidin-3  -rutinoside 
Delphinidin-3-glucoside 
Delphinidin-3  -rutino  side 
Isoflavanones 
apple;  red  wine 
apple;  red  wine 
chocolate;  red  wine 
blackcurrant 
4-165;  16-536 
67-1035;  9-426 
165;  229 
7607 
5907 
Genistein-7-glycoside  soy  beans  4808 
Daidzein-7-glycoside  3308 
Adapted  from:  '  Hollman  &  Arts  (2000);  `  Hertog  et  al.  (1993);  '  Häkkinnen  et  al. 
(1999);  4  Mouley  et  al.  (1994);  5  Arts  et  al.  (2000a);  6  Arts  et  al.  (2000b);  7  Nyman  & 
Kumpalainen  (2001);  8  Mazur  et  al.  (1998);  9  Hammerstone  et  al.  (2000). Catherine  Tsang,  2004  29 
1.3.2  Non-flavonoids 
The  main  non-flavonoids  found  in  the  diet  are  the  C6-Ci  hydroxybenzoates,  C6-C3 
hydroxycinnamates  and  polyphenolic  C6-C2-C6  stilbenes.  Phenolic  acids  exist  primarily 
as  conjugates  and  are  rarely  found  in  their  acidic  forms,  often  found  bound  to  alcohols, 
sugars,  polysaccharides,  or  organic  acids  through  ester  bonds. 
1.3.2.1  Hydroxybenzoates 
Hydroxybenzoates  also  referred  to  as  phenolic  acids  include  benzoic  acid  and 
derivatives  including  salicyclic  acid.  Gallic  acid  is  the  major  hydroxybenzoate  and  is 
synthesised  from  phenylalanine  via  3-dehydroshikimic  acid.  It  is  converted  to  ellagic 
acid  and  a  range  of  gallotannins,  with  the  formation  of  hydrolysable  tannins  (polymers 
of  gallic  and  ellagic  acids).  Black  tea  and  red  wine  provide  rich  dietary  sources  of  gallic 
acid  (Dunfresne  &  Fransworth,  2001;  Soleas  et  al.  1997). 
1.3.2.2  Hydroxycinnamates 
Hydroxycinnamic  acids:  p-coumaric,  ferulic,  sinapic,  caffeic  acids  and  their  derivatives 
are  the  most  important  subclass  of  phenolic  acids.  Cinnamic  acid  is  produced  by  the 
deamination  of  the  amino  acid  phenylalanine  by  ammonia  lyase  (PAL),  with  p- 
Coumaric  acid  being  produced  by  hydroxylation  of  cinnamic  acid.  In  addition  to  being 
found  in  their  free  form  hydroxycinnamates  are  also  found  esterified  to  sugars,  organic 
acids  and  choline  (Strack,  1997).  Caffeic  acid  occurs  in  foods  mainly  as  an  ester  with 
quinic  acid  or  chlorogenic  acid  (5-caffeoylquinic  acid).  Coffee  is  a  major  dietary  source 
of  chlorogenic  acid  in  the  diet  with  dietary  intakes  estimated  at  0.5-1  g/day  (Clifford, 
2000b). 
1.3.2.3  Stilbenes 
The  stilbene  family  has  a  C6-C2-C6  structure  and  are  known  to  be  phytoalexins,  a  class 
of  antibiotic  compounds  produced  as  a  part  of  a  plant's  defense  system  against  disease. 
Trans-resveratrol  (trans-3,5,4'-trihydroxystilbene)  is  synthesised  by  condensation  of  4- Catherine  Tsang,  2004  30 
coumaroyl  CoA  with  three  units  of  malonyl  CoA,  each  of  which  donates  two  carbon 
atoms,  in  a  reaction  catalysed  by  stilbene  synthase.  Resveratrol  exists  as  two  isomers; 
cis  and  trans  with  trans-resveratrol-3-O-glucoside  commonly  found  in  various  families 
of  plant  tissues  such  as  eucalyptus,  spruce,  and  lily.  Grapes,  peanuts  and  their  products 
are  considered  the  most  important  dietary  sources  of  the  resveratrol,  with  levels  of  0.02- 
1.79  gg/g  and  0.6-8  gg/mL  reported  in  peanuts  and  red  wine  (Sanders  et  al.,  2000). 
1.4  Dietary  Sources  &  Levels  of  Intake 
Dietary  intake  values  for  phenolic  and  polyphenolic  compounds  is  limited  and 
often  difficult  to  interpret  largely  due  to  the  limited  food  composition  data  available. 
There  are  also  large  differences  in  the  phenolic  content  of  foods  depending  on  variety, 
storage  conditions,  methods  of  preparation  and  degree  of  ripeness  (Crozier  et  al.,  1997). 
Differences  in  dietary  habits  and  food  preferences  further  complicate  dietary  intake 
estimations  for  example  it  is  estimated  that  phenolic  acids  account  for  approximately 
one  third  of  total  phenol  intake  and  flavonoids  account  for  two  thirds.  Coffee  is  a  major 
dietary  source  of  chlorogenic  acid  and  intakes  have  been  estimated  to  be  around  0.5-1 
g/day  (Clifford,  2000b),  therefore  heavy  coffee  drinkers  will  likely  consume  more 
phenolic  acids  than  flavonoids.  Conversely,  tea  drinkers  may  have  a  much  greater  intake 
of  flavonoids  since  the  average  flavonoid  intake  from  tea  alone  in  the  UK  has  been 
estimated  to  be  430  mg/d.  This  is  based  on  a  population  average  consumption  of  3.3 
cups  of  tea  per  day  (Wiseman  et  al.,  2001).  In  Japan,  isoflavone  intake  is  estimated  to  be 
around  30-40  mg/day  (Kimira  et  al.,  1998),  considerably  higher  than  those  in  western 
populations  (Kirk  et  al.,  1999).  The  bioavailability  of  certain  flavonoids  differs  greatly 
depending  on  the  food  source.  Hollman  et  al.  (1997)  reported  that  the  absorption  of 
quercetin  from  onions  is  four-fold  greater  than  from  apples  or  tea.  The  limited  food 
composition  data  available  to  date  do  not  take  these  factors  into  account  and  therefore 
their  use  may  introduce  significant  measurement  error  in  dietary  studies.  However,  there 
is  now  an  increasing  number  of  comprehensive  databases  providing  information  on  the 
flavonoid  content  for  a  wide  range  of  foods/beverages  in  a  range  of  populations 
including  the  USA  (www.  nal.  usda.  gov/fnic/foodcomp)  and  The  Netherlands  (Hollman 
&  Arts,  2000). Catherine  Tsang,  2004 
1.4.1  Flavonols  and  Flavones 
31 
Kuhrau,  (1976)  estimated  total  flavonoid  intake  at  over  1000  mg  per  day  (expressed  as 
glycosides)  in  the  USA,  consisting  mainly  of  the  flavonols,  flavanones  and  flavones. 
However,  the  analytical  methods  used  at  the  time  were  not  standardised  or  specific  and 
the  validity  of  the  data  remains  questionable.  HPLC  methods  were  developed  and 
validated  for  the  analysis  of  three  major  flavonols  (quercetin,  myricetin  and 
kaempferol),  and  two  flavones  (apigenin  and  luteolin)  in  commonly  consumed  fruits, 
vegetables  and  beverages  in  The  Netherlands  (Hertog  et  al.,  1992).  The  findings  from 
this  study  were  used  to  calculate  the  intake  of  flavonols  and  flavones  in  over  4000  free- 
living  adults  in  the  Dutch  National  Food  Consumption  Survey.  The  average  intake  of 
flavonols  and  flavones  was  estimated  to  be  23  mg/day,  with  quercetin  contributing  16 
%;  kaempferol,  3.9  mg/day;  myricetin,  1.4  mg/day  and  flavones  contributing  only  7% 
(Hertog  et  al.,  1993).  In  this  population  tea  provided  the  major  dietary  source  of 
flavonol  intake  (48  %),  followed  by  onions  (29  %)  and  apples  (7  %). 
Consistent  results  have  been  reported  in  the  USA  with  overall  intake  of  flavonoids 
estimated  at  20  mg/day  (Rimm  et  al.,  1996a),  and  in  the  UK  total  intake  of  flavonoids 
(quercetin,  kaempferol,  apigenin  and  luteolin)  was  estimated  to  be  30  mg/day,  with 
quercetin  contributing  64  %  of  the  total  intake  (Wearne,  2000).  In  the  Seven  Countries 
Study  Hertog  et  al.  (1995)  calculated  flavonol  intakes  and  reported  that  tea  was  the 
predominant  source  of  quercetin  in  The  Netherlands  and  Japan,  and  wine  was  the  major 
source  in  Italy.  Onions  and  apples  contributed  most  in  the  US,  Finland,  Greece  and 
former  Yugoslavia.  Similar  findings  have  been  reported  by  Sampson  et  al.  (2002), 
whereby  onions,  tea  and  apples  provided  the  major  dietary  sources  of  flavonoid  intake 
in  the  USA.  It  is  important  to  note  that  the  reported  dietary  flavonoid  intakes  and  food 
sources  are  largely  based  on  the  content  of  three  flavonols  (quercetin,  myricetin  and 
kaempferol)  and  two  flavones  (apigenin  and  luteolin)  therefore  total  flavonoid  intakes 
and  content  of  foods  can  be  assumed  to  be  greater  than  those  reported  (Table  1.4). Catherine  Tsang,  2004  32 
1.4.2  Flavan-3-ols 
Information  on  the  dietary  intakes  of  total  flavan-3-ols  has  been  reported  in  a  national 
survey  of  6200  Dutch  males  and  females  aged  1-97  years  (Arts  et  al.,  2000a).  Average 
intake  was  estimated  to  be  50  mg/day  with  tea  providing  a  major  dietary  source  in  all 
age  groups,  followed  by  chocolate,  apples  and  pears.  Similar  estimates  have  been 
reported  in  a  previous  study  with  levels  of  intake  at  20-50  mg/day  (Dragsted  et  al., 
1997).  However,  data  on  the  dietary  sources  and  levels  of  intakes  of  individual  flavan-3- 
ols  is  less  well  documented.  De  Pascual-Teresa  et  al.  (2000a)  quantified  individual 
flavan-3-ols  in  a  range  of  foods  and  beverages,  with  chocolate,  tea  and  red  wine 
providing  the  major  dietary  sources.  (-)-Epicatechin,  (+)-catechin  and  procyanidin  B2 
were  the  most  abundant  flavan-3-ols  identified  in  these  foods.  Similar  findings  were 
documented  by  Carando  and  Teissedre,  (1999)  whereby  catechins  (as  the  sum  of 
monomers,  procyanidin  dimers  and  trimers)  were  the  most  abundant  in  red  wine  (56 
mg/100  mL)  and  green  tea  (42  mg/100  mL).  Ruidavets  et  al.  (2000)  created  a  catechin 
food  composition  table  giving  information  on  the  total  catechin  average  supplied  by  100 
g  of  food.  Green  tea  (169  mg);  strawberries  (56  mg);  red  wine  (25  mg)  and  apricots  (20 
mg)  provided  the  richest  food  sources.  The  proanthocyanidin  content  of  grape,  apple, 
hawthorn,  elderberry,  chokeberry,  sour  cherry  and  blackcurrant  has  been  reported  to  be 
between  0.3  and  0.9  g/kg  (Wilska-Jeszka,  1996). 
1.5.3  Anthocyanins 
Anthocyanins  are  present  in  red  fruits  and  berries  as  well  as  red  wines  and  the  intake  of 
anthocyanins  may  exceed  200  mg/day  (Kuhnau,  1979).  The  content  in  fruits  varies 
considerably  between  0.25  to  700  mg/100  g  fresh  weight,  with  some  berries  containing 
in  excess  of  100  mg  per  100  g  (McGhie  et  al.,  2003).  Blackcurrants  contain  delphinidin 
conjugates  (1150-2500  mg/kg),  raspberries  and  redcurrants  contain  cyanidin  conjugates 
(100-600  mg/kg  and  177  mg/kg  respectively)  and  pelargonidin  conjugates  are  found  in 
strawberries  (150-350  mg/kg)  (Clifford,  2000a;  Maatta  et  al.,  2001).  Levels  in  red  wines 
have  been  reported  to  be  around  12  mg/  100  mL  (Timberlake,  1998). Catherine  Tsang,  2004  33 
Table  1.4  Reported  dietary  sources  and  intakes  of  flavonols  and  flavones 
Country  Dietary  intake  (mg/d)  Main  dietary  sources 
Denmark  26  tea,  onions,  apples 
Finland  0-41  fruit,  vegetables,  apples,  onions 
Greece  15  fruits  and  vegetables 
Italy  23-35  red  wine,  fruits  and  vegetables,  soups 
Japan  17-68;  green  tea 
The  Netherlands  23-33  tea,  onions,  apples 
United  States  20  onions,  black  tea 
Adapted  from  Aherne  &  O'Brien,  (2002). 
1.5  Epidemiology  and  Flavonoids 
1.5.1  Flavonoids  and  Cardiovascular  disease 
Several  epidemiological  studies  have  investigated  the  association  between 
flavonoid  intake  and  CHD.  Flavonoid  consumption  has  been  linked  to  a  lower  risk  of 
heart  disease  in  some,  but  not  all,  studies.  In  the  Zutphen  Elderly  Study  (Hertog  et  al., 
1993)  the  flavonoid  (flavonol  and  flavone)  intake  of  805  Dutch  men  aged  65-84  years 
was  assessed  and  a  significant  inverse  association  between  dietary  flavonoid  intake  and 
mortality  from  CHD  was  reported.  An  inverse  but  weaker  association  with  the  incidence 
of  myocardial  infarction  was  further  reported.  Those  in  the  highest  tertile  of  flavonoid 
intake  had  a  risk  of  heart  disease  that  was  about  58  %  lower  than  that  of  counterparts  in 
the  lowest  tertile  of  intake.  Those  in  the  lowest  tertile  consumed  19  mg  or  less  of 
flavonoids  per  day,  whereas  those  in  the  highest  tertile  consumed  approximately  30  mg 
per  day  or  more.  The  10-year  follow  up  of  the  Zutphen  Elderly  Study  reported  a  clear- 
dose  response  relationship  between  flavonol  intake  and  CHD  mortality  (Hertog  et  al., 
1997).  In  a  prospective  study  of  34,492  postmenopausal  women  in  Iowa  total  flavonoid 
intake  was  associated  with  a  decreased  risk  (RR=0.62)  in  the  group  with  the  highest 
flavonoid  intake  (Yochum  et  al.,  1999).  Mortality  from  CHD  was  weakly  associated 
with  flavonol  and  flavone  intake  in  a  Finnish  population  with  those  in  the  highest 
quartile  of  flavonoid  intake  having  a  risk  of  mortality  that  was  about  27  %  (for  women) 
and  33  %  (for  men)  lower  than  that  of  those  in  the  lowest  quartile  (Knekt  et  al.,  1996). 
In  a  recent  study  Knekt  et  al.  (2002)  examined  the  flavonoid  intake  of  10  054  men  and Catherine  Tsang,  2004  34 
women  and  found  that  a  high  dietary  intake  of  quercetin  was  associated  with  a  reduced 
mortality  from  ischaemic  heart  disease.  In  contrast  the  protective  effect  of  flavonoids 
could  not  be  confirmed  in  other  studies.  For  Welsh  men,  flavonol  intake  did  not  predict 
a  lower  rate  of  ischemic  heart  disease;  on  the  contrary  disease  outcome  was  higher  in  all 
quartiles  of  high  flavonol  intake  (Hertog  et  al.,  1997).  For  U.  S.  male  health 
professionals,  data  did  not  support  a  strong  link  between  flavonol  and  flavone  intake 
and  mortality  was  found  only  in  men  with  a  previous  history  of  CHD  (nimm  et  al., 
1996a).  In  a  recent  prospective  study  Sesso  et  al.  (2003)  reported  that  flavonoid  intake 
was  not  strongly  associated  with  a  reduced  risk  of  CVD,  and  there  was  no  evidence  of 
any  effect  from  individual  flavonols  or  flavones.  Similarly,  there  was  no  evidence  for  a 
protective  effect  from  any  food  source  although  there  was  an  inverse  but  non-significant 
association  with  broccoli,  tea  and  apple  consumption.  A  recent  study  by  Arts  et  al. 
(2001)  investigated  the  association  of  (+)-catechin  intake  and  incidence  of  and  mortality 
from  ischemic  heart  disease  and  stroke  using  data  from  The  Zutphen  Elderly  Study. 
While  the  authors  concluded  that  catechin  intake,  mainly  from  tea,  apples  and 
chocolate,  reduced  the  incidence  of  heart  disease  there  was  no  association  between 
catechin  intake  and  stroke. 
1.5.2  Flavonoids  and  cancer 
Observational  evidence  for  a  protective  effect  of  flavonoids  against  cancer  remains 
contradictory.  Analysis  of  the  data  from  the  Seven  Countries  Study  failed  to  detect  an 
association  between  intake  of  flavonoids  (flavonols  and  flavones)  and  mortality  from 
total  cancer,  lung  cancer,  stomach  cancer  and  colon  cancer  (Hertog  et  al.  1995)  or  with 
the  incidence  of  all-case  cancer  in  the  Zutphen  Elderly  Study  (Hertog  et  al.  1994). 
Consistent  findings  were  reported  in  a  large  cohort  study  of  120  850  Dutch  men  and 
women  between  intake  of  flavonols  and  flavones  with  stomach,  lung  or  colon  cancer 
(Goldbohm  et  al.  1995).  Conversely,  in  a  cohort  study  of  nearly  10  000  Finnish  men  and 
women  an  inverse  relationship  was  observed  between  dietary  flavonol  intake  and  the 
development  of  all-case  cancer,  particularly  against  lung  cancer  (Knekt  el  al.,  1997). 
Similar  findings  were  reported  in  a  case-control  study  by  Garcia-Closas  et  al.  (1998), 
whereby  the  flavonols  quercetin  and  kaempferol  were  found  to  be  the  most  protective 
against  the  incidence  of  gastric  cancer.  In  a  recent  case-control  study  Peterson  et  al. Catherine  Tsang,  2004  35 
(2003)  reported  an  inverse  relationship  between  consumption  of  vegetables  and 
incidence  of  breast  cancer.  Moreover,  they  reported  a  highly  significant  inverse 
association  of  flavone  intake  with  breast  cancer,  whereas  this  association  became  non 
significant  with  flavanones,  flavan-3-ols,  flavonols,  anthocyanidins  or  isoflavones. 
1.6  Grape  and  wine  phenolics 
Red  wine  is  a  product  of  the  natural  fermentation  of  grape  juice/must  and  is 
produced  from  a  variety  of  different  grape  cultivars  including  Cabernet  Sauvignon, 
Merlot,  Pinot  Noir,  Rondinella,  Sangiovese,  Grenache,  Tempranillo  and  Carignan.  The 
commercial  production  of  wine  is  a  long  and  rigorous  process  leading  from  the  initial 
crushing  or  pressing  of  the  grape  to  the  final  bottling  of  the  finished  wine.  The  methods 
used  for  red  wine  vinification  are  highly  variable  depending  on  the  country,  region, 
winery,  winemaker  and  vintage.  Generally,  once  the  grapes  are  harvested  they  are  de- 
stemmed  and  pressed  and  the  juices  (must)  together  with  the  crushed  grapes  are 
fermented  for  -  5-10  days  at  25  °C.  Phenolics  contained  within  the  skins,  seeds  and 
flesh  of  black  grapes  are  extracted  during  the  process  of  vinification  and  with  prolonged 
extraction  the  fermented  must  can  contain  up  to  40  %  of  the  phenolics  originally  present 
in  the  grape.  Once  alcoholic  fermentation  is  complete  the  solids  are  removed  and  the 
young  wine  is  subjected  to  malolactic  fermentation.  This  secondary  fermentation 
process  is  responsible  for  the  conversion  of  the  strong  malic  acid  found  in  wine  to  the 
weaker  lactic  acid.  This  softens  the  acidity  of  the  wine  and  adds  to  its  complexity  and 
stability.  The  wine  is  then  matured  in  stainless  steel  vats  or  in  the  case  of  higher  quality 
wines  in  oak  barrels  for  varying  periods  of  time  prior  to  filtration  and  bottling  (Soleas  et 
al.,  1997). 
The  production  of  white  wine  is  slightly  different  from  the  processes  used  during  the 
making  of  red  wine.  White  wine  is  produced  from  both  black  and  white  grape  varieties 
and  is  subject  to  limited  maceration  and  slight  juice  oxidation  prior  to  fermentation. 
Solids  are  removed  and  the  clarified  juice  is  fermented  for  5  days  at  16  °C.  The  resultant 
must  which  is  low  in  phenolics,  due  to  the  gentle  maceration  of  the  grapes  and  the  early 
removal  of  the  seeds  and  skin,  then  undergo  malolactic  fermentation  prior  to  maturation, Catherine  Tsang,  2004  36 
filtration  and  bottling.  Red  wines  therefore  contain  large  amounts  of  phenolic 
compounds  derived  from  the  skin,  seeds  and  flesh  of  black  grapes.  Phenolics  are  of 
particular  importance  to  the  characteristics  and  the  quality  of  red  wine,  influencing  the 
appearance,  taste,  aroma,  mouth-feel  and  anti-microbial  properties  (Soleas  et  al.,  1997). 
1.6.1  Phenolic  composition  of  red  wine 
Red  wine  is  a  rich  and  concentrated  source  of  phenolic  compounds  containing  grape, 
yeast  and  even  oak  derived  products  (German  and  Walzem,  2000).  However,  the  major 
compounds  are  grape  derived;  from  the  seeds,  flesh  and  skins  of  black  grapes 
(Singleton,  1982).  Wines  are  extremely  heterogenous  in  terms  of  their  colour,  flavour, 
appearance,  taste  and  composition  as  a  consequence  of  the  differences  in  viticulture  and 
vinification  methods  (Table  1.5).  Vineyard  factors  such  as  grape  variety,  quality,  and 
level  of  maturity,  climate,  geographical  origin  and  disease  pressure  affect  the  phenolic 
compounds  which  accumulate  in  the  grape.  During  vinification  the  length  of  skin 
contact,  temperature  and  presence  of  seeds,  vine  stems  and  enzymes  have  all  been 
reported  to  influence  the  extraction  of  phenolics  into  the  fermenting  juice  (McDonald  et 
al.,  1998;  Price  et  al.,  1995;  Kovac  et  al.,  1992).  The  most  common  phenolics  present  in 
significant  quantities  include  free  and  conjugated  flavonols,  hydroxycinnamates,  gallic 
acid,  ellagitannins,  stilbenes,  flavan-3-ols,  free  and  polymeric  anthocyanins  (Fig.  1.4). Catherine  Tsang,  2004  37 
Table  1.5  Range  of  concentrations  of  phenolics  in  red  wines 
Phenolics  Range  (mg/L) 
Total  flavonols  5-55 
Total  stilbenes  1-18 
Gallic  acid  8-71 
Total  hydroxycinnamates  66-124 
(+)-Catechin  and  (-)-epicatechin  8-60 
Free  and  polymeric  anthocyanins  41-150 
Total  phenolics  824-4059 
Adapted  by  Burns  et  al.  (2000). Catherine  Tsang,  2004 
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Figure  1.4  Structure  of  the  major  phenolics  present  in  red  wine Catherine  Tsang,  2004 
1.6.1.1  Flavonols 
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The  major  flavonols  detected  in  grapes  and  wine  are  quercetin  and  myricetin,  and  to  a 
lesser  extent  kaempferol  and  isorhamnetin.  In  black  grapes  flavonols  are  exclusively 
found  in  the  skin  predominantly  as  sugar  conjugates  which  aids  their  solubility, 
transport  and  storage  within  the  tissue.  In  contrast  to  grapes,  up  to  50  %  of  the  flavonols 
in  red  wine  can  be  found  in  the  free  form  as  a  consequence  of  vinification  which  acts  to 
liberate  the  aglycone.  In  grapes  and  wine  they  occur  as  0-  glucosides  and  glucuonides, 
typically  bound  to  glucose  or  rhamnose  (McDonald  et  al.,  1998). 
1.6.1.2  Flavan-3-ols 
(+)-Catechin  and  (-)-epicatechin  are  located  in  the  seeds  of  grapes,  and  to  a  lesser 
degree  in  the  skins  of  black  grapes.  Lower  levels  of  epigallocatechin  (ECG),  epicatechin 
gallate  (ECG)  and  epigallocatechin  gallate  (EGCG)  are  found  in  grapes,  which  decrease 
further  during  ripening  and  wine  maturation  (Singleton,  1982).  Polymerization  of  (+)- 
catechin  and  (-)-epicatechin  and  their  gallate  esters  produce  oligomers  and  polymers 
called  proanthocyanidins  (often  referred  to  as  procyanidins  or  condensed  tannins),  high 
molecular  weight  polymers  of  flavan-3-ol  units  linked  by  C-C  bonds. 
Until  recently  the  complete  characterisation  of  procyanidins  in  grapes  and  wine  was 
impossible  due  to  the  difficulty  in  analysing  high  molecular  weight  compounds  and  the 
lack  of  commercially  available  standards.  Grape  seed  contains  high  amounts  of 
procyanidins.  Dimeric  procyanidins  are  the  simplest  and  most  common  in  grapes,  and 
they  have  4-8  linked  monomers.  B  1,  B2,  B3  and  B4  are  the  most  common  procyanidin 
dimers.  These  are  followed  by  the  less  common  4-6  linked  isomers  such  as  B5,  B6,  B7 
and  B8  (Sun  et  al.,  1998).  Young  red  wines  contain  (+)-catechin,  (-)-epicatechin  and 
oligomeric  procyanidins  composed  mainly  of  soluble  dimers,  trimers  and  tetramers. 
However,  during  wine  maturation  the  levels  of  these  compounds  decrease  and  there  is  a 
concomitant  increase  in  higher  oligomers  which  are  less  soluble  (Haslam,  1998). Catherine  Tsang,  2004 
1.6.1.3  Anthocyanins 
40 
Anthocyanins  are  responsible  for  the  red-purple  tones  of  grapes  and  their  corresponding 
wines.  They  are  not  found  in  white  wine  due  to  a  synthetic  blockage  in  the  shikimate 
pathway  and  also  due  to  the  removal  of  the  skins  during  the  process  of  white  wine 
making  (Soleas  et  al.,  1997).  They  are  found  exclusively  in  the  skins  of  black  grapes 
and  are  efficiently  extracted  into  the  wine  during  maceration.  The  term  anthocyanidin 
refers  to  the  aglycone  structures  such  as  malvidin.  Anthocyanins  may  be  acylated  on  the 
sugar  moiety  with  aromatic  and  aliphatic  acids.  The  3-O-glucosides  of  malvidin, 
peonidin,  petunidin,  petunidin  and  delphinidin  are  the  most  abundant  anthocyanins  in  V. 
Vinifera  and  red  wines  (Bums  et  al.,  2000;  Baldi  et  al.,  1995).  During  storage  and 
ageing  of  red  wine  anthocyanins  react  with  procyanidins  to  produce  complex  pigments 
which  may  precipitate.  This  is  evident  by  the  colour  change  in  a  wine  from  the  original 
sharp  bright  blue-red  tone  to  red-orange  giving  the  wine  a  deeper  hue. 
1.6.1.4  Non-flavonoids 
The  primary  non-flavonoids  in  wines  are  derivatives  of  hydroxycinnamic  and 
hydroxybenzoic  acids,  especially  gallic  acid  and  its  ellagic  acid  dimer  and  stilbenes 
(Soleas  et  al.,  1997).  They  are  structurally  simpler  and  are  stored  primarily  in  cell 
vacuoles  of  grape  cells  and  are  easily  extracted  on  crushing.  Gallic  acid  is  present  in  the 
flesh  of  black  and  white  grapes  and  their  respective  wines;  however  they  found  in  much 
higher  levels  in  red  wines  and  may  be  5-10-fold  higher  (Frankel  et  al.,  1995). 
Substantial  amounts  of  caffeic  acid  are  converted  to  caftaric  acid  and  lower  levels  of 
coutaric  acid,  fertaric  acid  also  accumulate  in  the  skin  and  flesh  of  black  and  white 
grapes.  In  wine  the  stilbene,  trans-resveratrol  (3,5,4  -trihydroxystilbene)  is  found  in  the 
free  form  and  also  as  the  conjugate  trans-resveratrol-3-0-ß-glucoside  (also  known  as 
polydatin  or  piceid).  Piceid  is  known  to  play  a  role  in  disease  resistance  acting  as  a 
phytoalexin  in  grapes  where  is  accumulates  in  the  skin  in  response  to  fungal  infection. 
The  presence  of  the  cis  isomer  of  both  free  and  conjugated  resveratrol  has  also  been 
reported  in  red  wine.  However,  the  levels  of  trans-resveratrol  in  red  wine  are  found  in 
much  lower  concentrations  compared  with  other  phenolics  (Soleas  et  al.,  1997). Catherine  Tsang,  2004 
1.7  Wine  and  CHD 
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Since  ancient  times  wine  has  closely  been  associated  with  diet  particularly  in 
Mediterranean  countries,  and  is  thought  to  contribute  to  the  good  health  of  the 
Mediterranean  population  (Willett,  1994).  The  association  between  a  moderate  and 
regular  consumption  of  red  wine  in  the  protection  against  CHD  has  been  well  publicised 
(Puddley  &  Croft,  1999)  an  association  popularised  as  the  "French  paradox'  (Renaud 
and  de  Logeril,  1992).  The  paradox  describes  the  seemingly  low  mortality  rates  in 
certain  populations  of  France  despite  high  levels  of  associated  risk  factors;  serum 
cholesterol,  systolic  blood  pressure,  dietary  saturated  fat  intakes  and  prevalent  smoking 
rates.  Red  wines  do  not  contain  significant  amounts  of  vitamins  or  selenium  however 
provides  an  especially  abundant  and  palatable  source  of  polyphenols  and  one 
explanation  for  this  anomaly  is  that  the  Mediterranean  diet  typically  found  in  France, 
along  with  the  regular  consumption  of  red  wine  offered  a  form  of  protection. 
1.7.1  The  French  paradox 
A  high  dietary  intake  of  saturated  fat  is  a  well  known  risk  factor  for  CHD  (St.  Leger  et 
al.,  1979).  In  most  countries  the  level  of  dietary  saturated  fat  is  positively  associated 
with  mortality  from  CHD,  however  in  some  regions  of  France  this  relationship  is  less 
obvious  (Renaud  and  de  logeril,  1992).  Evidence  from  the  Monica  program,  one  of  the 
world's  largest  CHD  surveillance  systems,  confirmed  that  death  rates  from  CHD  were 
much  lower  in  France,  particularly  in  Toulouse,  than  in  any  other  industrialised  country 
(WHO,  1989).  In  fact  the  incidence  of  CHD  in  France  was  found  to  be  the  lowest  in  a 
study  of  several  countries,  second  to  Japan  where  the  intake  of  dietary  saturated  fat  is 
exceptionally  low  (Criqui  and  Ringel,  1994).  This  finding  is  paradoxical  since  saturated 
fat  intake  in  France  represents  14-15  %  of  energy  intake,  higher  than  the  recommended 
10  %  of  total  energy.  St.  Leger  et  al.  (1979)  observed  that  among  all  countries  France 
had  the  highest  per  capita  intake  of  wine  and  the  lowest  rate  of  heart  disease.  This 
observation  was  further  supported  by  data  from  the  US  that  showed  a  negative 
correlation  between  death  from  acute  myocardial  infarction  and  wine  consumption 
across  all  states  (Werth,  1980).  In  a  prospective  study  in  men  from  Eastern  France 
Renaud  et  al.  (1998)  observed  that  a  moderate  intake  of  alcohol,  mostly  in  the  form  of Catherine  Tsang,  2004  42 
wine,  was  negatively  associated  with  CHD  mortality  in  those  consuming  two  or  more 
glasses  of  wine  per  day.  Similarly,  in  a  large-scale  Danish  prospective  study  intake  of 
beer  or  spirits  was  not  associated  with  a  reduction  in  the  risk  of  mortality  from  CHD, 
but  rather  a  moderate  consumption  of  red  wine  was  most  beneficial  (Groenbaek  et  al., 
1995).  It  is  well  established  that  a  moderate  consumption  of  alcohol  (-10-30  g/day)  is 
associated  with  a  reduced  risk  of  CHD  and  overall  total  mortality  (Rimm  et  al.,  1991; 
Klatsky  et  al.,  1992).  Many  studies  have  observed  a  U-  or  J-shaped  correlation  between 
alcohol  consumption  and  risk  of  death  from  all  cause  mortality,  with  those  consuming  a 
moderate  intake  (1-2  drinks  per  day)  having  a  lower  incidence  than  abstainers  and 
heavy  drinkers  (Marmont  et  al.,  1981;  Doll  et  al.,  1994).  The  protective  effect  of 
alcohol  has  been  shown  to  be  independent  of  sex,  age,  ethnicity,  smoking  habits  and 
physical  activity  (Kittner  et  al.,  1983).  However,  red  wine  is  thought  to  provide 
additional  health  benefits  beyond  those  of  alchol  alone  (Rosenberg  et  al.,  1981;  Rimm 
et  al.,  1996b).  Polyphenols  in  red  wine  act  as  antioxidants  and  can  reduce  the  free- 
radical  mediated  oxidation  of  LDL  and  the  resulting  atherogenicity  (Furham  et  al., 
1995;  Teissedre  et  al.,  1996;  Nigidkar  et  al.,  1998),  inhibit  platelet  aggregation  (Pace- 
Asiak  et  al.,  1995)  and  endothelium-dependent  relaxation  of  blood  vessels,  mediated  by 
the  NO-cGMP  pathway  (Fitzpatrick  et  al.,  1993). 
1.7.2  Red  wine  and  HDL  cholesterol 
The  cardio-protective  effects  of  alcohol  have  largely  been  attributed  to  its  ability  to  raise 
the  concentration  of  HDL  cholesterol,  a  well  defined  negative  risk  factor  for  CHD 
(Gaziano  et  al.,  1999).  This  lipoprotein  is  central  to  the  removal  of  excess  cholesterol 
from  the  peripheral  cells  to  the  liver  for  excretion  via  reverse  cholesterol  transport. 
Although  there  is  conflicting  evidence  some  studies  have  reported  that  red  wine  can 
increase  the  concentration  of  HDL  cholesterol  and  apolipoprotein  Al,  an  important  anti- 
atherogenic  factor.  Lavy  et  al.  (1994)  reported  a  significant  increase  in  plasma  HDL 
cholesterol  concentrations  following  the  consumption  of  400  mL  of  red  wine  in  human 
subjects.  These  effects  were  not  observed  following  the  consumption  of  white  wine.  In  a 
recent  clinical  trial  the  effects  of  red  wine  and  alcohol  alone  were  assessed  for  their 
ability  to  increase  HDL  cholesterol  concentrations.  Serum  HDL  cholesterol  significantly Catherine  Tsang,  2004  43 
increased  following  alcohol  and  red  wine  intake,  as  well  as  raising  apolipoprotein  Al 
concentrations  (Estruch,  2000). 
To  determine  the  possible  beneficial  effects  of  alcohol  and  non-alcoholic  components  of 
red  wine  Senault  et  al.  (2000)  compared  the  effect  of  red  wine,  de-alcoholised  red  wine 
and  alcohol  consumption  on  HDL  cholesterol  concentrations  in  humans.  De-alcoholised 
red  wine  had  no  effect  while  red  wine  increased  the  serum  levels  of  HDL  cholesterol 
and  apolipoprotein  Al.  Alcohol  also  increased  apolipoprotein  Al,  however  total 
cholesterol  and  triacylglyercides,  which  are  known  to  be  atherogenic,  were  also  raised 
with  alcohol  alone.  The  authors  concluded  that  the  increase  in  HDL  cholesterol  with  red 
wine  consumption  may  have  been  due  to  the  antioxidant  properties  which  may  protect 
lipoproteins  against  the  pro-oxidant  effects  of  alcohol. 
1.7.3  Red  wine  and  Platelet  aggregation 
Platelets  contribute  to  the  development  of  CHD  through  a  number  of  mechanisms 
including  alterations  in  platelet  function,  coagulation  and  fibrinolysis,  resulting  in 
atherosclerotic  plaques  or  plugs  which  ultimately  result  in  thrombus  formation  and 
vessel  occlusion.  An  inhibitory  effect  of  alcohol  on  platelet  aggregation  was  first 
reported  by  Haut  et  al.  (1974),  and  since  then  a  number  of  in  vivo  and  in  vitro  studies 
have  shown  an  inverse  association  between  platelet  aggregation  and  alcohol 
consumption. 
Hendriks  et  al.  (1994)  investigated  the  effect  of  moderate  alcohol  consumption  on  the 
fibrinolytic  factors  involved  in  clot  formation.  An  increase  in  the  level  of  tissue 
plasminogen  activator  (tPA),  a  clot  dissolving  enzyme,  was  observed.  Other  studies 
have  shown  that  alcohol  consumption  inhibits  thromboxane  A2  production;  a  factor 
formed  in  platelets  via  the  cyclo-oxygenase  (COX)  pathway  and  is  a  powerful  pro- 
aggregatory  agent  favouring  platelet  aggregation  (Seignuer  et  al.,  1990;  Pace  Asciak  et 
al.,  1996). 
A  number  of  animal  studies  have  demonstrated  the  ability  of  grape  and  red  wine  derived 
phenolic  compounds  to  inhibit  platelet  aggregation  (Osman  et  al.,  1998).  Demrow  et  al. 
(1995)  investigated  the  effect  of  red  wine,  white  wine  and  grape  juice  on  platelet Catherine  Tsang,  2004  44 
activity  and  thrombus  formation  in  an  in  vivo  dog  model.  Red  wine  and  grape  juice  was 
effective  anti-platelet  and  anti-thrombic  compounds  when  administered  intravenously 
(1.6  mg/mL,  13  %  alcohol  in  200  mL  saline)  and  intragastrically  (4  mL/kg)  indicating 
that  the  active  compounds  are  absorbed  and  transported  to  the  bloodstream. 
Administration  of  white  wine  had  no  effect  suggesting  that  specific  compounds  in  grape 
juice  and  red  wine  containe  anti-thrombotic  and  platelet  inhibitors  in  addition  to 
ethanol. 
There  is  evidence  that  specific  phenolics  exert  anti-thrombotic  properties  in  vitro.  Russo 
et  al.  (2000)  reported  a  significant  anti-aggregatory  effect  with  de-alcoholised  red  wine 
fraction  rich  in  procyanidins,  (+)-catechin  and  anthocyanins.  No  activity  was  associated 
with  other  phenolic  constituents.  Additional  studies  have  shown  trans-resveratrol  to  be  a 
strong  inhibitor  of  the  COX  pathway  in  reducing  thromboxane  A2  production  (Pace- 
Asciak  et  al.,  1995),  and  consumption  of  grape  juice  enriched  with  trans-resveratrol 
decreased  thrombin  induced  platelet  aggregation  in  human  subjects  (Pace-Asciak  et  al., 
1996).  However,  other  studies  have  not  shown  the  same  effect  following  consumption 
of  de-alcoholised  red  wine  in  human  subjects  (Lavy  et  al.,  1994;  Pellegrini  et  al.,  1996; 
Rein  et  al.,  2000). 
1.7.4  Red  wine  and  Vasorelaxation 
The  vascular  endothelium  forms  a  barrier  between  the  vascular  smooth  muscle  and  the 
flow  of  blood  and  controls  the  contraction  and  relaxation  of  the  vascular  muscle  by 
responding  to  vaso-active  stimuli,  blood  flow  and  stress  (Stoclet  et  al.,  1997).  The 
inability  of  blood  vessels  to  contract  and  relax  efficiently  has  been  implicated  in  the 
development  of  atherosclerosis. 
A  number  of  studies  have  investigated  the  vasodilatory  activity  of  red  wine,  grape  juice 
and  grape  skin  extract  (Fitzpatrick  et  al.,  1993;  1995;  Andriambelosen  et  al.,  1998).  In 
the  presence  of  three  red  wines,  pre-contracted  rat  aortic  rings  were  relaxed  by  86,89 
and  53  %,  compared  with  0  and  20  %  for  the  two  white  wines  analysed  (Fitzpatrick  et 
al.,  1993).  The  skin  extracts  resulted  in  relaxations  of  100  and  96  %  for  red  and  white 
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relaxation  of  blood  vessels  via  enhanced  generation  and/or  increased  biological  activity 
of  NO  leading  to  increased  levels  of  cGMP.  Ethanol  at  concentrations  comparable  to  a 
typical  wine  showed  no  relaxation  capacity.  Diebolt  et  al.  (2001)  demonstrated  a 
reduction  in  blood  pressure  in  normal  and  hypertensive  rats  following  the  administration 
of  red  wine.  While  consumption  of  purple  grape  juice  improved  endothelium  dependent 
flow  mediated  vasodilation  in  coronary  artery  patients  with  impaired  endothelial 
function  (Stein  et  al.,  1999). 
The  identification  of  the  active  compounds  in  grape  skins  and  red  wines  remains  under 
investigation.  However,  Andriambelosen  et  al.  (1998)  investigated  the  ability  of  wine 
fractions  to  relax  pre-contracted  aorta.  Fractions  containing  oligomeric  tannins  and 
anthocyanins  exhibited  similar  vasodilation  activity  as  the  original  wine  extract, 
however  the  anthocyanin  containing  fraction  was  more  potent  than  the  oligomeric 
tannin  fraction.  Similarly,  a  correlation  between  the  anthocyanin  content  of  red  wines 
with  vasodilation  effect  was  reported  by  Burns  et  al.  (2000).  Further  studies  have  shown 
that  monomeric  catechins  and  gallic  acid  have  no  effect  on  vasodilation,  but 
anthocyanins  and  procyanidins  enriched  wine  fractions  were  the  most  active.  The 
threshold  for  relaxation  by  procyanidin  oligomers  was  between  0.5  and  4  µg/mL 
(Fitzpatrick  et  al.,  2000),  with  much  higher  concentrations  >  0.1  mg/L  required  for 
anthocyanins  (Andriambelosen  et  al.,  1998). 
Besides  NO,  red  wine  has  also  been  shown  to  have  an  effect  on  the  formation  of  other 
mediators  of  vascular  tone  including  prostacyclin  (Derek  et  al.,  1997).  In  addition  the 
synthesis  of  a  potent  vasoconstrictor,  endothelin-1  has  recently  been  shown  to  be 
reduced  by  red  wine  in  bovine  aortic  endothelial  cells.  The  decreased  synthesis  of 
endothelin-1  was  associated  with  the  inhibition  of  tyrosine  kinase  family  of 
phosphorylating  enzymes.  This  effect  was  associated  with  the  phenolic  content  of  red 
wine  (Corder  et  al.,  2001). 
1.8  Role  of  oxidised  LDL  in  atherosclerosis 
The  exact  chemical  nature  of  the  pathogenesis  of  atherosclerosis  remains  unknown 
however  oxidative  modification  of  LDL,  a  major  cholesterol  carrying  lipoprotein  in Catherine  Tsang,  2004  46 
human  plasma,  has  been  implicated  as  a  key  factor  in  its  development  (Steinberg  et  al., 
1989).  Endothelial  cell  damage  is  the  initial  event  leading  to  atherosclerosis  and 
increases  the  permeability  of  the  blood  vessel  allowing  LDL  to  pass  into  the  intima 
layer  where  they  become  internalised  and  begin  to  accumulate  in  the  vessel  cell  wall 
(Fig.  1.5).  At  this  stage  LDL  is  oxidised  through  peroxidation  by  free  radicals.  The 
oxidatively  modified  LDL  no  longer  binds  to  the  native  LDL  receptor  but  to  a  scavenger 
receptor  of  macrophages  (which  bind  toxic  or  foreign  particles)  and  is  accumulated 
internally.  This  leads  to  the  production  of  cytokines  which  stimulate  the  indlux  of 
monocytes  into  the  intima  leading  to  further  uptake  of  oxidised  LDL.  The  monocytes 
gradually  become  lipid  laden  and  transform  into  foam  cells.  These  cells  build  up  leading 
to  the  formation  of  a  fatty  streak  and  to  vascular  occlusion  Oxidised  LDL  have  other 
attributes  conductive  to  atheromatous  changes  including  blocking  of  reverse  cholesterol 
transport  uptake  by  HDL  and  chemotactic  properties  promoting  the  adhesion  of  platelets 
to  the  superficial  endothelium  (Witzum,  1994). 
1.8.1  In  vitro  studies  on  the  inhibition  of  LDL 
The  inhibition  of  LDL  oxidation  by  wines,  grape  juice  and  grapes  have  been 
demonstrated  in  vitro  and  have  been  attributed  to  their  total  phenolic  content.  Red  and 
white  wines  have  been  reported  to  inhibit  LDL  oxidation  in  vitro  (Frankel  et  al.,  1993, 
1995;  Kanner  et  al.,  1994;  Teissedre  et  al.,  1996).  An  investigation  of  20  Californian 
wines,  standardised  to  10  µM  GAE  found  that  red  wines  inhibited  LDL  oxidation  by 
between  37  and  65  %  compared  with  between  27  and  46  %  with  white  wines  (Frankel  et 
al.,  1995).  The  correlation  between  the  antioxidant  activity  of  the  wines  with  LDL 
oxidation  was  further  investigated.  Gallic  acid  (r=0.92,  p<0.001),  (+)-catechin  (r=0.76. 
p<0.001),  myricetin  (r=0.70,  p<0.001)  and  quercetin  (r=0.08,  p<0.001)  were  all  found 
to  be  highly  correlated  with  the  prevention  of  LDL  oxidation.  Moreover,  Teissedre  et  al. 
(1996)  demonstrated  that  a  wine  fraction  containing  (+)-catechin,  (-)-epicatechin  and 
procyandin  dimers  and  trimers,  specifically  B2,  B8  and  C1,  were  the  most  active  in 
inhibiting  LDL  oxidation  by  70.6  %  by  determining  hexane,  a  specific  volatile  oxidation 
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In  a  recent  study  Serafini  et  al.  (2000)  failed  to  show  any  protective  effects  from  white 
wine.  In  this  study  the  ability  of  red  wine,  alcohol  free  red  wine  and  white  wine  to 
inhibit  LDL  oxidation  was  investigated.  The  presence  of  a  high  concentration  of  red 
wine  in  the  medium  protected  LDL  from  oxidation  in  a  dose-dependent  manner  (0.3, 
0.5,0.7  µl)  and  was  the  most  efficient  in  protecting  against  oxidation.  The  ability  of 
grapes  and  grape  juices  to  inhibit  LDL  oxidation  has  also  been  reported.  Meyer  et  al. 
(1997)  investigated  the  ability  of  V.  Vinifera  grapes  to  inhibit  LDL  oxidation.  At  a 
concentration  of  10  pM  GAE  grapes  were  able  to  inhibit  LDL  oxidation  by  between  22 
and  60  %,  compared  with  62  and  91  %  at  concentrations  of  20  pM  GAE.  The  inhibition 
of  oxidation  by  grapes  was  strongly  correlated  with  levels  of  total  phenols  (r=0.89, 
p<0.01)  and  also  with  anthocyanins  (r=0.56,  p<0.05)  and  flavonols  (r=0.56,  p<0.05). 
Similar  results  were  obtained  by  Frankel  et  al.  (1998)  whereby  commercial  grape  juice 
(10  µM  GAE)  were  able  to  inhibit  LDL  oxidation  by  between  62  and  75  %. 
1.8.2  In  vivo  studies  on  the  inhibition  of  LDL 
Although  in  vitro  studies  have  consistently  shown  that  wine  phenolics  have  significant 
abilities  to  inhibit  LDL  oxidation,  ex  vivo  and  in  vivo  studies  have  produced  contrasting 
results  to  date.  This  suggests  that  there  are  other  determining  factors  in  vivo  which  may 
limit  their  ability  to  produce  protective  effects,  for  example  nutrient  interactions  and  gut 
microflora  may  limit  the  bioavailability  of  phenolics.  Furhman  et  al.  (1995)  investigated 
the  effect  of  red  and  white  wine  consumption  on  the  susceptibility  of  LDL  to  oxidative 
modification  in  human  subjects  following  the  consumption  of  400  mL/  day  of  wine  for 
2  weeks.  Red  wine  consumption  decreased  LDL  lipid  peroxidation  in  response  to 
copper  induced  oxidation  by  46  %,  72  %  and  54  %  as  determined  by  TBARS,  lipid 
peroxides  and  conjugated  dienes.  In  contrast,  white  wine  consumption  resulted  in  an 
increase  in  the  propensity  of  LDL  to  undergo  oxidation.  The  pro-oxidant  effect  of  white 
wine  may  be  due  to  the  combination  of  alcohol  and  the  absence  of  protective 
polyphenols. 
The  effect  of  alcohol  was  eliminated  in  a  later  study  by  de  Rijke  et  al.  (1996).  In  this 
study  the  alcohol  content  of  red  and  white  wine  was  reduced,  however  no  effect  on  the 
oxidizability  of  LDL  was  observed  after  consumption  of  either  red  or  white  wine.  It  was Catherine  Tsang,  2004  48 
speculated  that  the  removal  of  alcohol  might  have  impeded  the  absorption  of  the 
phenolic  compounds.  Interactions  between  phenolics  and  other  nutrients  contained  in 
beverages  such  as  red  wine  can  lead  to  the  formation  of  insoluble  complexes  such  as 
protein-tannin  interactions  that  can  affect  the  bioavailability.  Reducing  the  alcohol 
content  of  wine  has  been  shown  to  produce  a  linear  increase  in  protein-tannin 
interactions  and  a  decrease  in  the  antioxidant  capacity  (Serafini  et  al.,  1997). 
Nigdikar  et  al.  (1998)  investigated  the  effect  of  consuming  different  forms  of 
polyphenols  on  the  inhibition  of  LDL  oxidation.  Subjects  consumed  either  red  wine,  a 
capsule  of  powdered  red  wine  phenolics,  the  same  extract  dissolved  in  either  white  wine 
or  an  alcoholic  drink,  for  two  weeks.  After  this  period  the  levels  of  phenolics  in  plasma 
increased  by  38  %  for  red  wine,  and  27  and  28  %  for  white  wine  containing  the  extract, 
and  the  extract  respectively.  The  lag  time  for  copper-induced  LDL  oxidation  increased 
by  17.8  min  after  red  wine;  14.2  min  after  the  capsule  and  11.7  min  after  the  white  wine 
and  the  extract.  The  results  from  this  study  are  in  agreement  with  a  previous  study  in 
which  subjects  consumed  400-500  mL  red  wine  daily  for  2  weeks  (Kondo  et  al.,  1994). 
Moreover,  the  effect  of  consuming  a  red  grape  juice  concentrate  on  the  oxidizability  of 
LDL  was  demonstrated  in  a  study  by  Day  et  al.  (1997).  7  subjects  consumed  125  mL  of 
red  grape  juice  concentrate  for  7  days.  An  increase  in  the  serum  total  antioxidant 
capacity  from  441  to  478  µmol/L  was  observed  1h  after  consumption  and  LDL  showed 
an  increased  resistance  to  oxidation  by  UV  light. 
The  protective  effects  of  consuming  red  wine  with  a  high  fat  meal  was  demonstrated  in 
a  recent  study  by  Natella  et  al.  (2001).  Six  subjects  consumed  a  high  fat  meal  with 
either  400  mL  of  red  wine  or  an  isocaloric  hydroalcoholic  solution.  Following  red  wine 
consumption  an  increase  in  the  antioxidant  capacity  of  the  plasma  was  observed  and 
LDL  obtained  after  the  meal  was  more  resistant  to  lipid  peroxidation  than  fasting  LDL. 
The  findings  from  this  study  suggest  that  phenolic  antioxidants  in  red  wine  protect  LDL 
from  the  susceptibility  of  oxidative  modification  and  might  offer  a  plausible  mechanism 
for  the  French  paradox. Catherine  Tsang,  2004  49 
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Figure  1.5  Macrophage-mediated  oxidation  and  aggregation  of  LDL  and  foam  cell 
formation.  NADPH-Ox:  NADPH  oxidase;  LPO:  lipoxygenase;  GSH:  reduced 
glutathione;  CE:  cholesteryl  ester;  UC-SM:  unesterified  cholesterol-sphyngomyelin. 
Adapted  from  Avriam  &  Fuhrman,  (1998). Catherine  Tsang,  2004 
1.9  Biomarkers  of  lipid  peroxidation 
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Lipid  peroxidation  is  a  complex  process  resulting  in  a  number  of  potential  products 
which  can  be  measured  as  indicators  of  free-radical  mediated  degradation  of  lipids. 
Therefore  a  wide  range  of  markers  can  be  used  for  their  evaluation.  Peroxidation  of 
lipids  can  be  assessed  either  by  determination  of  the  concentrations  of  primary 
peroxidation  products  or  secondary  degradation  products  in  body  fluids  or  on  the 
susceptibility  of  lipids  to  oxidation  induced  ex  vivo  either  by  transition  metals  or  by  the 
generation  of  free  radicals  (Fig.  1.6). 
PUFA 
L" 
LOO- 
0 
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Figure  1.6  The  products  and  pathways  relating  to  lipid  peroxidation.  PUFA- 
polyunsaturated  fatty  acids;  L--lipid  radical;  LOO"-peroxyl  radical;  LO"-alkoxyl  radical; 
LOOH-lipid  hydroperoxides;  CD-conjugated  dienes;  MDA-malonaldehyde;  HNE-4- 
hydroxynonenal.  Adapted  from  Dotan  et  al.  (2004). Catherine  Tsang,  2004 
1.9.1  TBARS 
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The  TBARS  method  is  the  most  common  for  determining  plasma  lipid  peroxidation. 
Malonaldehyde  (MDA)  is  generated  as  a  degradation  product  from  peroxidised  lipids, 
and  as  a  side  product  of  enzymatic  metabolism  of  thromboxanes  and  prostaglandins 
(McMillan  et  al.,  1978),  and  is  the  major  TBARS  formed  primarily  by  the 
decomposition  of  peroxides  of  fatty  acids  with  3  or  more  double  bonds  (Esterbauer  et 
al.,  1990).  The  basis  of  the  TBA  method  is  the  reaction  of  MDA  with  TBA  at  low  pH 
and  high  temperatures  to  form  a  coloured  complex  (MDA-TBA  complex)  which  can  be 
quantified  based  on  intensity  of  fluorescence  between  532-535  nm.  A  major 
disadvantage  of  this  method  is  that  it  is  non-specific  and  other  compounds  (other 
aldehydes,  carbohydrates,  amino  acids,  bile  pigments)  can  react  with  TBA  to  form 
complexes.  However,  despite  its  limitations  this  method  remains  an  accepted  and 
widely  used  procedure  (Draper  et  al.,  1993). 
1.9.2  Conjugated  dienes 
Conjugated  diene  structures  with  a  double-single-double  bond  (-C=C-C=C-) 
arrangement  absorb  UV  light  in  the  wavelength  range  230-235  nm,  and  therefore  can  be 
measured  spectrophotometrically.  Conjugated  diene  measurement  is  a  successful 
method  used  to  study  peroxidation  of  isolated  lipoprotein  fractions  and  gives  an 
estimate  of  the  susceptibility  of  the  lipoprotein  to  oxidation  (Esterbauer  et  al.,  1989) 
It  is  based  on  the  continuous  monitoring  of  the  change  in  absorbance  at  234  nm  due  to 
the  formation  of  conjugated  dienes  in  LDL  which  have  been  initiated  by  metal  ions  such 
as  copper  (Kleinveld  et  al.,  1992)  or  AAPH.  Two  consecutive  phases  can  be  determined 
by  the  kinetic  profile.  The  lag  phase  occurs  from  the  initation  of  oxidation  until 
conjugated  dienes  begin  to  accumulate.  The  length  of  the  lag  phase  is  directly 
proportional  to  the  concentration  of  antioxidants.  As  the  reaction  proceeds  antioxidants 
are  consumed  linearly  with  time  and  the  rate  completing  reaction  slows  down.  As  a 
result,  the  propagation  phase,  the  period  during  which  conjugated  dienes  accumulate, 
increases  until  a  maximum  rate  of  the  uninhibited  autoxidation  is  reached  for  steady 
state  conditions  (Fig.  1.7). Catherine  Tsang,  2004 
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Figure  1.7  Kinetic  profile  of  conjugated  diene  formation 
1.9.3  Measurement  of  exhaled  alkanes 
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Volatile  hydrocarbons  mainly  ethane  and  pentane  have  been  used  and  validated  as  a 
measure  of  lipid  peroxidation  in  vitro  and  in  vivo  studies  (Frank  et  al.,  1980).  n-3  PUFA 
oxidation  has  been  shown  to  result  in  an  increase  in  ethane  excretion  while  n-  4,6  and  7 
PUFA  oxidation  yield  increased  excretion  of  propane,  pentane  and  hexane.  Significant 
background  levels  resulting  from  hydrocarbon  contamination  of  inhaled  air  are  a  major 
limitation  of  this  technique  (Springfield  et  al.,  1994). 
1.9.4  F2-Isoprostanes 
The  discovery  of  the  isoprostanes  as  products  of  lipid  peroxidation  has  been  a  major 
advance  in  the  ability  to  assess  lipid  peroxidation  in  vivo  (Lawson  et  al.,  1999). 
Isoprostanes  are  a  complex  family  of  compounds  produced  from  arachidonic  acid  via  a 
free-radical  catalyzed  mechanism.  In  vitro  generation  of  auto-oxidation  products 
derived  from  PUFA  was  described  more  than  30  years  ago.  However,  the  first 
demonstration  that  these  compounds  were  produced  in  humans  was  shown  by  Morrow 
et  al.  (1990),  whereby  prostaglandin-F2-like  compounds,  termed  F2-isoprostanes,  were 
generated  by  free-radical-induced  peroxidation  of  arachidonic  acid.  Quantification  of Catherine  Tsang,  2004  53 
F2-isoprostanes  is  used  as  a  reliable  marker  of  lipid  peroxidation  in  vivo  (Roberts  & 
Morrow,  2000),  and  several  methods  are  currently  used  including  GC-MS  with 
negative-ion  chemical  ionization  using  a  deuterium-labeled  F2-isoprostane  as  an 
internal  standard  (Tsikas,  1998).  These  methods  are  highly  sensitive  and  specific  but 
their  cost  and  technology  limit  their  routine  use.  Several  immunoassays  have  been 
developed  to  measure  the  levels  of  F2-isoprostanes  including  enzyme  immunoassays 
(EIA)  and  radio  immunoassays  (RIA).  One  problem  with  these  methods  is  cross- 
reactivity  of  related  compounds  to  the  antibodies,  however  most  of  the  antibodies  used 
commercially  have  been  tested  with  other  major  isoprostanes  and  their  metabolites  and 
their  degree  of  cross-reactivity  is  low  (Basu  et  al.,  1998).  8-iso-prostaglandin  F2a  (8-iso 
PGF2a)  is  one  of  the  major  F2  isoprostanes  formed  in  vivo  and  have  been  shown  to  be 
present  in  increased  amounts  in  human  atherosclerotic  lesions.  Plasma,  serum  or  urinary 
levels  have  been  shown  to  be  increased  in  subjects  with  hypercholesterolemia,  liver 
cirrhosis  and  diabetes  mellitus  (Morrow  et  al.,  1995)  and  in  smokers  (Reilly  et  al., 
1996). 
1.10  Absorption  and  metabolism  of  polyphenols 
The  fate  of  ingested  polyphenols  in  the  digestive  tract,  including  the  absorption 
and  metabolism,  remains  largely  unknown.  Research  in  this  area  has  produced 
conflicting  results;  however  current  knowledge  in  this  regard  is  briefly  summarized 
below  and  illustrated  in  Fig.  1.8. 
Ingested  polyphenols  enter  the  digestive  system  primarily  in  the  form  of  glycosides 
(although  some  aglycones  may  be  present).  The  glycosides  may  then  be  de-conjugated 
by  the  action  of  non-specific  ß-glucosidases,  present  in  the  food  itself  or  on  the  surface 
of  the  muscosal  cells  (Aherne  &  O'Brien,  2002).  Both  aglycones  and  glycosides  have 
been  reported  to  be  absorbed,  however  conjugates  are  more  hydrophilic  than  the 
aglycones  and  the  removal  of  the  hydrophilic  moiety  appears  to  be  important  for  the 
passive  diffusion  across  the  intestinal  mucosa  (Scalbert  &  Williamson,  2000).  It  has 
been  suggested  that  the  intestinal  sodium  glucose  transporter  might  be  involved  in 
carrying  phenolic  glucosides  through  the  intestinal  cell  wall.  However,  this  has  not  been 
proven  in  vivo  (Aherne  &  O'Brien,  2002). Catherine  Tsang,  2004  54 
Polyphenols  undergo  extensive  metabolism,  mainly  involving  conjugation  reactions 
including  O-methylation  and/or  conjugation  with  glucuronides  and/or  sulphates,  during 
their  passage  through  the  enterocytes  (Kuhrau,  1976).  Certain  transporter  proteins  in  the 
enterocytes  may  actively  transfer  the  glycoisides  back  into  the  intestinal  lumen. 
Absorbed  polyphenols  are  bound  to  albumin  and  transported  in  the  circulation  to  reach 
the  liver  via  the  portal  vein  (Manach  et  al.,  1996).  In  the  liver,  they  are  metabolized  or 
secreted  into  the  bile  (Aherne  &  O'Brien,  2002).  Although  the  liver  seems  to  be  the 
main  organ  involved  in  the  metabolism  of  polyphenols  there  is  evidence  of  metabolism 
occurring  in  the  intestinal  mucosa  and  kidney.  Administration  of  2g  of  (+)-catechin  in 
rats  resulted  in  free  catechin  in  the  plasma  after  30  min,  while  a  low  dose  of  2  mg/kg 
resulted  in  the  formation  of  conjugated  metabolites.  The  results  from  this  study  suggest 
that  the  intestine  is  an  important  site  for  the  metabolism  of  polyphenols,  with  the  liver 
playing  a  secondary  role  to  further  modify  the  conjugated  phenolic  (Piskula  et  al., 
1998). 
Un-absorbed  or  re-excreted  polyphenols  reach  the  large  intestine  where  they  may 
undergo  metabolism  to  more  simple  compounds  by  the  colonic  microflora  and  the 
degradation  products  (e.  g.  phenolic  acids  in  the  case  of  flavonoid  metabolism)  may  be 
absorbed  by  passive  diffusion.  The  polar,  and  therefore  water  soluble,  polyphenol 
glucuronides  and  sulfate  that  escaped  biliary  excretion  and  enterohepatic  circulation  are 
eliminated  from  the  body  by  urinary  excretion Catherine  Tsang,  2004 
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Figure  1.8  Possible  routes  for  consumed  polyphenols  in  humans.  Adapted  from 
Scalbert  &  Williamson,  (2002). 
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1.10.1  Factors  affecting  bioavailability  of  phenolics 
The  rate  and  extent  of  intestinal  absorption  and  metabolism  of  phenolics  are  influenced 
by  a  number  of  factors  including  their  chemical  structure,  molecular  weight, 
glycosylation  and  esterification. 
1.10.1.1  Molecular  weight 
High  molecular  weight  compounds  including  tea  theaflavins  (M=568)  and 
proanthocyanidins  (M=577+)  are  unlikely  to  be  absorbed  in  the  GI  tract  (Donovan  et  al., 
2002;  Lee  et  al.,  1995).  However,  Deprez  et  al.  (2001)  reported  that  procyanidin  dimers 
and  trimers  were  absorbed  through  a  cell  monolayer  derived  from  the  human  intestinal 
cell  line  Caco-2,  and  dimer  B2  has  been  detected  in  human  plasma  following 
consumption  of  a  flavan-3-ol  rich  cocoa  (Holt  et  al.,  2002). 
1.10.1.2  Glycosylation 
Certain  classes  of  polyphenols  (flavonols,  isoflavones,  flavones,  anthocyanins)  are 
usually  glycosylated  in  plants  and  this  influences  their  chemical,  physical  and  biological 
properties.  The  partition  co-efficients  measure  the  relative  affinity  of  a  compound  for 
aqueous  and  organic  phases  and  are  important  in  determining  whether  a  compound  will 
passively  diffuse  across  a  biological  membrane  and  how  they  might  partition  in  a  cell. 
The  flavonol  quercetin  has  a  partition  co-efficient  of  1.2  ±  0.1  however  quercetin-3-O- 
rhamnoglucoside  has  a  value  that  is  considerably  lower  (0.37  +  0.1)  showing  greater 
hydrophilicity  (Brown  et  al.,  1998). 
1.10.1.3  Esterification 
Ester  linked  substitutions  have  marked  effects  on  absorption  and  subsequent 
bioavailability.  Hydroxycinnamates  such  as  caffeic  acid  are  commonly  esterified  to 
sugars,  organic  acids  and  lipids.  It  has  been  reported  that  caffeic  acid  is  better  absorbed 
than  chlorogenic  acid;  it's  ester  with  quinic  acid.  Olthof  et  al.  (2001)  reported  95  %  of 
intestinal  absorption  for  caffeic  compared  with  only  35  %  for  chlorogenic  acid  in Catherine  Tsang,  2004  57 
ileostomy  subjects.  Similarly,  in  an  isolated  rat  intestine  model  absorption  of  caffeic 
acid  was  higher  (0.695  nmol)  than  its  quinic  ester  (0.115  nmol)  (Spencer  et  al.,  1999). 
1.10.2  Absorption  of  flavonols 
There  is  now  a  considerable  body  of  evidence  supporting  the  view  that  the  flavonol 
conjugates  are  preferentially  absorbed,  and  that  the  nature  of  the  conjuation  may  be 
important.  Hollman  et  al.  (1995)  investigated  the  absorption  of  quercetin  in  ileostomy 
subjects  following  the  consumption  of  an  onion  test  meal  or  capsules  containing 
quercetin  or  quercetin  rutinoside.  52  %  of  quercetin  glucosides,  24  %  quercetin  and  17 
%  quercetin  rutinoside  were  absorbed.  Although  the  authors  demonstrated  the 
absorption  of  quercetin  they  emphasized  the  importance  of  glycosylation  as  a  means  of 
enhancing  absorption  and  considered  quercetin  glucosides  to  be  the  predominant  form 
of  the  flavonol  in  human  plasma. 
Consistent  findings  were  observed  by  Graefe  et  al.  (2001),  whereby  quercetin 
glucuronides  were  found  in  the  plasma  of  human  subjects  reaching  a  peak  plasma 
concentration  at  0.7  h  after  the  ingestion  of  an  onion  supplement  containing  100  mg  of 
quercetin,  and  following  the  consumption  of  red  wine  (Crozier  et  al.,  2000).  It  has  been 
proposed  that  flavonol  glucosides,  such  as  quercetin-4'-glucoside  could  be  absorbed 
intact  into  the  small  intestine  using  the  sodium-dependent  glucose  transporter  (SGLT1) 
(Hollman  et  al.,  1995).  However,  studies  with  human  intestinal  Caco-2  cell  monolayers 
have  shown  that  quercetin-4'-glucoside  and  quercetin-3,4'-diglucoside  were  not 
absorbed  despite  the  operation  of  SGLT1  which  was  demonstrated  by  the  active 
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1.10.3  Absorption  of  flavan-3-ols 
Generally,  flavan-3-ols  are  found  in  plasma  methylated  and/or  conjugated  to  sulphate  or 
glucuronic  acid.  Recent  work  by  Okushio  et  al.  (1999)  reported  that  both  the  0- 
methylated  and  glucuronidated  conjugates  were  detected  in  rat  urine  following  oral 
administration  of  (-)-epicatechin.  Moreover,  epicatechin-5-O-ß-glucuronide  and 
catechin-5-O-ß-glucuronide  have  been  detected  in  plasma,  bile  and  urine  of  rats 
following  oral  administration  of  (-)-epicatechin  and  (+)-catechin  respectively  (Harada  et 
al.,  1999). 
In  humans,  3-O-methylcatechin,  sulphated  and  glucuronidated  metabolites  have  been 
detected  in  plasma  following  consumption  of  either  red  wine  or  de-alcoholised  red  wine 
(Donovan  et  al.,  1999).  Maximum  levels  of  50-170  nmol/L  of  total  (+)-catechin 
metabolites  were  detected  1h  after  consumption.  Although  free  (+)-catechin  and  3-0- 
methylcatechin  were  detected,  they  were  comparatively  lower  than  those  of  (+)-catechin 
sulphate  and/or  glucuronide  conjugates.  More  recently,  Bell  et  al.  (2000)  investigated 
the  absorption  of  (+)-catechin  in  human  subjects  following  the  consumption  of  red 
wine.  Free  and  conjugated  forms  attained  peak  plasma  concentrations  at  60  min  with  7.9 
%  of  the  administered  dose  being  absorbed. 
Low  urinary  recoveries  of  (+)-catechin  were  reported  by  Golberg  et  al.  (2003b).  Twelve 
healthy  volunteers  were  randomly  assigned  to  consume  25  mg/kg  of  (+)-catechin  in  3 
different  matrices  including  white  wine,  grape  juice  and  vegetable  juice.  Only  1.2-3  % 
of  the  dose  of  (+)-catechin  administered  was  excreted  in  the  urine  over  24  h.  To  explain 
the  low  absorption  of  (+)-catechin  the  authors  concluded  that  some  re-absorption  of  (+)- 
catechin  in  the  renal  tubules  might  have  occurred,  and  there  is  some  evidence  that  (+)- 
catechin  may  be  preferentially  excreted  in  the  bile  (Das  et  al.,  1971).  Piskula  &  Terao 
(1998)  proposed  that  the  mechanism  of  flavan-3-ol  metabolism  involved 
glucuronidation  in  the  small  intestine  as  the  first  detoxification  step  followed  by  0- 
methylation  in  the  liver  and  kidney.  Kuhnle  et  al.  (2000)  demonstrated  in  an  isolated 
intestinal  model  that  (-)-epicatechin  and  (+)-catechin  are  extensively  0-methylated 
during  transfer  across  the  jejunum.  The  major  metabolites  transferred  across  the 
intestinal  epithelium  of  the  jejunum  are  glucuronidated  and  0-methylated  metabolites  of Catherine  Tsang,  2004  59 
the  parent  flavanol.  Up  to  30%  of  compounds  detected  in  the  jejunal  serosal  fluid  were 
O-methylated  and  an  additional  20%  were  O-methylated  and  glucuronidated.  Current 
knowledge  on  the  absorption  and  metabolism  of  the  oligomeric  and  polymeric  flavan-3- 
ols,  or  procyanidins  in  humans  and  animals  is  limited  and  contradictory. 
Nonetheless,  dimer  B2  has  been  detected  in  human  plasma  following  ingestion  of  a 
cocoa  supplement,  with  concentrations  reaching  a  maximum  of  41  nmol/L  by  2h  (Holt 
et  al.,  2002).  Moreover,  Baba  et  al.  (2002)  reported  on  a  study  with  rats  on  the 
absorption  of  dimer  B2.50mg/Kg  of  a  cocoa  powder  was  fed  to  rats  and  analysis  by 
HPLC-MS  confirmed  the  presence  of  B2  (0.5  µM),  epicatechin  (0.2  µM)  and  3'-O- 
methyl-epicatechin  (0.15  µM)  30  min  post-ingestion  of  the  cocoa  in  plasma.  B2  (83 
nmol/L),  epicatechin  (free  12.5  nmol/L  or  conjugated  29.6  nmol/L)  and  3'-O-methyl- 
epicatechin  (free  12.8  nmol/L  or  conjugated  13.9  nmol/L)  were  also  detected  in  the 
urine  within  18  h. 
1.10.4  Absorption  of  anthocyanins 
One  of  the  first  studies  to  provide  evidence  for  the  uptake  of  anthocyanins  in  humans  in 
vivo  was  reported  by  Paganga  &  Rice-Evans  (1997).  HPLC  analysis  confirmed  the 
identification  of  anthocyanins  in  plasma  in  their  glycosylated  form.  Following  the 
consumption  of  300  mL  of  red  wine  containing  -218  mg  of  anthocyanins,  1.5-5.1  %  of 
the  anthocyanins  were  recovered  in  the  urine  within  12  h  (Lapidot  et  al.,  1998).  Two  of 
the  identified  compounds  were  unchanged,  whereas  other  compounds  appeared  to  have 
undergone  molecular  modifications.  More  recently,  Miyazawa  et  al.  (1999)  investigated 
the  absorption  and  metabolism  of  anthocyanins  in  human  subjects  following  the 
ingestion  of  elderberry  and  black  currant  juice  concentrates.  Subjects  ingested  2.7  mg  of 
cyanidin-3-glucoside  and  0.25  mg  of  cyanidin  2,5-diglycoside/kg  of  body  weight.  Only 
intact  anthocyanins  were  detected  in  plasma.  After  1h  plasma  levels  of  cyanidin-3- 
glucoside  reached  13  µg/L  with  only  trace  levels  of  cyanidin-2,5-diglycoside  detected. 
Anthocyanins  have  also  been  detected  in  plasma  in  very  low  concentrations  0.5-1  h  after 
consumption,  falling  to  near  baseline  levels  within  6-8  h  (Cao  et  al.,  2001). Catherine  Tsang,  2004  60 
In  a  recent  study,  Wu  et  al.  (2002)  demonstrated  that  methylation  of  the  3'-hydroxyl 
group  in  addition  to  glucuronidation  of  anthocyanins  is  possible.  Cyandin-3-O- 
glucoside  and  cyanidin-3-sambubioside  were  detected  in  the  urine  of  elderly  women 
following  the  ingestion  of  an  elderberry  extract.  Four  metabolites  (peonidin-3- 
glucoside,  peonidin-3-sambuboside,  peonidin  monoglucuronide  and  cyanidin-3-O- 
glucoside  monoglucuronide)  were  further  detected  in  the  urine,  however  were  present  in 
much  lower  levels.  Similarly,  Felgines  et  al.  (2003)  reported  the  presence  of 
pelargonidin  glucuronides,  a  pelargonidin  sulphate  and  the  aglycone  pelargonidin 
following  the  consumption  of  strawberries  in  human  subjects.  However,  the  levels  of 
anthocyanins  recovered  are  exceptionally  low,  with  0.1  %,  or  less,  of  the  ingested  dose 
being  detected  in  the  urine  (McGhie  et  al.,  2003). 
1.10.5  Absorption  of  non-flavonoids 
1.10.  S.  1  Gallic  acid 
The  absorption  and  metabolism  of  gallic  acid  has  been  widely  investigated  in  a  number 
of  animal  studies  (Booth  et  al.,  1959;  Glick  et  al.,  1981;  Murdiati  et  al.,  1992). 
Conjugation,  4-0  methylation,  decarboxylation  and  dehydroxylation  reactions  have 
been  reported  with  4-0-methylgallic  acid,  resorcinol  glucuronide  and  2-0 
methypyrogallol  being  the  major  urinary  metabolites  found  in  animals.  Following  the 
administration  of  50  mg  gallic  acid  in  humans,  4-0-methylgallic  acid  and  gallic  acid 
were  detected  in  the  urine  and  plasma  by  HPLC-UV  detection  with  recoveries  for  both 
reaching  >  90  %.  No  further  metabolites  were  detected  in  either  plasma  or  urine  despite 
a  thorough  search  (Shahrzad  and  Bitsch,  1998).  Similar  findings  were  reported  by  Adu- 
Amsha  Caccetta  et  al.  (2000)  whereby  4-0-methylgallic  acid  was  detected  in  the  urine 
following  red  wine  consumption  in  human  subjects.  Additional  metabolites  have  been 
identified  in  humans  following  prolonged  consumption  of  black  tea  (Hodgson  et  al., 
2000),  with  4-0-methylgallic  acid,  3-0-methylgallic  acid  and  3,4-0-dimethylgallic  acid 
being  detected  in  urine.  However,  it  is  remains  unknown  whether  these  metabolites  are 
derived  from  gallic  acid  alone,  as  there  is  some  evidence  to  suggest  that  gallate  esters 
may  contribute,  together  with  breakdown  products  of  the  flavonoids  (Zhu  et  al.,  1992). Catherine  Tsang,  2004 
1.10.5.2  Hydroxycinnamates 
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Caffeic,  p-coumaric  and  ferulic  acid  have  been  detected  in  human  urine  following  a 
high  intake  of  fruit  (Bourne  &  Rice-Evans,  1998),  and  there  is  evidence  that  caffeic  acid 
is  absorbed  in  the  small  intestine  (Olthof  et  al.,  2001).  Ferulic  acid,  isoferulic  acid, 
caffeic  acid  and  vanillic  acid  have  been  detected  in  urine  after  administration  of  Ig  of 
caffeic  acid  (Jacobson  et  al.,  1983).  The  mechanism  of  absorption  of 
hydroxycinnamates  remains  uncertain  although  it  is  thought  to  involve  the  sodium 
dicarboxylate  co-transporter  (SDCT  1)  (Clifford  et  al.,  2000b). 
1.10.5.3  Trans-resveratrol 
Trans-resveratrol  has  been  detected  intact  in  plasma  after  the  administration  of  red  wine 
(Bertelli  et  al.,  1996)  and  pure  trans-resveratrol  (Juan  et  al.,  1999)  to  rats.  Moreover, 
free,  glucuronidated  and  sulphated  conjugates  of  trans-resveratrol  were  detected  in 
human  plasma  and  urine  following  administration  of  25  mg/kg,  with  16-17  %  of  the 
dose  excreted  in  the  urine  by  24  h  (Goldberg  et  al.,  2003b).  Kuhnle  et  al.  (2000) 
demonstrated  the  absorption  and  metabolism  of  trans-resveratrol  using  an  isolated  rat 
small  intestine  model.  Trans-resveratrol  was  metabolised  to  its  glucuronide  conjugate. 
However,  only  small  amounts  of  resveratrol  were  absorbed  across  the  enterocytes  of  the 
jejunum  and  ileum  unmetabolised.  The  major  compound  detected  on  the  serosal  side 
was  the  glucuronide  conjugate  of  resveratrol  (96.5  %±4.6  of  the  amount  absorbed) 
indicating  the  susceptibility  of  resveratrol  to  glucuronidation  during  transfer  across  the 
rat  jejunum. 
In  summary,  although  there  is  some  evidence  indicating  potential  health  benefits  of 
dietary  polyphenols,  information  concerning  their  bioavailability  remains  undetermined. 
This  is  largely  due  to  a  lack  of  data  concerning  flavonoid  composition  in  food  and  the 
inconsistent  use  of  current  methodologies.  The  work  presented  in  this  thesis 
circumvents  these  problems  by  providing  a  quantitative  analysis  of  grape  and  wine 
derived  phenolics  and  their  subsequent  metabolites  in  biological  samples. Catherine  Tsang,  2004  62 
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Chapter  2  Materials  and  Methods 
2.1  Chemicals 
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(+)-Catechin,  (-)-epicatechin  and  (-)-epicatechin-3-O-gallate  were  obtained  from 
AABB  Chemicals  (Southampton,  UK).  Quercetin,  gallic  acid  and  epigallocatechin  were 
obtained  from  Sigma  (Poole,  Dorset,  UK).  Malvidin-3-O-glucoside  was  purchased  from 
Extrasynthase  (Lyon,  France).  The  grape  seed  extract  used  in  this  study  was  produced 
by  Partoeno  (Bordeaux,  France).  Standards  of  the  procyandin  dimers  B  1,  B2,  B3  and  B4 
were  generously  provided  by  Dr  Pierre-Louis  Teissedre  from  the  Faculty  of  Pharmacy, 
University  of  Montpellier  1,  France.  These  were  obtained  from  a  grape  seed  extract 
using  procedures  described  by  Teissedre  et  al.  (1995).  Methanol  (HPLC  grade),  ethanol 
and  acetonitrile  (HPLC  grade)  were  purchased  from  Rathburn  Chemicals  (Walkerburn, 
Peebleshire,  UK).  Formic  acid,  trifluoroacetic  acid  (TFA),  citric  acid,  1,1,3,3-tetra- 
ethoxypropane  (TEP)  and  Folin-Ciocalteau's  phenol  reagent  were  supplied  by  Sigma. 
Disodium  carbonate  (Na2CO3),  butylated  hydroxytoluene;  di-sodium  hydrogen  ortho- 
phosphate  and  sodium  dihydrogen  orthophosphate  dihydrate  were  obtained  from  BDH 
Chemicals  Ltd  (Poole,  UK).  Concentrated  hydrochloric  acid,  acetic  acid  (glacial), 
disodium  hydrogen  phosphate  (Na2HPO4)  and  sodium  hydroxide  (NaOH)  were  obtained 
from  Fisher  Scientific  (Loughborough,  Leicestershire,  UK).  All  other  chemicals  and 
reagents  were  obtained  from  Sigma-Aldrich  (Poole,  Dorset,  UK)  unless  otherwise 
stated. 
2.2  Wines 
2.2.1  Details  of  bottled  wines  analysed 
All  bottled  wines  were  supplied  by  Safeway  Stores  plc.  Details  of  origin  and 
varietal  composition  are  summarised  in  Table  2.1.  Wines  were  selected  to  represent  a 
variety  of  wines  produced  from  various  grape  cultivars,  geographical  regions  and  those 
most  commonly  consumed.  Aliquots  of  wine  were  removed  from  the  bottle  for  analysis 
and  the  remaining  wine  stored  under  nitrogen  and  re-corked.  Unless  otherwise  stated 
wine  was  untreated  prior  to  analysis. Catherine  Tsang,  2004 
2.3  Colorimetric  methods 
2.3.1  Determination  of  total  phenolics 
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The  method  of  Singleton  and  Rossi  (1965)  was  used  to  determine  the  total  phenolic 
content  of  wine.  This  method  determines  phenols  and  oxidized  substances  by  producing 
a  blue  colour  from  reducing  yellow  heteropoly  phosphomolibdate-tungstate  anions.  In 
brief,  200  µL  of  a  1:  5  dilution  of  sample  was  added  to  10  mL  of  a  1:  10  diluted  Folin  and 
Ciocalteu  reagent  and  1.8  mL  of  distilled  water.  After  5  min  7.0  mL  of  a  Na2CO3 
solution  (115  g  L-)  was  added  and  the  reaction  mixture  was  left  at  room  temperature  for 
2  h.  The  absorbance  of  the  solution  was  read  at  765  nm  against  water  blank  on  a  Cecil 
3000  series  spectrophotometer  (Cecil  Instruments  Ltd,  Cambridge,  UK).  The  optical 
density  (O.  D.  )  was  compared  to  a  standard  curve  prepared  with  50  to  500  mg"L  gallic 
acid  and  results  are  expressed  as  gallic  acid  equivalents  (GAE). 
Total  phenolics  in  plasma  were  also  estimated  with  Folin-Ciocalteu  reagent  using  a 
modification  of  the  method  of  Swain  and  Hillis  (1959).  This  method  avoids  interference 
from  proteins  in  biological  samples  (Serafini  et  al  1998).  In  brief,  500  µL  of  sample  was 
added  to  1  mL  of  1.0  M  HC1,  and  vigorously  vortexed  for  60  s.  Following  incubation  at 
37°C  for  60  min,  1.0  mL  of  a  2.0  mol/L  NaOH  in  75  %  methanol  was  added,  and  the 
resulting  mixture  vortexed  for  3  min.  1.0  mL  of  10  %  (v/v)  phosphoric  acid  was  added 
and  the  sample  was  centrifuged  at  1500  xg  10  min.  The  supernatant  was  removed  and 
kept  on  ice  in  the  dark  and  the  pellet  was  extracted  again  by  adding  1.0  mL  of  a  solution 
1:  1  (v/v)  acetone:  water  and  centrifuged  for  10  min  at  2700  x  g.  The  two  supernatants 
were  combined  and  filtered  through  a  0.45  µm  filter  (Millipore,  Tyne  and  Wear,  UK), 
and  200  µL  of  sample  were  assayed  for  total  phenolics  with  Folin-Ciocalteau  as 
described  above  and  expressed  as  µM  GAE. 
2.3.2  Colorimetric  analysis  of  anthocyanins 
The  anthocyanin  content  of  red  wines  was  estimated  using  a  pH  shift  method  adapted 
from  Ribereau-Gayon  and  Stonestreet  (1965).  Two  test  tubes  were  set  up  each 
containing  140  µL  of  wine  and  140  µL  0.1  %  concentrated  HCl  in  95  %  ethanol.  1.5  mL 
of  2%  concentrated  HCl  (pH  0.6)  was  added  to  one  tube  and  1.5  mL  of  pH  3.5  buffer Catherine  Tsang,  2004  65 
(300  mL  0.2  M  Na2HPO4  and  700  mL  0.1M  citric  acid,  adjusted  to  pH  3.5  with  0.1  M 
citric  acid)  to  the  other.  Absorbance  was  read  at  700  nm  to  allow  for  the  correction  of 
haze  and  then  at  520  nm  for  anthocyanin  determination.  Anthocyanins  were  quantified 
as  malvidin-3-glucoside  equivalents,  the  major  anthocyanin  in  red  wine,  using  the 
extinction  co-efficient  28000.  At  <  pH  1  anthocyanins  are  found  entirely  in  their  red 
flavylium  form  allowing  determination  of  the  total  anthocyanins.  At  pH  3.5  the 
flavylium  form  of  the  anthocyanin  is  primarily  in  equilibrium  with  the  colourless 
carbinol,  therefore  absorbance  is  due  to  polymeric  anthocyanins  or  interfering  brown 
substances.  The  difference  in  absorbance  between  pH  <1  and  pH  3.5  is  due  to  the  free 
anthocyanin  content. 
2.3.3  Determination  of  total  catechins 
Total  catechins  were  determined  in  wine  fractions  spectrophotometrically  with  4- 
dimethylaminocinnamaldehyde  (DMACA)  as  described  by  Kivitis  et  al.  (1997). 
Samples  were  diluted  10-fold  with  12.5  %  ethanol  prior  to  the  addition  of  3  mL  of  6 
mM  DMACA  (dimethylaminocinnamaldehyde)  in  a  methanol/perchloric  acid/water  mix 
(8:  1:  1,  v/v).  A  scan  of  absorbance  between  500  nm  and  750  nm  was  determined  6  min 
after  the  initiation  of  the  reaction.  Peak  area  was  related  to  a  standard  curve  obtained 
with  (+)-catechin  standard.  Due  to  the  interference  from  anthocyanins,  the  604-684  nm 
region  of  the  scan  was  used  for  catechin  quantification. Catherine  Tsang,  2004  66 
Table  2.1  Details  of  red  wines  analysed  for  total  phenolic  content  and  antioxidant 
capacity. 
Wine  Year  Origin  Grape  variety 
1.  Claret  non-vintage 
2.  Beaune 
3.  Beaujolais 
4.  Cotes  du  Rhone 
5.  Vin  de  pays  de  L'Ardeche 
6.  Etienne  Barret  Crozes 
Hermitage 
7.  Minervois 
8.  Corbieres 
9.  Chianti  Classico 
10.  Valpolicella 
11.  Aged  in  Oak  Valdepenas 
Reserva 
12.  Castillo  de  Sierra  Rioja 
13.  Young  Vatted  Tempranillo 
14.  Bairrada 
15.  Young  Vatted  Merlot 
16.  Vin  de  Pays  L'Ardeche  Rose 
17.  Australian  Red 
18.  Australian  Oaked  Cabernet 
Sauvignon 
19.  Young  Vatted  Pinotage 
20.  Cinsault 
21.  Cabernet  Sauvignon 
22.  Caballo  de  Plata 
23.  Cabernet  Sauvignon 
24.  Argentinian  Shiraz 
25.  Inti  Malbec 
26.  Chilean  Dry  Red 
27.  Chilean  Cabernet  Merlot 
28.  Chilean  Cabernet  Sauvignon 
29.  Granverano  Carmenere 
30.  Pinot  Noir  Estancia 
31.  Young  Vatted  Cabernet 
2000  Bordeaux,  France  Cabernet  Sauvignon 
2000  France  Pinot  Noir 
2001  Beaujolais,  France  Gamy 
2001  Rhone,  France  Carignon,  Cinsault 
2000  Ardeche,  France  Syrah,  Grenache 
2001  France  Syrah 
2000  Aude,  France  Carignon 
2001  France  Corbieres 
1999  Tuscany,  Italy  Chianti 
2000  Veneto,  Italy  Valpolicella 
1996  Valdepenas,  Spain  Cencibel 
1998  Rioja,  Spain  Rioja 
2000  Spain  Tempranillo 
1999  Portugal  unknown 
2001  Bulgaria  Merlot 
2001  Ardeche,  France  Grenache,  Syrah 
2001  Australia  Cabernet  Sauvignon 
2000  Australia  Cabernet  Sauvignon 
2000  South  Africa  Pinotage 
2001  South  Africa  Cinsault 
2000  South  Africa  Cabernet  Sauvignon 
2000  Argentina  Bonarda-Barbera 
2001  Argentina  Cabernet  Sauvignon 
2001  Argentina  Shiraz 
2001  Argentina  Malbec 
2001  Chile  Cabernet  Sauvignon 
2001  Chile  Cabernet  Sauvignon, 
Merlot 
2001  Chile  Cabernet  Sauvignon 
2001  Chile  Carmanere 
2000  California  Pinot  Noir 
2000  Bulgaria  Cabernet  Sauvignon 
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2.3.4  Determination  of  the  antioxidant  power  using  ferric  reducing 
ability  of  plasma 
The  FRAP  assay  described  by  Benzie  and  Strain  (1996)  was  used  to  estimate  the 
antioxidant  power  of  wine  samples.  This  method  measures  the  ability  of  a  solution  to 
reduce  a  ferric-2,4,6-tri-2-pyridyl-s-triazine  (TPTZ)  complex  (Fe3+  TPTZ)  to  the  ferrous 
form  Fee+,  producing  an  intense  blue  colour  with  absorption  at  593  nm.  The  reaction  is 
non-specific  and  any  half  life  reaction,  which  has  a  less  positive  redox  potential,  under 
reaction  conditions,  than  the  Fei+/  Fee+-TPTZ  half-life  reaction  will  drive  the  Fei+- 
TPTZ  reduction.  In  the  FRAP  assay  excess  Fe3+  is  used  and  the  rate  limiting  factor  of 
the  Fee+-TPTZ,  and  hence  the  colour  formation,  is  the  reducing  ability  of  the  sample. 
The  absorbance  at  593  nm  was  measured  4  min  after  the  addition  of  the  FRAP  reagent 
(acetate  buffer,  pH  3.6;  FeCl3,  TPTZ  in  40  mM  HCl)  to  the  reaction  mixture  (0.025  % 
solution).  The  absorbance  change  of  the  aliquot  diluted  1:  40  in  distilled  water  was  due 
to  the  combined  reductive  activity  of  all  the  reacting  antioxidants  present  within  the 
sample.  Optical  density  was  compared  to  a  standard  curve  prepared  with  0-1.0  mM 
ferrous  sulphate  (FeSO4)  and  results  are  expressed  as  the  mean  concentration  of  Fe 
2+  produced  /  mM. 
2.3.5  ABTS+  determination  of  antioxidants 
The  antioxidant  capacity  of  rat  plasma  was  measured  at  the  Unit  of  Nutrition, 
University  of  Montpellier  II,  France  using  a  commercial  kit  (Randox  Laboratories  Ltd, 
Crumlin,  UK).  This  method  measures  the  ability  of  ABTS  (2,2V-azino-di-(3- 
ethylbenzothiazoline  sulfonate)  to  produce  the  radical  cation  ABTS+  when  incubated 
with  peroxidase  and  hydrogen  peroxide,  producing  a  relatively  stable  blue-green  color 
with  absorption  at  600  nm.  Antioxidants  present  in  plasma  suppress  the  production  of 
ABTS+  to  a  degree  proportional  to  their  concentration.  Trolox  (1  mmol/L)  was  used  as  a 
standard  and  the  plasma  antioxidant  power  is  expressed  as  Trolox  equivalents  (Miller  et 
al.,  1993). Catherine  Tsang,  2004 
2.3.6  Protein  estimation 
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An  estimation  of  the  protein  concentration  of  dialysed  LDL  was  carried  out  according  to 
the  method  of  Markwell  et  al.  (1981).  To  each  tube,  100  µL  of  a  1:  10  dilution  of  LDL, 
300  µL  of  distilled  water  and  2  mL  of  Biruet's  reagent  (100  mL  Na2CO3  in  0.1  M 
NaOH;  1:  1  ratio  of  Folin-Ciocalteau  reagent;  1  mL  NaK  tartrate;  1  mL  CuSO4;  1  mL 
SDS  [sodium  dodecyl  sulfate])  was  added.  Samples  were  mixed  and  left  to  stand  at 
room  temperature  for  10  min.  Two  hundred  µL  of  Folin-Ciocalteau  reagent  was  added 
to  each  tube,  vortexed  and  left  to  stand  at  room  temperature  for  30  min.  A  standard 
curve  was  prepared  with  0  to  50  µg  L  bovine  serum  albumin  and  samples  were  adjusted 
to  a  protein  concentration  of  50  µg  LDL  protein/mL  and  1  µM  EDTA  in  quartz  cuvettes 
and  the  optical  density  was  read  at  750  nm. 
2.3.7  Thiobarbituric  reactive  substances 
Malondialdehyde  is  one  of  many  aldehyde  compounds  produced  by  lipid  peroxidation, 
and  is  the  most  commonly  measured  index  of  oxidative  stress  in  human  studies.  A 
commonly  used  method  for  the  assessment  of  oxidative  stress  is  the  TBARS  assay, 
which  aims  to  quantify  the  amount  of  malondialdehyde  (MDA)  formed  as  a  result  of 
lipid  peroxidation.  This  assay  involves  reacting  samples  with  2-thiobarbituric  acid 
(TBA)  under  high  temperatures  (90-100°C)  and  acidic  conditions.  TBA  reacts  with 
malondialdehyde  to  produce  a  stable  adduct  that  can  be  quantified 
spectrophotometrically.  LDL  that  was  oxidised  for  measurement  of  conjugated  dienes 
was  subsequently  used  for  the  measurement  of  TBARS  (Buege  &  Aust,  1978). 
Following  3h  oxidation,  the  reaction  was  stopped  by  addition  of  200  µM  EDTA  and  40 
µM  butylated  hydroxytoluene  (BHT)  and  the  samples  were  stored  at  4°C  for  a 
maximum  of  7  d.  TBARS  were  determined  by  adding  1  mL  TCA-TBA-HCL  reagent  (15 
%  trichloroacetic  acid:  0.375  %  thiobarbituric  acid:  25  mol  HCL)  to  a  0.8  ml  aliquot  of 
the  LDL  solution  (oxidised  as  above),  mixing  the  sample,  and  heating  it  in  boiling  water 
at  100  °C  for  15  min.  After  placing  the  tubes  in  a  bath  of  cold  water  for  5  min  samples 
were  centrifuged  at  2000  rpm  for  10  min  and  absorbance  was  measured  at  535  nm. 
Quantification  of  TBARS  was  performed  by  comparison  with  a  standard  curve  of 
malonaldehyde  equivalents  generated  by  acid  catalysed  hydrolysis  of  1,1,3,3  -tetra- 
ethyoxypropane  (TEP). Catherine  Tsang,  2004 
2.4  Spectral  assays 
2.4.1  Electron  spin  resonance 
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The  ability  of  phenolics  to  reduce  free  radicals  in  the  aqueous  phase  was 
estimated  by  electron  spin  resonance  spectroscopy  (ESR)  as  described  by  Gardner  et  al. 
(1998).  This  method  is  based  on  the  ability  of  antioxidants  in  a  sample  to  donate  a 
hydrogen  atom  or  electron  to  the  synthetic  free  radical  potassium  nitro-disulphonate 
(Fremy's  salt).  A  300  µL  aliquot  of  plasma  was  added  to  2.7  mL  phosphate  buffered 
saline  (PBS)  and  mixed  with  an  equal  volume  of  50  µM  of  Fremy's  radical  in 
ethanol/water  (12:  88,  v/v).  After  20  min  following  completion  of  the  reaction  the  ESR 
spectra  of  the  low  field  resonance  of  the  Fremy's  radical  was  obtained.  Signal  intensity 
was  obtained  by  double  integration  and  the  concentration  was  calculated  by  comparison 
with  a  control  reaction  using  ethanol/water  (12:  88,  v/v)  without  sample.  Spectra  were 
obtained  at  21°C  on  a  Bruker  ECS  106  spectrophotometer  equipped  with  a  TM110 
mode  cavity  operating  at  9.5  GHz  (x-band  frequency).  The  microwave  power  and 
modulation  amplitude  was  set  at  2  mW  and  0.01  mT. 
2.4.2  Conjugated  dienes  assay 
LDL  was  isolated  from  plasma  by  density  gradient  ultra-centrifugation  at  35,000  rpm 
for  15  h  at  15°C  according  to  the  method  of  Griffin  et  al.  (1990).  The  LDL  fraction  was 
removed  and  samples  were  dialysed  at  4°C  against  40  L  of  PBS  containing  10  µM  Nat 
EDTA  (pH  7.4)  for  42  h  while  shaking  gently  in  a  microdialysis  unit  (GibcoBRL,  Life 
Technologies  Ltd,  Paisley,  UK).  The  protein  concentration  of  dialysed  LDL  was 
adjusted  to  a  concentration  of  50  µg  LDL  protein/mL  and  1  µM  EDTA  in  quartz 
cuvettes.  Oxidation  of  LDL  was  initiated  by  addition  of  CuSO4  (10  µL,  3.75  mM)  added 
to  2.5  mL  of  LDL  solution  (50  µg  protein/mL)  to  give  a  final  concentration  of  15  µM 
CuS04  (Kleinveld  et  al.,  1992).  Absorbance  was  measured  at  234  nm,  every  2  min  at 
30°C.  Maximal  oxidation  rate  (nmol/mg  LDL  protein/min),  maximal  diene 
concentration  (nmol/mg  LDL  protein)  and  lag  phase  (min)  were  estimated  using  exact 
co-ordinates  provided  by  the  kinetics  software  application  (Beckman  DU  600). Catherine  Tsang,  2004  70 
2.5  High  performance  liquid  chromatography  analyses 
2.5.1  Measurement  of  carotenoids,  retinol  &  tocopherols 
The  levels  of  six  carotenoids  (lutein/zeaxanthin,  ß-cryptoxanthin,  all  trans- 
lycopene,  a-carotene  and  all  trans  0-carotene),  retinol  and  a-  and  y-tocopherol  were 
measured  in  plasma  by  reversed  phase  HPLC  with  UV  and  fluorimetric  detection 
according  to  the  method  of  Hess  et  al.  (1991).  Two  hundred  µL  plasma  was  added  to 
200  µL  water  and  400  µL  ethanol  and  mixed  for  10  s.  To  this  700  µL  hexane  and  100 
µL  echinone  were  added,  mixed  and  centrifuged  for  5  min.  The  hexane  layer  was 
reduced  to  dryness  and  dissolved  in  200  µL  of  1,4  dioxan;  ethanol:  acetonitrile  (1:  1:  3, 
v/v).  After  shaking  for  5-10  min,  150  µL  of  sample  was  injected  onto  a5  µm 
Ultrasphere  ODS,  25  cm  x  4.6  mm  (i.  d.  )  column  (Beckman  Instruments  Ltd,  High 
Wycombe,  Bucks,  UK)  and  eluted  at  a  flow  rate  of  1.3  mL/min.  The  detector 
wavelengths  were  changed  during  the  run  as  follows:  absorbance:  0-11.5  min  at  450 
nm;  11.6-18.0  min  at  470  nm  and  18.0-30  min  at  450  nm.  For  fluorescence  detection:  0- 
5.5  min  at  330/470  nm  (excitation/emission);  5.6-20.0  min  at  298/328  nm  and  20.1-30 
min  at  349/480  nm.  The  elution  order  and  retention  times  of  the  compounds  were  as 
follows:  retinol  (tR  =  2.7  min);  ß-cyrptoxanthin  (tR=  6.0  min);  y-tocopherol  (tR=  6.4 
min);  a-tocopherol  (tR  =  7.2  min);  lycopene  (tR  =  8.9  min);  a-carotene  (tR  =  14.9  min);  0- 
carotene  (tR  =  15.8  min)  and  lutein/zeaxanthan  (tR  =  16.8  min).  The  HPLC  system 
comprised  of  a  Waters  470  scanning  fluorescence  detector,  a  600E  system  controller 
and  a  486  tuneable  absorbance  detector  (Waters  Chromatography,  Millford,  MA,  USA). 
The  system  was  run  using  Millenium  version  2.1  software.  Extraction  efficiency  was 
determined  by  use  of  an  echinone  internal  standard  and  quantified  by  reference  to  five 
point  calibration  curves. 
2.5.2  Determination  of  ascorbic  acid 
Ascorbic  acid  (tR  =  5.3  min)  was  determined  from  0.6  mL  plasma  and  measured  by  ion- 
pair  reversed  phase  HPLC  with  UV  detection  (Ross,  1994).  After  vortex  mixing  for  5 
min  samples  were  centrifuged  (9000  x  g,  4°C,  10  min)  and  the  clear  supernatant  was 
injected  onto  a5  µm  Nucleosil  ODS,  25  cm  x  4.6  mm  (i.  d.  )  column  (Jones Catherine  Tsang,  2004  71 
Chromatography,  Henygoed,  Mid  Glamorgan,  UK)  with  a  Supelco  C  18  guard  cartridge 
(Anachem,  Beds,  UK)  at  a  flow  rate  of  0.6  mL/min  monitored  at  263  nm.  The  HPLC 
system  comprised  of  two  Gilson  305  pumps  and  a  20  µL  loop  volume  automated 
sampler  module  connected  to  a  Gilson  116  UV  detector  (Anachem,  Beds,  UK).  The 
mobile  phase  comprised  25  mM  myristyltrimethyl  ammonium  bromide,  0.05  M  sodium 
hydroxide,  0.06  M  acetic  acid  and  7.5  %  acetonitrile  adjusted  to  pH  5.5.  Peak 
identification  and  purity  was  confirmed  using  ascorbate  oxidase. 
2.5.3  On-line  analysis  of  antioxidants:  ABTS+  decolourisation  assay 
The  antioxidant  activity  of  wine  was  determined  using  the  ABTS+  on-line 
decolourisation  assay  based  on  the  methods  of  Dapkevicius  et  al.  (2001)  and  Koleva  et 
al.  (2001).  On-line  assessment  allows  complex  mixtures  to  be  separated  by  HPLC  and 
the  antioxidant  contribution  of  individual  components  can  be  evaluated.  The 
instrumental  set-up  is  illustrated  in  Figure  2.1.  A2  mM  ABTS+  stock  solution 
containing  3.5  mM  potassium  persulfate  was  prepared  and  incubated  at  room 
temperature  in  darkness  overnight.  ABTS+  reagent  was  preparted  by  diluting  the  stock 
solution  8-fold  in  phosphate  buffer  at  pH  8.  Twenty  µL  of  a  1:  5  dilution  of  wine  was 
injected  into  a  HPLC  system  comprising  a  LC  pump,  a  PDA  detector  and  a  UV-VIS 
detector  (Surveyor  HPLC,  Thermo  Finnigan).  Separation  was  carried  out  using  a  250  x 
4.6  mm  i.  d.  4  µm  Synergi  RP-Max  column  (Phenomenex,  Macclesfield,  UK) 
maintained  at  40°C  and  eluted  at  a  flow  rate  of  1  mL/min  with  a  60  min  gradient  at  4-25 
%  acetonitrile  and  0.1  %  formic  acid.  Following  separation  of  the  compounds,  the 
eluent  was  mixed  with  the  ABTS+  reagent  at  a  flow  rate  of  0.5  mL/min  supplied  by  a 
Shimadzu  LC-10  AP  VP  liquid  chromatography  pump.  A  Shimadzu  GT-1543  vaccum 
degasser  was  used  to  remove  any  oxygen  in  the  reagent  prior  to  mixing.  After  mixing 
through  a3mx0.25  mm  i.  d.  loop,  the  absorbance  was  measured  by  a  UV  detector  at 
720  nm  (Nemphlar  Bioscience,  Lanark,  UK).  Data  were  analysed  using  Thermofinnigan 
ChromquestTM  software  version  4.0. Catherine  Tsang,  2004 
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Figure  2.1  Instrument  set-up  for  the  HPLC  analysis  of  radical  scavenging 
compounds  using  an  on-line  reaction  with  ABTS+. 
2.5.4  Plasma  homocysteine  concentrations 
Homocysteine  concentrations  were  measured  in  plasma  using  a  DS30  homocysteine 
assay  kit  and  a  DS30  analyser  (Drew  Scientific  Ltd,  Barrow-in-Furness,  Cumbria,  UK) 
according  to  the  method  of  Duthie  et  al.  (2002).  Following  addition  of  internal  standard 
(2-mercaptoethylamine)  the  disulphide  bonds  in  the  sample  are  reduced  using  tris  (2- 
carboxyethyl)  phosphine  hydrochloride.  Protein  is  precipitated  from  the  solution  and  the 
thiol  groups  in  the  supernatant  are  derivitised  with  a  fluorescent  specific  dye.  The 
derivatives  are  separated  and  detected  by  their  fluorescence  (kexcitation  =  385  nm,  Remission 
=  515  nm).  Quantitative  evaluation  of  the  homocysteine  concentration  was  achieved  by 
comparison  with  a  two-point  calibration. Catherine  Tsang,  2004 
2.5.5  Preparative  HPLC  fractionation  of  wine 
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A  Chilean  Cabernet  Sauvignon  (wine  28)  was  fractionated  using  preparative  HPLC  as 
described  previously  by  Mullen  et  al.  (2002a). 
2.5.5.1  Sample  preparation 
Alcohol  was  removed  from  100  mL  wine  by  rotary  evaporation.  The  de-alcoholised 
wine  was  then  loaded  onto  a  160.0  x  44  mm  i.  d.  column  packed  with  Diaion®  Ion 
Exhange  resin  (Supelco,  PA,  USA).  The  column  was  washed  with  10%  methanol  in 
0.1  %  aqueous  TFA  which  removed  the  sugars,  after  which  the  retained  phenolics  were 
eluted  with  four  column  volumes  of  methanol.  The  methanol  was  removed  by  rotary 
evaporation  in  vacuo  and  the  residue  resuspended  in  5%  ACN  in  0.5  %  TFA,  to  a  final 
volume  of  100  mL. 
2.5.5.2  Fractionation  of  wine 
Wine  was  analysed  using  a  preparative  HPLC  system.  The  system  comprised  a  Hewlett 
Packard  85B  gradient  controller  (CA,  USA),  two  LC-1OA  pumps  (Anachem,  Luton, 
UK),  a  CTO-6A  column  oven  set  at  40°C,  Rheodyne  preparative  injector  model  3725 
with  a  10  mL  injection  loop  (HPLC  technology,  Herts,  UK),  a  150  x  20  mm  i.  d.,  5  µm 
ODS-H  optimal®  column  (Capital  HPLC,  Broxburn,  UK)  and  linked  to  a  Dynamax  UV 
absorbance  detector  monitoring  at  k  520  nm  and  371  nm  (Rainin  Instrument  Co.  Inc., 
MA,  USA).  Fractions  were  collected  using  a  Gilson  FC  203  fraction  collector  (WI, 
USA).  Data  was  collected  and  processed  via  a  Reeve  Analytical  (Glasgow,  UK)  2700 
data  handling  system.  Ten  mL  of  wine  28  was  analysed  using  a  40  min  gradient  of  5  to 
30  %  ACN  in  0.5  %  TFA  (with  a5  min  hold  at  30  %)  eluted  at  a  flow  rate  of  10 
mL/min.  Sixty  fractions  were  collected  3  minutes  after  the  injection  of  the  wine 
collecting  7.5  mL/min  of  eluent. Catherine  Tsang,  2004 
2.6  HPLC-tandem  mass  spectrometry  analysis 
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HPLC-tandem  mass  spectrometry  (MS-MS)  was  the  major  analytical  device 
used  for  the  identification  of  phenolic  compounds  in  wine  and  biological  samples. 
Samples  were  analysed  on  a  Surveyor  HPLC  system  comprising  a  HPLC  pump,  diode 
array  absorbance  detector,  scanning  from  250  to  700  nm  and  an  autosampler,  cooled  to 
4°C  (Thermo  Finnigan,  San  Jose,  USA).  Separation  was  carried  out  using  a  250  x  4.6 
mm  i.  d.  4  µm  Synergi  RP-Max  column  (Phenomenex,  Macclesfield,  UK)  eluted  at  a 
flow  rate  of  1  mL/min,  with  the  column  oven  maintained  at  40°C.  After  passing  through 
the  flow  cell  of  the  diode  array  detector  the  column  eluate  was  split  and  0.3  mL  was 
directed  to  a  LCQ  Deca  XP  ion  trap  mass  spectrometer  fitted  with  an  electrospray 
interface  as  illustrated  in  Figure  2.2  (Thermo  Finnigan,  San  Jose,  USA).  Analysis  was 
carried  out  using  both  negative  and  positive  ion  mode  for  the  detection  of  phenolic 
compounds  in  wine  and  biological  samples. 
Various  gradients  and  conditions  were  used  to  detect  phenolic  compounds  in  wine  and 
biological  samples  (Table  2.2).  Full  scan  mode  was  used  for  the  accurate  determination 
of  the  parent  ion  and  data-dependant  MS2  mode  used  to  obtain  fragmentation  data.  In 
this  analysis  the  spectrum  of  ions  is  first  scanned  from  m/z  (mass  to  charge  ratio)  100  to 
2000  amu.  The  most  significant  ion  in  the  scan  is  then  collected  in  the  ion  trap, 
fragmented  and  the  spectrum  of  the  fragments  recorded.  The  mass  spectral  information 
was  used  to  identify  the  compounds.  The  m/z  ratio  of  the  molecular  ion  and  the 
fragmentation  pattern  from  these  give  unique  fingerprints  for  each  compound.  Selective 
reaction  monitoring  was  used  where  compounds  could  not  be  identified  using  the  full 
scan  mode.  Selective  reaction  monitoring  mode  provides  an  extremely  selective  method 
for  detecting  target  compounds.  During  chromatography  the  SRM  mode  removes  all 
signals  except  from  the  characteristic  process,  MS  1  is  set  to  transmit  a  precursor  ion  that 
is  specific  to  the  target  compound  and  MS2  is  set  to  transmit  a  product  ion  of  that 
precursor. Catherine  Tsang,  2004 
Figure  2.2  LCQ  DECA  XP  ion  trap  mass  specvtrometer 
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Table  2.2  Gradient  conditions  and  MS  techniques  used  for  the  analysis  of  wine 
and  biological  fluids. 
Sample  Gradient  Ion  mode  Inj.  Vol.  SRM 
(mL) 
wine  5-40  %  acetonitrile  in  1%  formic  +/-  100  no 
acid  over  60  minutes 
wine  fractions  4-25  %  acetonitrile  in  1%  formic  +1-  100  no 
acid  over  60  minutes 
plasma  5  to  40  %  acetonitrile  in  0.1  %-  100  yes 
formic  acid  over  60  minutes 
urine  5  to  20  %  acetonitrile  in  0.1%  -  100  yes 
formic  acid  over  60  minutes 
rat  tissues  5  to  40  %  acetonitrile  in  0.1%  -  100  yes 
formic  acid  over  60  minutes 
+:  positive  ion,  -:  negative  ion,  SRM:  selective  reaction  monitoring Catherine  Tsang 
2.7  Analysis  of  phenolics  in  biological  tissue 
2.7.1  Extraction  of  phenolics  from  plasma 
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Proteins  in  plasma  were  precipitated  according  to  a  modified  method  of  Day  et 
al.  (2002).  In  brief  1.5  mL  of  acetonitrile  was  added  to  0.5  mL  plasma.  Samples  were 
vortexed  for  30  s  every  2  min  over  a  10  min  period,  before  centrifugation  at  4000  rpm 
for  20  min.  The  supernatant  was  removed  and  the  pellet  was  further  extracted  with  1.5 
mL  methanol  and  the  process  was  repeated  as  described  above.  The  two  supernatants 
were  mixed  and  dried  in  a  centrifugal  vaccum  concentrator  at  38°C  and  resuspended  in 
500  µL  of  10  %  methanol  in  1%  aqueous  formic  acid.  The  sample  was  centrifuged  at 
25000  g  for  10  min  and  analysed  by  HPLC-MS-MS. 
2.7.2  Extraction  of  phenolics  from  rat  tissues 
Liver,  kidney,  brain,  stomach,  duodenum/jejunum,  ileum,  caecum,  colon  and  faeces 
were  extracted  according  to  the  method  of  Mullen  et  al.  (2002b).  In  brief  4g  of  liver, 
kidney  and  brain,  and  2.5  g  of  gastrointestinal  tract  organs  were  extracted  by  continuous 
shaking  with  15  mL  of  50  %  methanol  in  50  %  0.1  M  phosphate  buffer  (pH  7) 
containing  20  mM  sodium  diethyldithiocarbamate.  After  30  min,  the  mixture  was 
centrifuged  at  4000  rpm  for  20  min.  The  methanolic  supernatant  was  decanted  and  the 
pellet  re-extracted  a  further  two  times.  The  three  methanolic  supernatants  were 
combined  and  the  methanol  was  removed  in  vacuo.  The  remaining  aqueous  phase  was 
adjusted  to  pH  3.0  and  partitioned  three  times  with  an  equal  volume  of  ethyl  acetate. 
The  ethyl  acetate  extracts  were  combined  and  reduced  to  dryness  in  vacuo  prior  to 
HPLC-MS  analysis.  Residual  ethyl  acetate  was  removed  from  the  aqueous  phase  prior 
to  loading  onto  a  pre-conditioned  2g  Sep-Pak  C18  cartridge.  Methanol  was  used  to 
remove  polar  compounds,  and  the  extract  was  dried  in  vacuo  and  subsequently  analysed 
by  HPLC-MS-MS. Catherine  Tsang 
2.8  Measurement  of  fasting  plasma  lipids 
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Fasting  plasma  lipids  including  total  cholesterol,  high-density  lipoprotein  (HDL) 
cholesterol,  LDL  cholesterol  and  triacylglycerol  (TAG)  concentrations  were  determined 
by  the  Routine  Lipids  Laboratory,  Department  of  Pathological  Biochemistry,  Glasgow 
Royal  Infirmary  using  an  automated  Hitatchi  197  multichannel  analyser  (Roche 
Diagnostics,  Lewes,  East  Sussex,  UK).  Total  cholesterol  and  TAG  concentrations  were 
determined  using  enzymatic  in  vitro  colorimetric  assays.  HDL  cholesterol 
concentrations  were  determined  using  an  enzymatic  in  vitro  colorimetric  assay  after 
precipitation  of  apo-B  containing  lipoproteins  with  heparin/0.092  M  MnC12  and  LDL 
cholesterol  concentrations  were  calculated  using  the  Friedewald  formula  (Friedewald  et 
al.,  1972). 
2.9  Statistics 
Data  are  presented  as  mean  values  ±  standard  error  of  mean  (SEM),  n=3.  Each 
sample  was  analysed  in  triplicate  and  calibrated  against  relevant  standards  where 
appropriate.  Multivariate  correlation  analysis  of  experimental  data  was  performed 
according  to  Pearson's  Correlation  (Chapter  3).  Calculations  quantified  the  relationship 
between  two  sets  of  experimental  variables.  The  correlation  coefficient  r,  quantified  the 
direction  and  magnitude  of  the  correlation  and  ranged  from  -1  to  +1.  Independent  2- 
sample  paired  t-tests  were  used  to  assess  differences  between  groups  and  an  unpaired  t- 
test  was  used  to  assess  differences  within  groups  (Chapter  4).  A  one-way  ANOVA  was 
used  to  determine  the  differences  in  plasma  antioxidant  capacity  between  each  time 
interval  (Chapter  5).  Values  at  P<0.05  were  considered  statistically  significant.  ns  =  not 
significant,  *P<0.05,  **P<0.01,  ***P<0.001,  as  compared  to  relevant  control.  Analysis 
was  carried  out  using  Minitab  software  version  12  (Minitab  Inc.,  Addison-Wesley 
Publishing  Co.,  Reading,  MA,  USA). Catherine  Tsang  78 
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Chapter  3  Identification  of  the  major  phenolics  in  red 
wine 
3.1  Introduction 
Phenolic  compounds  are  important  components  of  red  wine  contributing  to  the 
organoleptic  and  sensory  properties,  preservation  and  ageing  of  wine  (Robichaud  & 
Noble,  1990;  Soleas,  1997).  Phenolic  compounds  are  largely  derived  from  the  skins  of 
grapes,  particularly  the  epidermal  cells,  and  seeds,  with  their  concentration  being  very 
low  in  the  pulp.  Red  wine  provides  an  excellent  source  of  various  classes  of  phenolic 
compounds  and  may  contain  between  1000-4000  mg  L-1  (Bravo  et  al.,  1998).  Although 
structurally  diverse,  phenolics  fall  into  one  of  two  major  classes  -  the  flavonoids  and  the 
non-flavonoids.  Flavonoids  include  the  flavonols  quercetin,  myricetin,  kaempferol  and 
Isorhamnetin,  existing  as  aglycones  and  sugar  conjugates;  the  flavan-3-ols  (+)-catechin 
and  (-)-epicatechin;  and  the  anthocyanins,  pigments  responsible  for  the  colour  of  red 
wines.  Collectively  flavonoid  levels  are  20-fold  higher  in  red  wines  than  in  white  wine 
(Soleas  &  Goldberg,  1999).  The  non-flavonoids  comprise  the  hydroxybenzoates, 
including  gallic  acid  and  the  hydroxycinnamates,  encompassing  p-coumaric  acid, 
caffeic  acid  and  caftaric  acid.  The  concentration  and  composition  of  phenolics  in  wine 
depends  on  a  range  of  factors  including  grape  variety  and  vintage  (Landrault  et  al., 
2001),  variations  in  climate  and  vinification  practices  (Goldberg  et  al.,  1998;  Price  et 
al.,  1995),  and  the  ageing  process  (Shahidi  &  Naczk,  1995).  As  a  result  the  phenolic 
content  and  antioxidant  capacity  of  red  wine  is highly  variable. 
Recently  much  effort  has  been  expended  on  the  analysis  of  red  wine,  particularly  the 
relationship  between  the  phenolic  content  and  antioxidant  activity.  The  antioxidant 
activity  of  red  wines  have  been  associated  with  their  total  phenolic  content  (Minussi  et 
al.,  2002;  Fogliano  et  al.,  1999;  Sato  et  al.,  1996),  yet  the  contribution  of  individual 
phenolic  compounds  to  the  total  antioxidant  activity  has  been  little  studied.  Results  to 
date  have  been  inconsistent  with  studies  reporting  associations  between  the  antioxidant 
properties  of  red  wines  with  the  levels  of  flavan-3-ols  (Teissedre  et  al.,  1996;  Simonetti 
et  al.,  1997),  anthocyanins  (Ghiselli  et  al.,  1998;  Pellegrini  et  al.,  2000)  and  tannic  acid 
(Larrauri  et  al.,  1999). Catherine  Tsang  80 
The  existing  methods  for  the  separation  and  identification  of  phenolic  compounds  in 
wine  have  been  largely  based  on  standard  HPLC  techniques  with  absorbance  (Burns  et 
al.,  2000)  and  fluorimetric  (Rodriguez-Delgado  et  al.,  2002)  detection.  Among  other 
detection  systems  used,  mass  spectrometry  has  proved  to  be  effective  and  of 
considerable  value.  The  technique  of  fractionation  has  been  employed  in  an  attempt  to 
separate  phenolic  compounds  in  foods  and  beverages  using  both  solid  phase  and  liquid- 
liquid  extraction.  Previous  studies  have  demonstrated  that  red  wine  phenolics  have  been 
separated  using  small-scale  liquid-liquid  extraction  (C18  Sep-Pak  cartridge)  methods 
(Ghiselli  et  al.,  1998;  Oszmianski  et  al.,  1998;  Sun  et  al.,  1998).  However  one  of  the 
major  disadvantages  with  this  method  is  the  lack  of  selectivity  due  to  the  differences  in 
polarity  between  different  phenolics  within  a  group.  Therefore,  the  accurate 
identification  of  single  phenolic  compounds  in  complex  mixtures,  such  as  red  wine,  is 
not  straight  forward.  Recently  large-scale  preparative  HPLC  has  been  used  for  the 
separation  of  phenolic  compounds  in  raspberries  (Mullen  et  al.,  2002a)  and  tea  (McGinn 
et  al.,  2001).  This  facilitated  the  identification  of  sanguin-H6  as  the  major  antioxidant  in 
raspberries,  while  in  green  tea  ECGC  was  the  main  antioxidant  component. 
This  chapter  reports  on  a  study  in  which  the  major  phenolic  contributors  to  the 
antioxidant  capacity  of  red  wines  were  investigated.  Thirty-one  red  wines  were  analysed 
using  several  complimentary  techniques  to  determine  their  phenolic  content  and 
antioxidant  activity.  HPLC  with  diode  array  detection  and  tandem  mass  spectrometry 
was  used  to  identify  the  phenolic  composition  of  the  wines.  Antioxidant  activity  was 
determined  in  the  FRAP  and  ESR-derived  antioxidant  assays.  Preparative  HPLC  and  an 
on-line  ABTS+  antioxidant  assay  were  carried  out  to  identify  specific  compounds  in 
wine  possessing  antioxidant  activity. Catherine  Tsang 
3.2  Phenolic  content  and  antioxidant  activity  of  wines 
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Thirty  one  red  wines  were  analysed  for  their  phenolic  content  and  antioxidant 
capacity.  Samples  were  selected  to  represent  a  variety  of  wines  produced  from  various 
grape  cultivars  and  geographical  regions.  Details  of  vintage,  origin  and  varietal 
composition  of  each  wine  are  detailed  in  Chapter  2  (Table  2.1).  The  total  phenolic 
content  of  each  wine  was  determined  in  the  Folin-Ciocalteu  colorimetric  assay 
(Singleton  and  Rossi,  1965).  Total,  free  and  polymeric  anthocyanins  were  measured  in 
the  colorimetric  method  of  Ribereau-Gayon  and  Stonestreet  (1965),  and  the  FRAP- 
derived  antioxidant  assay  of  Benzie  and  Strain  (1996)  was  used  to  estimate  the 
antioxidant  capacity  of  each  wine.  The  results  obtained  are  presented  in  Table  3.1. 
3.2.1  Determination  of  total  phenolics 
There  were  almost  four-fold  differences  in  the  concentrations  of  total  phenolics 
observed  in  the  different  wines  analysed.  Total  phenolic  content  varied  from  587  to 
2827  mg  L'  gallic  acid  equivalents  (GAE).  These  figures  are  comparable  with  values 
obtained  for  red  wines  by  other  investigators  (Burns  et  al.,  2000;  Frankel  et  al.,  1995; 
Sato  et  al.,  1996).  In  the  current  study  phenolic-rich  wines  included  a  2000  Young 
Vatted  Spanish  Tempranillo  (wine  13),  a  2000  South  African  Cabernet  Sauvignon  (wine 
21),  a  2001  Young  Vatted  Bulgarian  Merlot  (wine  15)  and  a  2000  Young  Vatted 
Bulgarian  Cabernet  Sauvignon  (wine  31).  Lowest  concentrations  were  detected  in  wine 
3,  a  2001  Beaujolais,  and  a  2001  Vin  de  pays  L'Ardeche  (wine  16)  with  values  of  1389 
and  587  mg  UI  obtained,  respectively. 
3.2.2  Determination  of  anthocyanins 
Polymeric  anthocyanins  were  present  in  all  wines  in  larger  amounts  than  free 
anthocyanins.  The  highest  total  anthocyanin  concentrations,  212.1  and  202  mg  L"1 
malvidin-3-glucoside  equivalents,  were  detected  in  wine  6,  a  2001  French  Syrah  and 
wine  15,  a  Young  Vatted  Bulgarian  Merlot,  respectively  (Table  3.2).  The  lowest  levels, 
28  and  43.3  mg  L"1  malvidin-3-glucoside  equivalents,  were  observed  in  wine  16,  a  2001 
Vin  de  pays  L'Ardeche  and  wine  9,  a  1999  Chianti  Classico,  respectively. Catherine  Tsang 
3.2.3  Measurement  of  reducing  ability 
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The  ability  of  each  wine  to  reduce  a  Fe("  -2,4,6-Tri-(2-pyr-idyl)-s-triazine  (iron 
chloride-TPTZ)  complex  to  Fe("  -TPTZ  (iron-sulphate  TPTZ)  was  assessed  in  the 
FRAP-derived  antioxidant  assay  and  values  ranging  from  6.3  to  29.4  mM  Fe(")  were 
obtained.  Wine  3,  a  French  Beaujolais  and  Vin  de  pays  L'Ardeche  (wine  16)  showed 
the  lowest  activities,  while  a  Spanish  Young  Vatted  Tempranillo  (wine  13)  and  a  South 
African  Cabernet  Sauvignon  (wine  21)  were  ranked  first  and  second,  respectively.  The 
relationship  between  phenolic  content  with  reducing  ability  in  the  FRAP-derived 
antioxidant  assay  of  each  wine  was  analysed  using  Pearson's  correlations.  FRAP- 
derived  antioxidant  activity  was  highly  and  significantly  correlated  with  total  phenolic 
concentration  (r=0.972,  P<0.001)  and  moderately  correlated  with  total  anthocyanin 
content  (r=0.434,  P<0.05)  and  polymeric  pigment  content  (r2=0.594;  P<0.001). Catherine  Tsang  83 
Table  3.1  Phenolic  composition  and  antioxidant  capacity  of  red  wines. 
wine  TP  a  PR  TA'  PP  FA  e 
1.  Claret  non-vintage  2245  f  30  22  ±0  138  ±6  66  ±0  72  ±7 
2.  Beaune  2458  f  36  23  ±1  61  ±7  27  ±5  34  ±1 
3.  Beaujolais  1389±7  12±0  72±4  46±4  27±1 
4.  Cotes  du  Rhone  2034  ±  24  18  ±0  89  ±2  64  ±8  25  ±0 
5.  Vin  de  pays  de  L'Ardeche  1983  f  11  20  ±1  101  ±2  85  ±  10  16  ±0 
6.  Etienne  Barret  Crozes  Hermitage  2004  f  13  18  ±0  212  ±6  66  ±3  146  ±3 
7.  Minervois  2038  ±  32  19  ±0  123  ±  10  73  ±1  50  ±9 
8.  Corbieres  2352  t  25  23  ±1  144  ±0  108  ±2  36  ±0 
9.  Chianti  Classico  2424  t  23  24  ±1  43  ±  34  57  ±5  n.  d 
10.  Valpolicella  1762  ±  38  18  ±1  97  ±6  50  ±8  47  ±0 
11.  Aged  in  Oak  Valdepenas  Reserva  2202  ±  69  23  ±0  93  ±4  71  ±1  22  ±3 
12.  Castillo  de  Sierra  Rioja  1537  ±  42  16  ±0  81  ±1  46  ±6  35  ±0 
13.  Young  Vatted  Tempranillo  2827  ±  26  29  ±1  118  ±0  77  ±2  41  ±0 
14.  Bairrada  2032±40  20±0  83  ±4  38±4  45  ±0 
15.  Young  Vatted  Merlot  2729  ±  69  29  ±0  202  ±1  105  ±1  97  ±0 
16.  Vin  de  Pays  L'Ardeche  Rose  587  ±  10  6±0  28  ±1  10  ±5  18  ±0 
17.  Australian  Red  1819  ±  15  19  ±1  86  ±1  61  ±5  25  ±0 
18.  Australian  Oaked  Cab.  Sauv.  1811  ±  10  18  ±0  113  ±2  55  ±0  59  ±2 
19.  Young  Vatted  Pinotage  2578  ±  30  27  ±1  127  ±6  83  ±6  43  ±1 
20.  Cinsault  1611  ±  13  16±1  81±1  41±5  40±0 
21.  Cabernet  Sauvignon  2776  ±8  28  ±1  139  ±3  83  ±2  57  ±1 
22.  Caballo  de  Plata  1666  f  32  16  ±0  72  ±6  52  ±6  21  ±0 
23.  Cabernet  Sauvignon  2048  f  36  21  ±0  112  ±1  61  ±2  51  ±0 
24.  Argentinian  Shiraz  1784  ±  39  19  ±0  109  ±3  65  ±6  44  ±0 
25.  Inti  Malbec  2133  f  12  22  ±0  156  ±4  61  ±1  95  ±3 
26.  Chilean  Dry  Red  1801  ±  16  18  ±0  132  ±0  95  ±7  37  ±0 
27.  Chilean  Cabernet  Merlot  1965  ±  13  20  ±0  140  ±0  82  ±0  58  ±0 
28.  Chilean  Cab.  Sauv.  2246  ±  26  23  ±0  152  ±1  92  ±9  61  ±0 
29.  Granverano  Carmenere  2115  ±  11  22  ±1  172  ±0  94  ±2  78  ±0 
30.  Pinot  Noir  Estancia  2282  ±  23  24  ±1  97  ±1  44  ±5  53  ±0 
31.  Young  Vatted  Cab.  Sauv.  2597  ±  131  23  ±3  159  ±4  105  ±9  53  ±0 
a  TP-total  phenolics  expressed  as  gallic  acid  equivalents  (mg  L-1);  b  PR-ferric  reducing 
power  (FRAP)  expressed  as  concentration  of  Fe  (II)  produced  (mM);  "  d'e  TA-total 
anthocyanins;  PP-polymeric  pigments  and  FA-free  anthocyanins.  Results  are  expressed 
as  malvidin-3-glucoside  equivalents  (mg  L-1)  ±  standard  error,  where  n=3.,  n.  d.  not 
detected. Catherine  Tsang 
3.3  HPLC-tandem  mass  spectrometry  analysis  of  wines 
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The  levels  of  individual  phenolics  were  determined  by  HPLC-tandem  mass 
spectrometry  (MS-MS)  and  diode  array  detection.  A  selection  of  the  wines  exhibiting 
high  and  low  phenolic  contents  and  antioxidant  activities  were  analysed  including  a 
2000  Young  Vatted  Bulgarian  Cabernet  Sauvignon  (wine  31),  a  2000  Young  Vatted 
Spanish  Tempranillo  (wine  13),  a  2001  Young  Vatted  Bulgarian  Merlot  (wine  15),  a 
2001  Chilean  Cabernet  Sauvignon  (wine  28)  and  wine  3,  a  2001  French  Beaujolais. 
Samples  were  analysed  on  a  Surveyor  HPLC  system  using  a  60  min,  5-40  %  gradient  of 
acetonitrile  in  1%  aqueous  formic  acid.  The  column  eluate  being  directed  first  to  a 
diode  array  absorbance  monitor  and  then  to  a  mass  spectrometer  with  an  electrospray 
interface  operating  in  full  scan  MS/MS  mode.  Samples  were  analysed  in  both  positive 
and  negative  ionization  mode.  In  total  19  phenolic  compounds  were  identified  in  each 
wine  based  on  MS/MS  data  and  Xmax"  The  results  are  summarised  below  and  presented 
in  Table  3.2. 
Peak  1  (tR  =  5.3  min,  Xmax  =  265  nm)  had  a  [M-H]-  at  m/z  169  with  MS2  yielding 
a  charged  fragment  ion  at  m/z  125.  The  mass  spectrometric  data  and  co-chromatography 
with  an  authentic  standard  confirmed  that  this  compound  is  gallic  acid. 
Peak  2  (tR  =  6.9  min,  X,,,  ax  =  265  nm)  had  a  [M-H]-  at  m/z  865  with  MS2  yielding 
two  charged  fragment  ions  at  m/z  577  and  289.  Based  on  the  mass spectral  data  this 
compound  is  a  procyanidin  trimer  and  its  elution  prior  to  dimer  B1  (Santos-Buelga  et 
al.,  1995)  indicates  that  it  is  likely  to  be  the  trimer  procyanidin  C2,  a  known  component 
of  red  wine  (De  Pascual-Teresa  et  al.,  2000b). 
Peak  3  (tR  =  13.4  min, 
%max  =  280  nm)  had  a  [M-H]"  at  m/z  577,  with  MS2 
producing  three  major  charged  fragment  ions  at  m/z  425,407  and  289.  Based  on  the 
mass  spectral  data  this  compound  is  a  procyanidin  dimer.  Co-chromatography  with  a 
standard  indicated  the  dimer  was  procyanidin  B  1,  a  known  component  of  red  wine  (De 
Pascual-Teresa  et  al.,  2000b). 
Peak  4  (tR  =  14.3  min,  Xmax  =  515  nm)  had  a  [M-H]+  at  m/z  465  which 
fragmented  with  MS2  to  produce  a  delphinidin-like  ion  at  m/z  303  with  the  [M-H]+-162, 
corresponding  to  loss  of  a  glucose  moiety.  This  peak  is,  therefore,  the  anthocyanin 
delphinidin-3-glucoside,  previously  identified  in  red  wine  by  Bums  et  al.  (2002). Catherine  Tsang  85 
Peak  5  (tR  =  15.4  min,  Amax  =  280  nm)  had  a  [M-H]-  at  m/z  289,  yielding  two 
charged  ions  at  m/z  245  and  205.  This  mass  spectrum  and  co-chromatography  with  an 
authentic  standard  established  that  peak  4  is  the  flavan-3-ol  (+)-catechin. 
Peak  6  (tR  =  17.8  min,  X.,,  =  515  nm)  had  a  [M-H]+  at  m/z  479  which  on  MS2 
yielded  a  fragment  ion  at  m/z  317  which  corresponds  with  petunidin  ([M-H]+-162, 
cleavage  of  a  glucosyl  unit)  indicating  the  presence  of  petunidin-3-glucoside  which  has 
previously  been  detected  in  red  wines  (Burns  et  al.,  2002). 
Peak  7  (tR  =  18.3  min,  a,,,,  ax  =  280  nm)  had  a  [M-H]-  at  m/z  577  with  MS2 
yielding  three  charged  fragment  ions  at  m/z  425,405  and  289.  Based  on  the  mass 
spectral  data  this  peak  is  a  procyanidin  dimer  and  co-chromatography  with  a  reference 
compound  revealed  that  it  is  procyanidin  B2,  previously  detected  in  red  wine  by  De 
Pascual-Teresa  et  al.  (2000b). 
Peak  8  (tR  =  19.8  min,  Amax  =  280  nm)  had  a  [M-H]-  at  m/z  289,  which  on  MS2 
yielding  ions  at  m/z  245,205  and  179.  Co-chromatography  with  an  authentic  standard 
confirmed  the  identification  of  peak  7  as  (-)-epicatechin. 
Peak  9  (tR  =  20  min,  ?  max  =  510  nm)  had  a  [M-H]+  at  m/z  463  which  on  MS2 
exhibited  a  162  amu  loss,  corresponding  to  cleavage  of  a  glucosyl  unit,  producing  a 
fragment  ion  at  m/z  301  which  corresponds  to  peonidin.  This  is  in  keeping  with  the 
presence  of  peonidin-3-O-glucoside,  a  known  component  of  red  wine  (Burns  et  al., 
2002). 
Peak  10  (tR  =  21  min,  Xmax  =  515  nm)  had  a  [M-H]+  at  m/z  493,  MS2  produced  a 
fragment  ion  at  m/z  331  ([M-H]+-162,  loss  of  a  glucosyl  unit).  This  peak  was  confirmed 
as  malvidin-3-O-glucoside  by  reference  to  an  authentic  standard. 
Peak  11  (tR  =  21.7  min,  Xma.  =  280  nm)  had  a  [M-H]-  at  m/z  865  with  MS2 
yielding  two  charged  fragment  ions  at  m/z  577  and  289.  Based  on  the  mass  spectral  data 
this  compound  is  a  procyanidin  trimer  and  its  elution  after  (-)-epicatechin  (Santos- 
Buelga  et  al.,  1995)  indicates  that  it  is  procyanidin  C1,  a  known  component  of  red  wine 
(Sanchez-Moreno  et  al.,  2003). 
Peak  12  (tR  =  25  min,  Xmax  =  510  nm)  had  a  [M-H]+  at  m/z  517  with  MS2 
yielding  a  charged  fragment  ion  at  m/z  355.  Although  a  reference  compound  is  not 
available,  the  elution  order  of  this  peak  after  malvidin-3-glucoside  and  the  mass  spectral 
data  indicate  that  it  may  be  vitisin  B  which  has  been  detected  in  red  wines  by  Morata  et 
al.  (2003)  and  is  the  adduct  resulting  from  the  reaction  between  malvidin-3-glucoside 
and  acetaldehyde. Catherine  Tsang  86 
Peak  13  (tR  =  25  min,  Xmax  =  370  nm)  had  a  [M-H]-  at  m/z  479  with  MS2  yielding 
a  fragment  ion  at  m/z  317,  (162  amu  loss,  cleavage  of  a  glucosyl  unit)  which 
corresponds  with  myricetin  indicating  that  this  compound  is  a  myricetin  glucoside. 
Peak  14  (tR  =  29.1  min,  ?  max  =  515  nm)  had  a  [M-H]+  at  m/z  533  which  on  MS2 
yielded  a  charged  fragment  ion  at  m/z  331  ([M-H]+-204,  loss  of  an  acetylglucosyl  unit). 
On  the  basis  of  the  MS2  spectra  and  the  elution  order  of  anthocyanins,  this  peak  is 
identified  as  malvidin-3-acetylglucoside  previously  detected  in  red  wines  (Burns  et  al., 
2002). 
Peak  15  (tR  =  29.6  min,  ?  max  =  350  nm)  had  a  [M-H]"  at  m/z  471,  MS2  yielded  a 
fragment  ion  at  m/z  301  ([M-H]--176,  cleavage  of  a  glucuronyl  group).  On  the  basis  of 
the  MS2  spectral  data  and  co-chromatography  with  an  authentic  standard  this  peak  is 
identified  as  quercetin-3-glucuronide. 
Peak  16  (tR  =  34.4  min,  Xax  =  350  nm)  had  a  [M-H]-  at  m/z  317  which 
corresponds  with  the  flavonol  aglycone  myricetin.  Co-chromatography  with  an 
authentic  standard  confirmed  the  presence  of  myricetin. 
Peak  17  (tR  =  35.2  min,  k  ax  =  525  nm)  had  a  [M-H]+  at  m/z  639  fragmentation 
by  MS2  yielded  a  charged  fragment  ion  at  m/z  331  ([M-H]+-308,  loss  of  a  p- 
coumaroylgluco  side  group).  Based  on  the  absorbance  and  mass  spectral  data  and  the 
elution  profile  of  this  compound  it  is  likely  to  be  the  anthocyanin  malvidin-3-(p- 
coumaroyl)-glucoside  (Bums  et  al.,  2002). 
Peak  18  (tR  =  43.5  min,  , max  =  370  nm)  had  a  [M-H]-  at  m/z  301  and  the  identity 
of  this  peak  was  confirmed  as  the  flavonol  aglycone  quercetin  by  co-chromatography. 
Peak  19  (tR  =  51  min,  Xmax  =  370  nm)  had  a  [M-H]-  at  m/z  285  which  indicates 
the  presence  of  kaempferol  and  this  identification  was  confirmed  by  co-chromatography 
with  an  authentic  standard. --------  ý-"  ý,  O  00  ']  Oý  vi  WN 
"O  oo  ýl  ON  (A  WN-  Cl 
vi  4ýI.  WWNNNNNN- 
r  --"  W  (A  -P  ýG  ýO  N  vh  -  ý-.  O  00  --j  cý  W  C> 
. 
O  (_A  N  O,  -O  0o  OO  00  0  00  WWw 
Ww  to  ww(-Aw  (j  )N  to  vi  NN  VA  N  L1)) 
ý1  JN  Uh  (-h  -  --)  -  00  --  00  00  -  00  -  00  00  01 
OO  UN  O0  V)  OOO  (j)  OOO  to  O  vi  O0  cn 
-,  <coea  CD  ncn  ^a  nn 
(D  (D  CL  CL 
CL 
týo  W  ('D 
CD  CD  o  CD 
WCD  no  oJ  ýn 
Ä.  ä  äý  NN 
(D  CD  CD 
ö  CD 
Cl. 
0 
c) 0 
1D 
CD 
NW  Oý,  W  vý  cý  pp  N  to  -;::,  N  -;  ý,  (A  Oo 
Oo  OW-  ýl  W  ýl  --  a1  ýO  Oý  00  ý]  --)  00  O,  ýl 
Vi  ý-"  ýO  vJ  ýO  ý1  vi  WW  ýG  J  "o  ýG  IýA  --l  t!  i  ýO 
+++++++ 
W 
wI 
WWWW 
Ow  .  -r  vý 
Vi  W 
-w 
W- 
O  .pW  -" 
N-  Oý 
W  Vi 
O  N-  N 
ý 
w 
öt  o  CD 
ILA 
d 
+xx  x  x  x  x 
u 
- 
u  `J 
b 
ýD 
Aý 
T' 
'H 
?' 
m 
x 
R 
n 
0 
ý' 
0 
c 
a 
ý7. 
a'. 
ý-. 
N 
O 
I 
N 
'-3 AZ'N 
wN 
N 
-1 
CD  N 
n 
C 
C 
Z$ 
Ö 
O 
ä  Q" 
CD 
CD 
O 
0 
CD 
cD 
CD 
O 
b 
n 
CD 
CD 
0 
rD 
p-. 
p.. 
CD 
U.. 
ý"  o0 
zi  v Catherine  Tsang 
3.4  Levels  of  phenolics  in  selected  wines 
88 
The  levels  of  19  phenolic  and  polyphenolic  compounds  were  measured  by 
HPLC-MS-MS  and  the  results  obtained  are  summarised  below  and  presented  in  Table 
3.3.  There  was  a  wide  variation  in  the  levels  of  phenolics  in  each  wine;  however  gallic 
acid,  the  flavan-3-ols  and  the  anthocyanins  were  the  most  abundant  compounds. 
The  levels  of  gallic  acid  varied  almost  4-fold  from  69  mg  L-1  in  a  French  Beaujolais 
(wine  3)  to  282  mg  L-I  in  wine  31,  a  Young  Vatted  Bulgarian  Cabernet  Sauvignon.  (+)- 
Catechin,  (-)-epicatechin  and  procyanidin  dimers  B1  and  B2  were  identified  by  LC-MS, 
with  total  flavan-3-ols  ranging  from  145  mg  L"1  to  260  mg  L-1  in  wine  15,  a  Young 
Vatted  Bulgarian  Merlot  and  a  Spanish  Tempranillo,  respectively.  (+)-Catechin  was 
invariably  present  in  larger  amounts  than  (-)-epicatechin  in  all  wines  analysed.  The 
highest  concentration  was  found  in  wines  31  and  13  contributing  22  %  and  17  %  of  the 
total  flavan-3-ols,  respectively. 
Seven  anthocyanins  (two  of  them  acylated)  were  identified  in  red  wines:  malvidin-3- 
glucoside,  delphinidin-3-glucoside,  petunidin-3  -gluco  side,  peonidin-3-glucoside, 
malvidin-3-acetyl-glucoside,  malvidin-3-(p-coumaroyl)  glucoside  and  vitisin  B.  Total 
anthocyanins  ranged  from  80  mg  L-1  to  477  mg  L-1  in  wine  3  and  28,  respectively. 
Malvidin-3-glucoside  constituted  the  main  anthocyanin  in  wines  and  levels  varied 
almost  8-fold  from  43  mg  L-1  in  wine  3,  a  French  Beaujolais  to  305  mg  L-1  in  wine  28,  a 
Chilean  Cabernet  Sauvignon. 
Flavonols  were  minor  components  in  the  wines  compared  with  other  classes  of 
phenolics  identified,  with  quercetin,  myricetin,  kaempferol  and  conjugates  of  quercetin 
and  myricetin  detected.  Total  flavonols  ranged  from  4  to  17.3  mg  L-1  in  wine  3,  a 
French  Beaujolais  and  and  a  Spanish  Tempranillo  (wine  13),  respectively. oC 
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3.5  Identification  of  the  major  antioxidants  in  red  wine 
90 
Two  techniques  were  employed  to  identify  the  major  phenolic  compounds  in 
wine  contributing  to  the  in  vitro  antioxidant  activity;  an  on-line  ABTS+  antioxidant 
assay  and  preparative  HPLC  as  detailed  in  Chapter  2  (section  2.5.3  and  2.5.5, 
respectively).  Although  the  technique  of  preparative  HPLC  has  been  successful  for  the 
separation  of  compounds  in  tea  and  raspberries,  it  did  not  allow  for  the  complete 
separation  of  compounds  in  red  wine.  Nevertheless,  the  results  indicated  a  significant 
correlation  between  the  total  catechin  content  of  wine  fractions  with  ESR-derived 
antioxidant  activity.  On-line  analysis  of  individual  compounds  in  red  wine  was 
measured  in  the  ABTS+  antioxidant  assay.  This  method  allowed  the  complete  separation 
of  compounds  in  wine,  while  at  the  same  time,  measured  their  antioxidant  activity. 
3.5.1  Preparative  HPLC 
Ten  mL  of  a  Chilean  Cabernet  Sauvignon  (wine  28)  was  injected  on  a  preparative 
HPLC  system  comprising  two  HPLC  pumps,  a  UV  absorbance  detector,  monitoring  at 
520  and  371  nm,  and  a  preparative  injector  with  a  10  mL  injection  loop.  Separation  was 
carried  out  using  a  40  min  gradient  of  5  to  30  %  ACN  in  0.5  %  TFA  (with  a5  min  hold 
at  30  %)  on  a  150  x  20  mm  i.  d.  5  µm  ODS-H  column  eluted  at  a  flow  rate  of  10 
mL/min,  with  the  column  oven  maintained  at  40°C.  Sixty  fractions  were  collected  3  min 
after  the  injection  of  the  wine  collecting  7.5  mL/min  of  eluent.  Each  fraction  was 
measured  for  total  phenolic  content,  anthocyanin  content  and  antioxidant  activity  in  the 
ESR-derived  antioxidant  assay.  Selected  fractions  exhibiting  high  phenolic  contents  and 
antioxidant  abilities  were  further  analysed  for  their  total  catechin  content,  and  HPLC- 
MS  was  used  to  identify  their  phenolic  composition. Catherine  Tsang 
3.5.1.2  Total  phenolics  and  ESR-derived  antioxidant  activity 
91 
The  total  phenolic  content  of  each  fraction  was  determined  using  the  Folin-Ciocalteu 
method  and  the  ability  of  the  sixty  wine  fractions  to  reduce  Fremy's  salt  free  radical  in 
the  ESR-based  antioxidant  assay  was  assessed  and  results  are  illustrated  in  Figure  3.1. 
Fraction  13  contained  the  highest  total  phenolic  content  with  78.3  mg  L-1  GAE 
obtained,  while  fractions  12  and  20  were  ranked  second  and  third  with  concentrations  of 
67  and  62.3  mg  L-1  GAE  obtained,  respectively.  The  greatest  antioxidant  activity  was 
observed  in  fraction  20  with  11.4  x  1021  radicals  reduced  L"1,  while  fractions  18  and  19 
were  ranked  second  and  third  with  antioxidant  activities  of  11.1  x  1021  and  11.0  x  1021 
obtained,  respectively.  The  total  phenolic  content  of  the  wine  fractions  were  highly  and 
significantly  associated  with  ESR-derived  antioxidant  activity  (r=0.816,  P<0.001) 
using  Pearson's  correlations. 
3.5.1.3  Determination  of  total  anthocyanins 
The  total  anthocyanin  content  of  each  wine  fraction  was  determined  using  a  pH  shift 
method  as  described  in  Chapter  2  (section  2.3.2)  and  results  are  illustrated  in  Figure  3.2. 
Fraction  31  contained  the  highest  concentration  of  total  anthocyanins  with  52  mg  UI 
malvidin-3-glucoside  equivalents  obtained,  followed  by  fraction  42  with  a  concentration 
of  20.1  mg  L-1  malvidin-3-glucoside  equivalents  obtained.  The  relationship  between 
total  anthocyanin  content  with  ESR-derived  antioxidant  activity  of  each  fraction  was 
assessed  using  Pearson's  correlations.  There  was  no  correlation  between  the  total 
anthocyanin  content  of  wine  fractions  with  antioxidant  activity  (r=0.188,  p=0.151). Catherine  Tsang  92 
3.5.1.4  Total  catechin  content  of  selected  fractions 
Selected  fractions  were  analysed  for  their  total  catechin  content  using  a  colorimetric 
method  by  Kivitis  et  al.,  (1997)  as  detailed  in  Chapter  2  (section  2.3.3).  Results  are 
illustrated  in  Figure  3.3.  Seventeen  fractions  were  analysed,  incorporating  fractions 
exhibiting  high  and  low  phenolic  contents  and  antioxidant  abilities.  Fraction  5  contained 
the  highest  concentration  with  75.1  mg  L-1  total  catechin  obtained,  while  the  lowest 
concentration  was  observed  in  fraction  31  with  a  value  of  1.5  mg  L-1  total  catechin.  The 
total  catechin  content  of  selected  fractions  was  highly  and  significantly  associated  with 
ESR-derived  antioxidant  activity  (r2  =  0.591,  P<0.01)  when  analysed  using  Pearson's 
correlations. 
3.5.1.5  HPLC-MS  analysis  of  selected  wine  fractions 
Analysis  of  the  individual  fractions  were  analysed  by  LC-MS/MS.  Separation  was 
carried  out  using  a  250  x  4.6  mm  i.  d.  4  µm  RP-Max  column  (eluted  at  a  flow  rate  of  1 
mL/min).  A  5-40  %  gradient  over  60  min  of  1%  formic  acid  and  acetonitrile  was  used 
for  the  complete  separation  of  all  compounds.  After  passing  through  the  flow  cell  of  the 
diode  array  detector  the  column  eluate  was  split  and  0.3  mL  was  directed  to  a  LCQ 
Deca  XP  ion  trap  mass  spectrometer  fitted  with  an  electrospray  interface  Analysis  was 
carried  out  in  full  scan  mode  from  100-2000  amu  using  the  positive  ion  mode  when 
analysing  anthocyanins  and  with  negative  ionisation  for  all  other  compounds.  LC- 
MS/MS  established  the  presence  of  gallic  acid  (tR=5.84  min,  , max  280  nm)  and 
procyanidin  trimer  (tR=8.52  min,  , max  277  nm)  in  fractions  4  and  5.  Two  further 
compounds  were  detected  in  these  fractions  but  could  not  be  identified.  Fractions  13-20 
contained  procyanidin  dimer  B1  (tR=10.8  min,  , max  285  nm);  (+)-catechin  (tR=15.5 
min,  2,  max  280  nm);  (-)-epicatechin  (tR=20.5  min,  , max  280  nm)  and  procyandin  B2 
(tR=19.6  min,  , max  280  nm),  consistent  with  the  data  obtained  by  colorimetric  analysis 
of  total  catechins.  Fractions  26-31  contained  anthocyanins,  consistent  with  the  data 
obtained  by  colorimetric  analysis,  with  petunidin-3-glucoside  (tR=16.92  min,  , max  519 
nm)  and  malvidin-3-glucoside  (tR=25.98  min,  , max  525  nm)  identified  in  Fraction  31. Catherine  Tsang 
3.5.2  ABTS+  on-line  decolourisation  assay 
93 
The  antioxidant  activity  of  individual  components  in  the  5  selected  wines  was 
determined  using  the  ABTS+  on-line  decolourisation  assay  based  on  the  methods  of 
Dapkevicius  et  al.  (2001)  and  Koleva  et  al.  (2001)  described  in  Chapter  2  (section 
2.5.3).  In  brief,  a2  mM  ABTS+  stock  solution  containing  3.5  mM  potassium  persulfate 
was  prepared  and  incubated  at  room  temperature  in  darkness  overnight.  ABTS+  reagent 
was  preparted  by  diluting  the  stock  solution  8-fold  in  phosphate  buffer  at  pH  8.  Twenty 
µL  of  a  1:  5  dilution  of  wine  was  injected  into  a  HPLC  system  comprising  a  LC  pump,  a 
PDA  detector  and  a  UV-VIS  detector.  Separation  was  carried  out  using  a  250  x  4.6  mm 
i.  d.  4  µm  RP-Max  column  maintained  at  40°C  and  eluted  at  a  flow  rate  of  1  mL/min 
with  a  60  min  gradient  at  4-25  %  acetonitrile  and  0.1  %  formic  acid.  Following 
separation  of  the  compounds,  the  eluent  was  mixed  with  the  ABTS+  reagent  at  a  flow 
rate  of  0.5  mL/min  supplied  by  a  Shimadzu  LC-10  AP  VP  liquid  chromatography 
pump.  A  Shimadzu  GT-1543  vaccum  degasser  was  used  to  remove  any  oxygen  in  the 
reagent  prior  to  mixing.  After  mixing  through  a3mx0.25  mm  i.  d.  loop,  the  absorbance 
was  measured  by  a  UV  detector  at  720  nm.  The  results  obtained  are  presented  in  Table 
3.4  and  shown  in  Figures  3.4-3.8. 
The  major  antioxidants  detected  in  each  wine  had  an  absorbance  maximum  at  280  nm, 
with  9  peaks  being  identified.  Antioxidant  activity  was  clearly  associated  with  the 
presence  of  gallic  acid  and  the  flavan-3-ols.  Gallic  acid  was  identified  as  a  major 
antioxidant  component  of  red  wine  with  values  ranging  from  103  mg  L-1  to  269.2  mg  U 
1  Trolox  equivalents  in  a  French  Beaujoalis  (wine  3)  and  a  Young  Vatted  Bulgarian 
Cabernet  Sauvignon  (wine  31),  respectively.  The  flavan-3-ols  were  also  identified  as 
major  antioxidants  in  red  wines  with  (+)-catechin  and  (-)-epicatechin  being  the  most 
abundant  in  all  wines  analysed.  Values  ranging  from  67  to  130.4  mg  L-1  Trolox 
equivalents  were  obtained  for  wine  3  and  wine  31,  respectively.  Procyanidin  dimer  B1 
ranged  from  32.4  mg  L-1  in  wine  15  to  128.3  mg  L-1  Trolox  equivalents  in  wine  3, 
contributing  6%  and  29  %  of  the  total  antioxidant  activity,  respectively.  The  Chilean 
Cabernet  Sauvignon  (wine  28)  exhibited  the  highest  activity  for  dimer  B2,  while  wine 
15  had  the  lowest  activity,  with  values  ranging  from  8.0  to  52  mg  L-1  Trolox 
equivalents. C-) 
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Figure  3.3  Total  (+)-catechin  content  of  selected  wine  fractions.  Results  are 
expressed  as  mg  L-1  (+)-catechin  equivalents  ±  standard  error,  where  n=3. ºý  A 
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Figure  3.4  On-line  ABTS+  analysis  of  a  Bulgarian  Cabernet  Sauvignon  (wine  31), 
showing  UV  absorbance  at  280  nm  (A)  and  720  nm  (B). Catherine  Tsang 
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Figure  3.5  On-line  ABTS+  analysis  of  a  French  Beaujolais  (wine  3),  showing  UV 
absorbance  at  280  nm  (A)  and  720  nm  (B). 
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Figure  3.6  On-line  ABTS+  analysis  of  a  Bulgarian  Merlot  (wine  15),  showing  UV 
absorbance  at  280  nm  (A)  and  720  nm  (B). Catherine  Tsang  101 
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Figure  3.7  On-line  ABTS+  analysis  of  a  Spanish  tempranillo  (wine  13),  showing  UV 
absorbance  at  280  nm  (A)  and  720  nm  (B). Catherine  Tsang 
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Figure  3.8  On-line  ABTS+  analysis  of  a  Chilean  Cabernet  Sauvignon  (wine  28), 
showing  UV  absorbance  at  280  nm  (A)  and  720  nm  (B). Catherine  Tsang 
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In  recent  years  there  has  been  a  great  interest  in  the  antioxidant  properties  of  red 
wine  emanating  from  a  wealth  of  epidemiological  evidence  indicating  that  a  moderate 
consumption  is  associated  with  a  reduced  mortality  from  cardiovascular  disease.  It  has 
been  suggested  that  the  antioxidant  properties  of  red  wine  may  be  linked,  to  some 
extent,  with  particular  classes  of  flavonoids.  In  the  present  study  a  highly  significant 
association  was  observed  between  total  phenolic  content  and  the  reducing  ability  in  the 
FRAP  derived  antioxidant  assay  and  is  comparable  with  the  findings  from  previous 
studies  (Arnous  et  al.,  2001;  Sanchez-Moreno  et  al.,  1999a).  Although  all  wines  showed 
activity,  those  produced  from  Cabernet  Sauvignon,  Merlot  and  Tempranillo  grape 
varieties  exhibited  the  highest  phenolic  contents  and  activities,  whereas  at  the  other  end 
of  the  scale  the  low  phenolic  content  of  wine  produced  by  Gamy  grapes  was 
characterized  by  a  markedly  lower  antioxidant  capacity.  Differences  in  the  techniques 
used  during  wine  production  further  contribute  to  the  large  variations  in  the  levels  of 
phenolics.  Extensive  skin  extraction  by  rotary  extraction  facilitates  the  release  of  more 
phenolics  than  traditional  methods  such  as  carbonic  maceration,  which  have  been 
described  for  the  Young  Vatted  Bulgarian  Cabernet  Sauvignon  and  Beaujolais, 
respectively  (Burns  et  al.,  2000). 
Gallic  acid,  the  flavan-3-ols  and  the  anthocyanins  were  the  most  abundant  phenolics 
identified  in  red  wines.  Although  the  flavonols  have  been  extensively  investigated 
recent  studies  have  shown  that  they  are  not  the  major  antioxidants  present  in  red  wine 
(Gardner  et  al.,  1999).  In  the  present  study  free  and  conjugated  flavonols  were  detected 
in  the  wines  but  their  concentration  was  comparatively  much  lower  than  any  other  class 
of  phenolic  identified.  Comparable  findings  have  been  documented  with  levels  of 
quercetin  ranging  from  0.5-5.3  mg  L-1  (Soleas  et  al.,  1997),  while  values  of  0.8  and  1.1 
mg  L-1  were  obtained  for  myricetin  and  kaempferol  in  red  wine,  respectively 
(Rodriguez-Delgado  et  al.,  2002).  The  flavonols  had  little  impact  on  the  antioxidant 
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Total  anthocyanin  content  of  each  wine  was  moderately  associated  with  FRAP-derived 
antioxidant  activity  (P  <  0.05),  however  no  correlation  was  observed  between  the 
anthocyanin  content  of  wine  fractions  with  ESR-derived  antioxidant  activity. 
Anthocyanins  have  been  shown  to  exhibit  antioxidant  properties  in  a  number  of  in  vitro 
systems  (Rice-Evans  et  al.,  1995;  Wang  et  al.,  1997),  however  other  studies  have 
indicated  that  they  are  not  the  major  antioxidants  in  red  wine  (Frankel  et  al.,  1995; 
Burns  et  al.,  2000).  The  determination  of  anthocyanins  by  spectrophotometry  has  been 
known  to  provide  an  inaccurate  estimation  of  the  total  monomeric  anthocyanins 
(Somers  and  Evans,  1977).  This  was  further  demonstrated  by  Bakker  et  al.  (1986),  who 
reported  the  large  differences  observed  in  total  anthocyanin  content  with 
spectrophotometry  and  HPLC  analysis.  The  weak  association  between  antioxidant 
activity  and  total  anthocyanin  content  may  also  be  due  to  the  fact  that  total  anthocyanin 
values  also  represent  polymeric  and  other  types  of  pigments  in  wine  which  may  not 
possess  any  antioxidant  activity.  Arnous  et  al.  (2002)  reported  that  the  correlation 
between  coloured  anthocyanins,  or  polymeric  pigments,  with  antioxidant  activity  was 
higher  compared  with  total  anthocyanin  content,  suggesting  that  the  ionization  state  of 
anthocyanins  may  be  important  with  respect  to  their  antiradical  activity.  In  the  present 
study  a  similar  pattern  was  observed  in  that  there  was  a  higher  correlation  between 
polymeric  anthocyanin  content  and  FRAP-derived  antioxidant  activity  (r2=0.594;  P< 
0.001)  than  with  total  anthocyanin  content  (r2=0.434;  P<0.01).  This  is  supported  by 
the  fact  that  pseudo-base  and  quinoidal-base  of  malvidin-3-glucoside,  generated  at  pH 
4.0  and  7.0,  respectively  show  different  antioxidant  behaviours  (Lapidot  et  al.,  1999).  In 
the  present  study  the  anthocyanins  in  red  wine  exhibited  modest  antioxidant  activity, 
however  previous  studies  have  shown  that  they  may  act  via  different  mechanisms. 
There  is  evidence  that  anthocyanins  derived  from  red  wine  induce  vasorelaxation 
mediated  via  the  release  of  nitric  oxide  (Andriambeloson  et  al.,  1998)  and  protect  the 
integrity  of  capillaries  against  free  radical  damage  in  animals  (Cao  et  al.,  1999). 
Additional  work  demonstrated  that  delphinidin,  but  not  malvidin  or  cyanidin,  was  able 
to  elicit  endothelium  dependent  vasorelaxation  in  vascular  tissue  (Fitzpatrick  et  al., 
1993). Catherine  Tsang  105 
McGinn  et  al.  (2000)  showed  an  inverse  relationship  between  vasodilatory  and 
antioxidant  activity  of  grape  extracts,  indicating  that  the  higher  the  antioxidant  activity 
of  the  extracts,  the  less  active  they  were  as  vasodilators.  The  authors  further  reported 
that  the  compounds  responsible  for  inducing  antioxidant  activity  were  distinct  from 
those  exhibiting  vasodilator  activities. 
Further  studies  have  reported  a  strong  correlation  between  the  total  flavan-3-ol  content 
of  red  wine  with  the  antioxidant  activity  (Simonetti  et  al.,  1997;  Burns  et  al.,  2000).  In 
this  study  the  total  catechin  content  of  selected  wine  fractions  separated  by  preparative 
HPLC  was  highly  and  significantly  associated  with  ESR-derived  antioxidant  activity  (P 
<  0.01).  Monomeric  and  oligomeric  flavanols;  (+)-catechin,  (-)-epicatechin,  procyanidin 
dimers  BI  and  B2,  were  major  antioxidant  components  of  red  wine,  while  trimers  and 
tetramers  exhibited  a  moderate  antioxidant  activity.  Low  molecular  weight  flavan-3-ols, 
especially  the  monomers  and  dimers  have  been  found  to  exert  greater  antioxidant 
activities  than  high  molecular  weight  compounds.  (+)-Catechin,  (-)-epicatechin, 
procyanidin  dimers  B1,  B2,  B3,  B4  and  procyanidin  trimers  C1  and  C2  inhibit  LDL 
oxidation  in  vitro  (Teissedre  et  al.,  1996)  more  efficiently  than  high  molecular  weight 
polymers  such  as  hexamers  (Lotito  et  al.,  2000).  Collectively  the  flavan-3-ols 
contributed  >  50  %  of  the  total  antioxidant  capacity  of  each  wine,  with  the  greatest 
activity  observed  in  the  Young  Vatted  Bulgarian  Cabernet  Sauvignon.  Gallic  acid  was 
also  a  major  antioxidant  component  of  red  wine  contributing  between  23-44  %  of  the 
total  antioxidant  capacity  in  a  French  Beaujolais  and  a  Bulgarian  Cabernet  Sauvignon, 
respectively.  Shahidi  &  Naczk,  (1995)  similarly  reported  the  presence  of  gallic  acid  as  a 
major  phenolic  component  of  red  wine,  followed  by  (+)-catechin  and  (-)-epicatechin.  A 
high  concentration  of  gallic  acid  would  be  expected  in  red  wine  since  this  phenolic  acid 
is  principally  formed  by  the  hydrolysis  of  flavonoid  gallate  esters,  which  are  largely 
absent  in  white  wines,  due  to  the  lack  of  skin  extraction  (Frankel  et  al.,  1995).  Previous 
studies  have  shown  a  high  association  between  total  antioxidant  activity  and  gallic  acid 
content  of  red  wine  (Minussi  et  al.,  2003;  Burns  et  al.,  2000;  Soleas  et  al.,  1997),  while 
Sanchez-Moreno  et  al.  (1999b)  observed  that  gallic  acid  exhibited  the  greatest  free- 
radical  scavenging  activity  in  wine  and  grape  juice.  Similarly,  Bohm,  (2000) 
demonstrated  that  gallic  acid  exerted  the  strongest  antioxidant  activity  in  TEAC,  TRAP 
and  LDL  oxidation  assays. Catherine  Tsang  106 
There  is  some  evidence  to  suggest  that  flavan-3-ols  and  gallic  acid  are  bio-available  in 
the  human  body.  Monomeric  and  dimeric  flavan-3-ols  are  absorbed  into  the 
bloodstream  following  the  ingestion  of  red  wine  (Bell  et  al.,  2000)  and  cocoa  (Holt  et 
al.,  2002),  and  gallic  acid  and  its  metabolite  4-O-methylgallic  acid  have  been  detected 
in  human  plasma  and  urine  following  oral  administration  of  50  mg  of  gallic  acid  and 
black  tea  (Shahrzad  &  Bitsch,  1998;  Shahrzad  et  al.,  2001). 
3.7  Conclusion 
The  antioxidant  properties  of  red  wines  appear  to  be  governed  by  the  total 
phenolic  content,  specifically  gallic  acid  and  monomeric  and  dimeric  flavan-3-ols;  (+)- 
catechin,  (-)-epicatechin  and  procyanidin  dimers  B1  and  B2,  while  the  anthocyanins  and 
flavonols  had  little  impact  on  the  antioxidant  capacity  of  red  wine.  The  findings  from 
this  study  highlight  the  importance  of  these  compounds  as  potent  antioxidants  in  vitro, 
however  further  information  regarding  their  bioavailability  and  protective  effects  in  vivo 
is  warranted. Catherine  Tsang  107 
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red  wine 
consumption  on  antioxidant  status  and  indices  of 
oxidative  stress  associated  with  coronary  heart  disease 
in  healthy  volunteers 
4.1  Introduction 
There  is  much  public,  media  and  scientific  interest  in  the  possibility  that  red  wine 
may  be  protective  against  CHD.  Mounting  evidence  suggests  that  moderate  red  wine 
consumption  is  inversely  associated  with  CHD,  an  association  popularised  as  the 
`French  Paradox'  (Renaud  &  de  Logeril,  1993).  The  paradox  describes  the  seemingly 
low  mortality  rates  in  certain  populations  of  France  despite  high  levels  of  associated  risk 
factors;  serum  cholesterol,  systolic  blood  pressure,  dietary  fat  intakes  and  low 
consumption  of  fruits  and  vegetables.  It  is  speculated  that  this  paradox  is  associated 
with  the  widespread  consumption  of  red  wine  (Criqui  &  Ringel,  1994).  Although  there 
is  evidence  to  suggest  that  light  to  moderate  intake  of  alcohol  is  beneficial  to  health 
(Albert  et  al.  1999),  it  has  been  shown  that  red  wine  provides  additional  health  benefits 
beyond  those  of  alcohol  alone  (Rimm  et  al.,.  1996,  Burns  et  al.,  2001  a). 
The  putative  cardio-protective  effects  of  red  wine  have  been  largely  attributed  to  the 
abundance  of  phenolic  compounds.  Plant-derived  phenolics  are  widely  distributed  in 
nature  and  are  present  in  varying  amounts  in  commonly  consumed  fruits,  vegetables  and 
beverages.  Red  wine  provides  an  especially  rich  source  of  these  compounds  which 
originate  from  grape  seeds,  skins  and  vine  stems  (Singleton,  1982).  The  levels  of 
phenolic  acids,  major  catechins  and  anthocyanins  in  red  wines  vary  in  concentration 
depending  on  different  grape  varieties  and  vintages  (Landrault  et  al.,  2001),  together 
with  variations  in  climate  and  vinification  practices  (Goldberg  et  al.,  1998,  Burns  et  al., 
2001  b).  Generally  red  wines  contain  between  1000  and  4000  mg/L  of  phenolics,  the 
majority  of  which  are  derived  from  anthocyanins  and  proanthocyanidins  (Burns  et  al., 
2000).  Although  the  exact  mechanisms  of  protection  conferred  by  red  wine  are 
unknown,  there  is  evidence  that  phenolic  compounds  act  as  antioxidants  by  protecting 
the  body  from  damaging  oxidation  reactions  caused  by  `free  radicals'  (Kanner  et  al., Catherine  Tsang  109 
1994).  There  is  further  evidence  that  they  may  inhibit  oxidative  modification  of  LDL 
based  on  their  ability  to  increase  the  resistance  of  isolated  LDL  to  copper  oxidation  in 
vitro  (Frankel  et  al.,  1995).  Several  studies  have  demonstrated  that  many  dietary 
phenolics  protect  against  the  oxidative  modification  of  LDL  in  vitro  (Vinson  &  Hontz, 
1995;  Teissedre  et  al.,  1996).  Despite  increasing  evidence  for  the  in  vitro  effectiveness 
of  phenolics,  there  remains  a  dearth  of  information  regarding  their  efficacy  in  vivo  and 
this  may  be  due,  in  part,  to  a  lack  of  knowledge  of  their  bioavailability  in  humans.  The 
results  from  wine  trials  to  date  have  shown  conflicting  results  with  some  showing  a 
protective  effect  following  red  wine  intake  (Serafini  et  al.,  1998;  Natella  et  al.,  2001), 
while  others  have  not  demonstrated  such  an  effect  (van  Golde  et  al.,  1999). 
This  chapter  reports  on  the  results  of  an  intervention  study  in  which  the  influence  of  red 
wine  consumption  on  the  antioxidant  status  and  on  indices  of  oxidative  stress  associated 
with  CHD  was  investigated  in  healthy  human  volunteers.  The  total  concentration  of 
phenolics  and  individual  phenolics  in  the  wine  and  plasma  were  analysed  in  the  Folin- 
Ciocalteu  assay  and  by  HPLC-tandem  mass  spectrometry.  The  antioxidant  capacity  of 
plasma  was  measured  with  ESR  while  homocysteine,  fasting  plasma  lipids  and  the 
production  of  conjugated  dienes  and  TBARS  in  copper  oxidised  LDL  were  further 
determined. Catherine  Tsang  110 
4.2  Study  design 
A  randomised,  controlled  study  was  performed  with  20  free-living  healthy  male 
and  female  volunteers.  Subjects  were  non-smokers  aged  between  23-50  and  taking  no 
medications  or  vitamin  supplements.  There  were  no  statistically  significant  differences 
observed  in  mean  age  (years);  height  (m);  weight  (kg);  or  body  mass  index  (kg/m2),  in 
the  red  wine  and  control  group,  respectively  (Table  4.1).  The  study  protocol  was 
approved  by  the  Research  Ethics  Committee,  Glasgow  Royal  Infirmary,  United 
Kingdom.  Written  informed  consent  was  obtained  from  each  volunteer.  Subjects  were 
randomised  into  two  groups;  red  wine  and  control.  Subjects  in  the  red  wine  group  were 
asked  to  consume  375  ml  red  wine  (Safeway,  1999  Bulgarian  Young  Vatted  Cabernet 
Sauvignon,  12  %  alcohol)  each  day  for  2  weeks.  Fasting  blood  samples  obtained  at 
weekly  intervals  were  collected  into  EDTA  and  lithium  heparin  tubes.  Plasma  was 
immediately  separated  by  low  speed  centrifugation  (2500  xg  for  10  min  at  4°C)  and 
stored  at  -80°C  prior  to  analysis.  For  vitamin  C  analysis  0.6  mL  plasma  was  mixed  with 
an  equal  volume  of  10  %  (w/v)  meta-phosphoric  acid  and  snap  frozen  in  liquid  nitrogen 
and  stored  at  -80°C  prior  to  analysis. 
4.2.1  Dietary  Assessment 
Volunteers  were  required  to  avoid  all  alcohol  and  foods/beverages  rich  in  polyphenols, 
and  to  limit  fruit  and  vegetable  intake  over  the  study  period.  A  record  of  food  and 
beverage  intake  was  monitored  over  the  study  period  and  this  information  was  used  to 
assess  compliance  to  the  dietary  instructions  given.  Subjects  were  asked  to  keep  a 
record  of  their  food  and  beverage  intake  for  3  days  (one  of  which  was  at  the  weekend) 
and  oral  and  written  instructions  were  given  on  keeping  the  diet  records  and  they  were 
supplied  with  diaries  and  portion  size  photographs  to  aid  with  quantification  (Appendix 
I).  Data  collected  was  analysed  using  a  dietary  analysis  software  package,  Diet  5TM  for 
windows  (Robert  Gordon  University,  Aberdeen,  UK). PV 
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4.3  Phenolic  composition  of  wine 
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The  red  wine  used  in  this  study  was  a  Bulgarian  Young  Vatted  Cabernet 
Sauvignon  and  analysis  by  HPLC-MS-MS  and  diode  array  detection  revealed  the 
presence  of  a  number  of  flavonoids  and  phenolic  compounds  of  which  19  were 
identified.  The  results  obtained  are  illustrated  in  Figure  4.1  and  are  summarised  below 
and  in  Table  4.2. 
Peak  1  (tp.  =  5.3  min,  ?  max  =  265  nm)  had  a  [M-H]"  at  m/z  169  with  MS2  yielding 
a  charged  fragment  ion  at  m/z  125.  The  mass  spectrometric  data  and  co-chromatography 
with  an  authentic  standard  confirmed  that  this  compound  is  gallic  acid. 
Peak  2  (tR  =  6.9  min,  k.,,  ax  =  265  nm)  had  a  [M-H]-  at  m/z  865  with  MS2  yielding 
two  charged  fragment  ions  at  m/z  577  and  289.  Based  on  the  mass  spectral  data  this 
compound  is  a  procyanidin  trimer  and  its  elution  prior  to  dimer  B1  (Santos-Buelga  et  al., 
1995)  indicates  that  it  is  likely  to  be  the  trimer  procyanidin  C2,  a  known  component  of 
red  wine  (De  Pascual-Teresa  et  al.,  2000b). 
Peak  3  (tR  =  13.4  min, 
%max  =  280  nm)  had  a  [M-H]-  at  m/z  577,  with  MS2 
producing  three  major  charged  fragment  ions  at  m/z  425,407  and  289.  Based  on  the 
mass  spectral  data  this  compound  is  a  procyanidin  dimer.  Co-chromatography  with  a 
standard  indicated  the  dimer  was  procyanidin  B1,  a  known  component  of  red  wine  (De 
Pascual-Teresa  et  al.,  2000b). 
Peak  4  (tR  =  14.3  min,  , max  =  515  nm)  had  a  [M-H]+  at  m/z  465  which 
fragmented  with  MS2  to  produce  a  delphinidin-like  ion  at  m/z  303  with  the  [M-H]+-162, 
corresponding  to  loss  of  a  glucose  moiety.  This  peak  is,  therefore,  the  anthocyanin 
delphinidin-3-glucoside,  previously  identified  in  red  wine  by  Burns  et  al.  (2002). 
Peak  5  (tR  =  15.4  min,  Xma,  t  =  280  nm)  had  a  [M-H]-  at  m/z  289,  yielding  two 
charged  ions  at  m/z  245  and  205.  This  mass  spectrum  and  co-chromatography  with  an 
authentic  standard  established  that  peak  4  is  the  flavan-3-ol  (+)-catechin. 
Peak  6  (tR  =  17.8  min,  X,,, 
ax  =  515  nm)  had  a  [M-H]+  at  m/z  479  which  on  MS2 
yielded  a  fragment  ion  at  m/z  317  which  corresponds  with  petunidin  ([M-H]+-162, 
cleavage  of  a  glucosyl  unit)  indicating  the  presence  of  petunidin-3-glucoside  which  has 
previously  been  detected  in  red  wines  (Burns  et  al.,  2002). Catherine  Tsang  113 
Peak  7  (tR  =  18.3  min,  ?  ￿ax  =  280  nm)  had  a  [M-H]-  at  m/z  577  with  MS2 
yielding  three  charged  fragment  ions  at  nn/z  425,405  and  289.  Based  on  the  mass 
spectral  data  this  peak  is  a  procyanidin  dimer  and  co-chromatography  with  a  reference 
compound  revealed  that  it  is  procyanidin  B2,  previously  detected  in  red  wine  by  De 
Pascual-Teresa  et  al.  (2000b). 
Peak  8  (tR  =  19.8  min,  ?  max  =  280  nm)  had  a  [M-H]-  at  m/z  289,  which  on  MS2 
yielding  ions  at  m/z  245,205  and  179.  Co-chromatography  with  an  authentic  standard 
confirmed  the  identification  of  peak  7  as  (-)-epicatechin. 
Peak  9  (tR  =  20  min,  Xmax  =  510  nm)  had  a  [M-H]+  at  m/z  463  which  on  MS2 
exhibited  a  162  amu  loss,  corresponding  to  cleavage  of  a  glucosyl  unit,  producing  a 
fragment  ion  at  m/z  301  which  corresponds  to  peonidin.  This  is  in  keeping  with  the 
presence  of  peonidin-3-O-glucoside,  a  known  component  of  red  wine  (Burns  et  al., 
2002). 
Peak  10  (tR  =  21  min,  X,,,  a,  t  =  515  nm)  had  a  [M-H]+  at  m/z  493,  MS2  produced  a 
fragment  ion  at  m/z  331  ([M-H]+-162,  loss  of  a  glucosyl  unit).  This  peak  was  confirmed 
as  malvidin-3-O-glucoside  by  reference  to  an  authentic  standard. 
Peak  11  (tR  =  21.7  min, 
%max  =  280  nm)  had  a  [M-H]-  at  m/z  865  with  MS2 
yielding  two  charged  fragment  ions  at  m/z  577  and  289.  Based  on  the  mass  spectral  data 
this  compound  is  a  procyanidin  trimer  and  its  elution  after  (-)-epicatechin  (Santos- 
Buelga  et  al.,  1995)  indicates  that  it  is  procyanidin  C1,  a  known  component  of  red  wine 
(Sanchez-Moreno  et  al.,  2003). 
Peak  12  (tR  =  25  min,  X,  max  =  510  nm)  had  a  [M-H]+  at  m/z  517  with  MS2 
yielding  a  charged  fragment  ion  at  m/z  355.  Although  a  reference  compound  is  not 
available,  the  elution  order  of  this  peak  after  malvidin-3-glucoside  and  the  mass  spectral 
data  indicate  that  it  may  be  vitisin  B  which  has  been  detected  in  red  wines  by  Morata  et 
al.  (2003)  and  is  the  adduct  resulting  from  the  reaction  between  malvidin-3-glucoside 
and  acetaldehyde. 
Peak  13  (tR  =  25  min,  Xmax  =  370  nm)  had  a  [M-H]-  at  m/z  479  with  MS2  yielding 
a  fragment  ion  at  m/z  317,  (162  amu  loss,  cleavage  of  a  glucosyl  unit)  which 
corresponds  with  myricetin  indicating  that  this  compound  is  a  myricetin  glucoside. 
Peak  14  (tR  =  29.1  min,  kmax  =  515  nm)  had  a  [M-H]+  at  m/z  533  which  on  MS2 
yielded  a  charged  fragment  ion  at  m/z  331  ([M-H]+-204,  loss  of  an  acetylglucosyl  unit). 
On  the  basis  of  the  MS2  spectra  and  the  elution  order  of  anthocyanins,  this  peak  is Catherine  Tsang  114 
identified  as  malvidin-3-acetylglucoside  previously  detected  in  red  wines  (Burns  et  al., 
2002). 
Peak  15  (tR  =  29.6  min,  /￿max  =  350  nm)  had  a  [M-H]-  at  m/z  471,  MS2  yielded  a 
fragment  ion  at  m/z  301  ([M-H]--176,  cleavage  of  a  glucuronyl  group).  On  the  basis  of 
the  MS2  spectral  data  and  co-chromatography  with  an  authentic  standard  this  peak  is 
identified  as  quercetin-3-glucuronide. 
Peak  16  (tR  =  34.4  min,  ?  max  =  350  nm)  had  a  [M-H]-  at  m/z  317  which 
corresponds  with  the  flavonol  aglycone  myricetin.  Co-chromatography  with  an 
authentic  standard  confirmed  the  presence  of  myricetin. 
Peak  17  (tR  =  35.2  min,  ?  max  =  525  nm)  had  a  [M-H]+  at  m/z  639  fragmentation 
by  MS2  yielded  a  charged  fragment  ion  at  m/z  331  ([M-H]+-308,  loss  of  a  p- 
coumaroylglucoside  group).  Based  on  the  absorbance  and  mass  spectral  data  and  the 
elution  profile  of  this  compound  it  is  likely  to  be  the  anthocyanin  malvidin-3-(p- 
coumaroyl)-glucoside  (Burns  et  al.,  2002). 
Peak  18  (tR  =  43.5  min,  X,,, 
a,  t  =  370  nm)  had  a  [M-H]-  at  m/z  301  and  the  identity 
of  this  peak  was  confirmed  as  the  flavonol  aglycone  quercetin  by  co-chromatography. 
Peak  19  (tR  =  51  min,  ?  max  =  370  nm)  had  a  [M-H]-  at  m/z  285  which  indicates 
the  presence  of  kaempferol  and  this  identification  was  confirmed  by  co-chromatography 
with  an  authentic  standard. Catherine  Tsang 
1 
0.8 
0.4 
2 
0 
c  0.4 
V 
C 
00.2 01 
.  92 
Q 
c 
o 
0.1 
Q 
11 
7  iii 
110 
A69 
13 
14 
17 
1E 
15  1 
115 
A 
B 
18 
19 
1. 
C 
00  10  20  30  40  50  60 
Time  (min) 
Figure  4.1  Gradient  HPLC  chromatogram  of  phenolics  identified  in  the  Bulgarian 
Young  Vatted  Cabernet  Sauvignon  with  diode  array  detector  operating  at  [A]  280  nm; 
[B]  520  nm  and  [C]  365  nm  for  the  detection  of  flavan-3-ols;  anthocyanins  and 
flavonols,  respectively.  (For  MS-MS  data  and  identification  and  quantification  of  peaks 
1-19,  see  Table  4.2). 'a  m 
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4.4  Plasma  content  and  activity 
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Total  phenolics  in  plasma  were  estimated  with  Folin  Ciocalteu  reagent  using  a 
modification  of  the  method  of  Swain  and  Hillis,  (1959)  which  avoids  interference  from 
proteins  in  biological  samples  (Serafini  et  al.,  1998)  as  described  previously  in  Chapter 
2  (section  2.3.1).  Two  separate  HPLC  methods  were  used  to  determine  the  plasma 
levels  of  six  carotenoids  (lutein/zeaxanthin,  ß-cryptoxanthin,  all  trans-lycopene,  a- 
carotene  and  all  trans  ß-carotene),  retinol,  a-  and  y-tocopherol  and  ascorbic  acid  (see 
sections  2.5.1  and  2.5.2).  Antioxidant  capacity  of  plasma  was  measured  in  the  ESR- 
derived  antioxidant  assay  and  HPLC-MS-MS  in  the  selective  reaction  monitoring  mode 
(SRM)  was  used  to  identify  plasma  metabolites.  Results  obtained  are  shown  in  Tables 
4.3  and  4.4. 
4.4.1  Total  phenolic  concentration 
Twelve  healthy  volunteers  consumed  375  mL  of  the  red  wine  on  a  daily  basis  for  two 
weeks  and  the  amounts  of  the  individual  flavonoids  and  phenolics  ingested  per  day  are 
presented  in  Table  4.2.  The  main  individual  component  was  gallic  acid  at  59.6  mg  per 
day  while  28.4  mg  of  anthocyanins,  8.4  mg  of  flavonols  and  72  mg  of  monomeric 
flavan-3-ols  and  proanthocyanidins  were  consumed  each  day.  Consumption  of  red  wine 
was  associated  with  a  small  but  significant  4.4  µM  GAE  increase  (unpaired  t-test)  in 
plasma  total  phenolics  which  was  associated  with  a7%  increase  in  plasma  antioxidant 
capacity  which  failed  to  achieve  statistical  significance  (Table  4.3).  Total  phenolic 
levels  were  increased  highly  significantly  (P=0.000)  from  12.4  µM  GAE  at  baseline  to 
16.6  pM  GAE  following  2-weeks  of  daily  red  wine  consumption  in  the  red  wine  group. 
No  change  in  plasma  total  phenolic  concentration  was  observed  in  the  control  group. Catherine  Tsang  118 
4.4.2  Plasma  levels  of  carotenoids,  tocopherols,  retinol  &  ascorbic 
acid 
The  levels  of  six  carotenoids  (lutein/zeaxanthin,  ß-cryptoxanthin,  all  trans-lycopene,  a- 
carotene  and  all  trans  ß-carotene),  retinol  and  a-  and  y-tocopherol  in  plasma  were 
measured  by  reversed  phase  HPLC  with  absorbance  and  fluorimetric  detection 
according  to  the  method  of  Hess  et  al.  (1991).  The  analysis  was  conducted  under  the 
auspices  of  the  US  National  Institute  of  Standards  Quality  Assurance  Scheme  for  fat- 
soluble  vitamins  and  full  details  of  the  method  are  described  in  Chapter  2  (section  2.5.1) 
and  in  Duthie  (1999).  Ascorbic  acid  content  was  determined  from  0.6  mL  plasma  and 
measured  by  reversed  phase  HPLC  using  an  ion-pairing  reagent  with  UV  detection 
(Ross,  1994).  Analysis  was  conducted  under  the  US  National  Institute  of  Standards 
Quality  Assurance  Scheme  for  Vitamin  C  analysis  in  biological  fluids  and  the  method  is 
described  in  detail  in  Chapter  2  (section  2.5.2)  and  in  Duthie  (1999).  The  plasma  levels 
of  carotenoids,  tocopherols,  retinol  and  ascorbic  acid  obtained  are  in  agreement  with 
previous  studies  (Mezzano  et  al.,  2001;  Higgins  et  al.,  2001),  however  there  were  no 
significant  changes  in  the  plasma  concentrations  of  a-and  y-tocopherols,  retinol  and 
ascorbic  acid  following  red  wine  consumption.  Similarly  no  differences  were  observed 
between  the  groups  in  plasma  concentrations  of  the  individual  carotenoids  and  data  have 
therefore  been  presented  as  total  carotenoids  in  Table  4.3. 
4.4.3  ESR-derived  antioxidant  activity 
Antioxidant  capacity  of  plasma  was  measured  in  the  ESR-derived  antioxidant  assay  as 
described  by  Gardner  et  al.  (1998).  This  method  is  based  on  the  ability  of  antioxidants 
in  plasma  to  donate  a  hydrogen  atom  or  electron  to  the  synthetic  free  radical  potassium 
nitro-disulphonate  (Fremy's  salt).  A  300  µL  aliquot  of  plasma  was  added  to  2.7  mL  PBS 
and  mixed  with  an  equal  volume  of  50  µM  of  Fremy's  radical  in  ethanol/water  (12:  88, 
v/v).  After  20  min  following  completion  of  the  reaction  the  ESR  spectra  of  the  low  field 
resonance  of  the  Fremy's  radical  was  obtained.  Signal  intensity  was  obtained  by  double 
integration  and  the  concentration  was  calculated  by  comparison  with  a  control  reaction 
using  ethanol/water  (12:  88,  v/v)  without  sample. Catherine  Tsang  119 
Values  obtained  ranged  from  37.4%  and  41  %  radicals  reduced/L  at  baseline  and  after 
2-weeks  of  wine  consumption,  respectively.  However,  the  results  obtained  did  not  reach 
statistical  significance  (p=0.303). 
4.4.4  HPLC-MS  detection  of  metabolites  in  plasma 
One  hundred  µL  of  plasma  was  extracted  according  to  a  modified  method  of  Day  et  al. 
(1999)  as  described  previously  in  Chapter  2  (section  2.7.1).  HPLC-MS-MS  in  the  SRM 
mode  detected  trace  amounts  of  flavan-3-ol  glucuronides  of  (+)-catechin  and  (-)- 
epicatechin  in  plasma  of  subjects  in  the  red  wine  group  post  intervention  (Table  4.4). 
Peaks  M-1  (tR  =  16.6  min,  , max  =  280  nm)  and  M-2  (tR  =  23  min,  , max  =  280  nm) 
both  had  a  [M-H]-  at  m/z  465  which  yielded  MS2  fragments  (M-176,  loss  of  a 
glucuronyl  unit)  corresponding  to  (+)-catechin/(-)-epicatechin  at  m/z  289  and  245.  The 
[M-H]--176  loss  is  in  keeping  with  the  cleavage  of  a  glucuronyl  unit.  The  MS 
fragmentation  pattern,  together  with  the  HPLC  elution  order,  indicates  that  the  earlier 
eluting  M-1  peak  is  a  (+)-catechin  glucuronide  while  M-2  is  an  (-)-epicatechin 
glucuronide. 
Peak  M-3  (tR  =  21.6  min,  Xmax  =  280  nm)  and  M-4  (tR  =  27.1  min,  X,  max  =  280 
nm)  also  had  similar  mass  spectra  with  a  [M-H]"  at  m/z  479  which  on  loss  of  176  amu 
(loss  of  a  glucuronyl  unit)  yielded  a  MS2  ion  at  m/z  303.  These  fragments  are  14  amu 
higher  than  the  equivalent  ions  in  the  spectra  of  M-1  and  M-2,  indicating  the  presence  of 
methylated  flavan-3-ol  glucuronides.  M-3  is  therefore  probably  a  methyl-catechin 
glucuronide  and  the  later  eluting  M-4  a  methyl-epicatechin  glucuronide  (Table  4.4). 
Without  reference  compounds  it  was  not  possible  to  determine  the  positions  on  the 
flavan-3-ol  skeleton  of  the  methyl  and  glucuronic  acid  substituents.  The  most  likely 
candidates  for  M-2  and  M-4  are  (-)-epicatechin-3'-O-glucuronide  and  4'-O-methyl-(-)- 
epicatechin-3'-O-glucuronide  which  have  been  identified  as  the  main  metabolites  in 
human  plasma  after  ingestion  of  (-)-epicatechin.  Other  methylated  and  glucuronide 
conjugates  of  (-)-epicatechin  were,  however,  also  present,  albeit  in  smaller  amounts 
(Natsume  et  al.,  2003).  None  of  the  four  flavan-3-ol  metabolites  were  detected  in  the 
plasma  of  subjects  from  the  control  group. H  %ý  R  H 
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4.5  Measurement  of  indices  of  oxidative  stress 
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Oxidative  modification  of  LDL  is  a  lipid  perioxidation  process  and  this  study 
focused  on  measuring  lipid  hydroperoxides  such  as  TBARS  and  conjugated  dienes  in 
copper  oxidised  LDL.  Fasting  plasma  lipids  including  triacylglycerols  (TAG),  total 
cholesterol,  LDL  and  HDL  cholesterol  were  measured  in  fasting  plasma  and  circulatory 
levels  of  homocysteine  were  also  determined.  Results  obtained  are  shown  in  Table  4.5 
and  Table  4.6. 
4.5.1  Production  of  lipid  hydroperoxides 
LDL  samples  were  adjusted  to  a  concentration  of  50  . tg  LDL  protein/mL  and  1  µM 
EDTA  in  quartz  cuvettes  and  oxidation  was  initiated  by  addition  of  15  MM  CuSO4 
according  to  the  method  of  Kleinveld  et  al.  (1992).  Absorbance  of  the  samples  was 
measured  at  234  nm,  every  2  min  at  30  °C.  Maximal  concentration  of  conjugated  dienes 
(nmol/mg  LDL  protein),  rate  of  production  of  conjugated  dienes  (nmol/mg  LDL 
protein/min)  and  lag  time  (min)  were  estimated  using  exact  co-ordinates  provided  by  the 
kinetics  software  application. 
LDL  that  was  oxidized  for  measurement  of  conjugated  dienes  was  subsequently  used 
for  the  measurement  of  TBARS,  based  on  the  method  of  Buege  and  Aust  (1978). 
Following  3h  oxidation,  the  reaction  was  stopped  by  addition  of  200  µM  EDTA  and  40 
µM  butylated  hydroxytoluene  and  the  samples  were  stored  at  4°C  for  a  maximum  of  7 
d.  TBARS  were  determined  by  adding  1.6  mL  TCA-TBA-HCL  reagent  (15  % 
trichloroacetic  acid:  0.375  %  thiobarbituric  acid:  0.25  mol  HCL)  to  a  0.8  mL  aliquot  of 
the  LDL  solution  (oxidized  as  above),  mixing  the  sample,  and  heating  it  at  100°C  for  15 
min.  After  placing  the  tubes  in  a  bath  of  cold  water  for  5  min,  samples  were  centrifuged 
for  10  min  at  2000rpm.  Absorbance  was  measured  at  535  nm  and  quantification  of 
TBARS  was  performed  by  comparison  with  a  standard  curve  of  malonaldehyde 
equivalents  generated  by  acid  catalysed  hydrolysis  of  1,1,3,3,  -tetraethoxypropane. Catherine  Tsang  123 
The  maximum  concentration  of  conjugated  dienes  produced  in  copper-oxidised  LDL 
was  reduced  significantly  (paired  t-test)  (P=0.026)  from  854  nmol/mg  LDL  protein  at 
baseline  to  715  nmol/mg  LDL  protein  following  wine  consumption  in  the  red  wine 
group  (Table  4.5).  Similarly,  the  TBARS  concentration  (nmoles/mg  LDL  protein)  in 
copper-oxidised  LDL  was  reduced  significantly  (paired  t-test)  (P=0.050)  from  69 
nmol/mg  LDL  protein  to  50  nmol/mg  LDL  protein  in  the  red  wine  group  (Table  4.5). 
There  were  no  significant  changes  observed  in  conjugated  dienes  or  TBARS  in  the 
control  group. 
4.5.2  Fasting  plasma  lipids 
Fasting  plasma  lipids  including  total  cholesterol,  HDL,  LDL  and  triacylglycerol  (TAG) 
concentrations  were  determined  using  standard  procedures  as  described  previously  in 
Chapter  2  (section  2.8).  LDL  cholesterol  concentrations  were  calculated  using  the 
Friedewald  formula  (Friedewald  et  al.,  1972).  There  was  a  significant  increase  (paired  t- 
test)  in  the  level  of  HDL  cholesterol  (P=0.020)  after  2-weeks  of  wine  consumption  in 
the  red  wine  group,  while  no  changes  were  observed  in  the  control  group.  Values 
ranging  from  0.92  to  2.21  mmol  L-1  were  obtained  for  subjects  in  the  red  wine  group 
with  an  average  value  of  1.5  mmol  L-1.  No  significant  change  was  observed  in  other 
fasting  lipids  in  either  group  (Table  4.6). 
4.5.3  Homocysteine  concentrations 
Homocysteine  concentrations  were  determined  in  plasma  as  described  in  detail  in 
Chapter  2  (section  2.5.4).  All  subjects  were  within  the  normal  range  for  plasma 
homocysteine  levels  (Range:  <  15.9  µmol  L-)  (Manilow,  1994).  Values  ranging  from 
4.9  to  11.6  µmol  L-1  were  obtained  for  subjects  within  the  red  wine  group,  with  an 
average  value  of  7.8  µmol  L-1.  In  the  control  group  values  ranging  from  7.3  to  13.1 
µmol  L-'  were  obtained  with  an  average  value  of  9.8  µmol  L"1.  There  appeared  to  be  a 
reduction  in  the  level  of  homocysteine  in  the  red  wine  group  compared  with  the  control 
group,  however  did  not  reach  statistical  significance  (p=0.082)  (Table  4.6). r+ ,.. 
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4.6  Discussion 
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There  is  a  growing  awareness  of  the  potential  health  benefit  of  diets  rich  in  fruits 
and  vegetables  and  nutritional  guidelines  indicate  that  an  increase  in  the  consumption  of 
foods  rich  in  antioxidant  nutrients  may  decrease  the  risk  of  CHD  and  certain  cancers 
(The  Scottish  Office,  1993).  Epidemiological  studies  have  reported  a  reduction  in  the 
incidence  of  CHD  with  moderate  daily  red  wine  consumption,  an  anomaly  referred  to  as 
the  `French  Paradox'.  This  effect  has  been  ascribed  to  the  low  molecular  weight 
phenolics  in  many  plant  based  foods  which  can  act  as  antioxidants  because  their 
extensive  conjugated  n-electron  systems  allow  ready  donation  of  electrons  or  hydrogen 
atoms  from  the  hydroxyl  moieties  to  free  radicals  (Scott,  1997). 
In  the  present  study,  moderate  daily  consumption  of  red  wine  for  2-weeks  significantly 
increased  plasma  total  phenolic  concentrations  (Table  4.3)  by  only  4.4  µM  GAE  which 
was  also  associated  with  a  non-significant  increase  in  antioxidant  capacity.  This  is  in 
contrast  to  several  studies  which  have  measured  total  phenols  and  plasma  antioxidant 
activity  at  various  time  intervals  up  to  24  h  following  the  consumption  of  red  wine 
(Maxwell  et  al.,  1994;  Whitehead  et  al.,  1995;  Day  et  al.,  1997;  Duthie  et  al.,  1998; 
Serafini  et  al.,  1998).  However,  in  such  studies  the  increases  in  the  plasma  phenolics 
and  antioxidant  capacity  decrease  within  4h  after  wine  ingestion.  In  the  present 
investigation,  blood  samples  for  the  measurement  of  antioxidant  capacity  were  taken  in 
the  morning  about  10-12  h  after  the  consumption  of  red  wine  the  previous  evening 
which  may  indicate  that  the  majority  of  the  phenolics  had  cleared  from  the  blood.  This 
suggests  that  regular  intake  over  2  weeks  does  not  lead  to  sustained  increase  in  total 
phenols  in  the  circulation.  In  the  present  study,  there  was  a  significant  increase  in  the 
concentration  of  HDL  cholesterol  (P  <_  0.05)  in  the  red  wine  group  post-intervention 
(Table  4.6).  HDL  cholesterol  concentrations  are  inversely  associated  with  risk  of  CHD 
(Marques-Vidal  et  al.,  1995).  This  is  due  to  the  role  of  these  lipoproteins  in  carrying 
cholesterol  from  peripheral  cells  to  the  liver,  where  it  is  degraded  and  repackaged,  a 
process  known  as  'reverse  cholesterol  transport'  (Eisenberg,  1984).  It  is  well 
documented  that  alcohol  increases  the  concentration  of  HDL  cholesterol  (Gaziano  et  al., 
1993)  and  there  is  some  evidence  to  suggest  that  red  wine  phenolics  may  provide  a 
protective  effect.  Lavy  et  al.  (1994)  reported  an  increase  in  HDL  cholesterol Catherine  Tsang  127 
concentrations  following  2-weeks  of  daily  moderate  red  wine  consumption  in  healthy 
volunteers.  These  effects  were  not  observed  following  consumption  of  white  wine 
indicating  that  red  wine  phenolics  may  influence  HDL  cholesterol.  In  the  present  study 
while  the  changes  in  the  concentration  of  HDL  cholesterol  were  statistically  significant, 
the  change  is  small  and  unlikely  to  be  of  clinical  significance.  There  were  no  significant 
differences  (unpaired  t-tests)  in  the  lag-phase  or  in  any  of  the  other  indices  of  LDL 
oxidation  between  the  red  wine  and  control  groups,  post-intervention  (Table  4.5). 
However,  within  the  red  wine  group  (paired  t-test);  there  was  a  significant  reduction  in 
the  maximum  concentration  of  conjugated  dienes  (P  <  0.05)  and  TBARS  (P  <  0.05) 
post-supplementation.  While  the  lag  phase  was  not  significantly  increased  in  the  red 
wine  group,  there  was  an  increase  in  8  of  the  12  subjects.  Our  finding  of  a  significant 
reduction  in  the  concentration  of  conjugated  dienes  and  TBARS  without  a  statistically 
significant  increase  in  the  lag  phase  could  lead  one  to  suspect  that  there  had  been 
changes  in  LDL  particle  fatty  acid  composition.  However,  while  we  did  not  directly 
measure  the  LDL  fatty  acid  composition,  analysis  using  a  computerised  version  of  the 
food  composition  tables  (Holland  et  al.,  1991)  of  the  subjects'  daily  diet  records  for  the 
period  of  the  trial  revealed  no  significant  changes  in  the  quantity  or  in  the  quality  of 
dietary  fat  intake.  It  is  very  unlikely,  therefore,  that  the  fat  composition  of  the  LDL 
particle  was  altered  in  the  case  of  8  of  the  12  subjects  and  the  4  who  responded 
differently  were  not  distinct  in  this  respect.  Thus,  while  there  was  not  a  statistically 
significant  reduction  in  susceptibility  of  LDL  to  oxidation  compared  with  the  control 
group,  changes  within  the  red  wine  supplemented  group  appear  to  show  some  protection 
against  LDL  oxidation.  This  is  mostly  likely  to  be  due  to  the  small  but  statistically 
significant  increase  in  the  plasma  concentration  of  phenolics,  which  can  bind  to  LDL 
and  offer  protection  against  LDL  oxidation.  It  is  likely  that  the  difference  in  response 
was  simply  due  to  person  to  person  variation  in  response  to  the  red  wine  intervention,  as 
individuals  may  respond  differently  to  supplementation  as  has  been  suggested  by 
Howard  et  al.  (2002).  Furthermore,  the  4  subjects  who  did  not  show  an  increase  in  the 
lag-phase  did  not  respond  differently  in  their  plasma  phenolic  concentrations,  TBARS 
or  the  maximum  concentration  and  the  rate  of  conjugated  dienes,  leading  us  to  the 
conclusion  that  compliance  to  the  intervention  was  met.  Two  previous  studies  (Furhman 
et  al.,  1995;  Nigdikar  et  al.,  1998)  have  shown  a  reduction  in  LDL  oxidation  using 
similar  red  wine  doses  (375  mL/d  and  400  mL/d,  respectively)  and  intervention  periods Catherine  Tsang  128 
(2  weeks)  as  the  current  study.  However,  there  may  be  a  number  of  possible  reasons  to 
explain  this  apparent  discrepancy.  The  phenolic  composition  of  the  wine  used  in  wine 
trials  is  important  with  regard  to  their  effect  on  LDL  oxidation  (Howard  et  al.,  2002).  In 
the  present  study  a  Young  Vatted  Bulgarian  Cabernet  Sauvignon  was  used  and  the 
intake  of  (mg/d)  phenolic  compounds  from  the  375  mL  serving  of  red  wine  was  165 
mg/d,  with  the  majority  of  the  phenolics  derived  from  anthocyanins,  gallic  acid  and  total 
flavan-3-ols  (Table  4.2).  The  overall  levels  of  phenolics  in  the  wines  used  in  the  studies 
of  Nigdikar  et  al.  (1998)  and  Fuhrman  et  al.  (1995)  were  somewhat  higher  than  in  the 
present  study,  for  example  the  amount  of  red  wine  phenolics  ingested  in  the  study  of 
Nigdikar  et  al.  (1998)  was  248  mg/d  in  a  375  mL  serving.  This  difference  in  dose  may 
explain  why  we  observed  no  statistically  significant  effect  on  LDL  oxidation.  A  further 
consideration  is  that  in  the  studies  of  Nigdikar  et  al.  (1998)  and  Fuhrman  et  al.  (1995) 
the  LDL  oxidation  assays  were  carried  out  on  fresh  plasma  samples.  In  this 
investigation  EDTA-treated  plasma  was  stored  at  -80°C  for  several  weeks  prior  to  being 
assayed.  Our  experience  (Higgins  et  al.,  2001),  along  with  that  of  Esterbauer  et  al. 
(1993)  and  Kleinveld  et  al.  (1992)  is  that  this  does  not  adversely  affect  the  reliability  of 
the  oxidation  assay.  Another  difference  between  the  present  investigation  and  the 
studies  of  Nigdikar  et  al.  (1998)  and  Fuhrman  et  al.  (1995)  is  that  in  both  these  studies 
the  volunteers  were  male,  while  both  male  and  female  volunteers  participated  in  our 
study.  This  could  have  increased  the  inter-individual  variability  in  the  response  to  the 
red  wine  intervention  making  it  more  difficult  to  see  a  statistically  significant  difference 
in  the  lag  phase  between  the  intervention  and  control  groups.  However,  we  did  not  find 
any  differences  in  any  of  the  parameters  measured  between  male  and  female  volunteers. 
A  power  calculation  was  carried  out  post-hoc  to  determine  whether  the  number  of 
subjects  used  in  this  study  was  adequate  to  see  a  statistically  significant  difference  in  the 
lag  phase.  The  sample  size  was  calculated  based  on  a  two-sample  t-test 
(wedstaff@stat.  ucla.  edu).  The  number  of  volunteers  required  to  see  a  difference  was 
calculated  to  be  n=16.  Thus  the  number  of  subjects  used  in  the  present  study  was 
slightly  less  than  the  number  required  to  see  a  difference  at  5%  significance  level  and 
80  %  power.  Although  there  was  a  trend  towards  a  reduction  in  the  plasma 
concentration  of  homocysteine  in  the  red  wine  group  the  results  were  not  statistically 
significant  (Table  4.6).  Elevated  circulating  levels  of  homocysteine  are  associated  with 
an  increased  risk  of  cardiovascular  disease  (Refsum  et  al.,  1998)  and  are  affected  by Catherine  Tsang  129 
diet,  mainly  due  to  inadequate  intakes  of  folate  and  vitamin  B  12.  There  is  evidence  that 
a  light  to  moderate  consumption  of  alcohol  is  associated  with  lower  fasting  plasma 
concentrations  of  homocysteine,  and  this  has  previously  been  reported  for  beer  (van  der 
Gaag  et  al.,  2002)  and  red  wine  (Dixon  et  al.,  2002).  Although  beer  contains  folate  and 
vitamin  B6,  red  wine  contains  negligible  amounts  of  vitamin  B6,  and  it  is  unlikely  that 
these  micronutrients  alone  can  explain  the  beneficial  effect.  Glucuronides  of  (+)- 
catechin  and  (-)-epicatechin  and  their  methylated  analogues  were  identified  in  plasma 
from  the  red  wine  group  post-intervention  (Table  4.4).  However,  the  amounts  present 
could  not  be  quantified  and  are  clearly  not  sufficient  to  make  a  significant  contribution 
to  the  increased  levels  of  phenolics  detected  in  plasma  after  red  wine  consumption 
(Table  4.3).  The  presence  of  the  flavan-3-ol  metabolites  is,  however,  in  line  with  the 
findings  of  a  previous  study  in  which  following  consumption  of  a  single  serving  of  120 
ml  of  red  wine  by  human  volunteers,  (+)-catechin  was  detected  in  plasma  after 
treatment  with  ß-glucuronidase  and  arylsulphatase  (Bell  et  al.,  2000).  Although  the  red 
wine  used  in  the  present  study  contained  a  substantial  amount  of  anthocyanins, 
particularly  malvidin-3-glucoside  (Table  4.2),  no  anthocyanins  were  detected  in  plasma 
despite  a  thorough  search  using  HLC-MS-MS.  This  is  in  keeping  with  the  findings  of 
other  human  studies  where  reported  urinary  recoveries  of  anthocyanins  after 
consumption  of  red  wine  or  anthocyanin-rich  produce,  typically  range  from  0.05  to  0.11 
%  of  intake  (Frank  et  al.,  2003;  McGhie  et  al.,  2003).  Similarly,  very  low  plasma 
anthocyanin  concentrations  have  been  reported  in  humans  (Cao  &  Prior,  1999)  and 
frequently  the  levels  are  below  the  limits  of  detection  (Felgines  et  al.,  2002;  Wu  et  al., 
2002).  It  is  unclear  at  this  juncture  whether  anthocyanins  enter  the  circulatory  system  in 
trace  amounts  or  whether  they  are  absorbed  in  more  substantial  quantities  and  rapidly 
removed  from  the  bloodstream.  Likewise,  although  the  red  wine  contained  a  high  level 
of  gallic  acid,  despite  a  thorough  search  no  gallic  acid  or  metabolites  of  gallic  acid  were 
detected  in  the  plasma  of  volunteers  who  consumed  red  wine. Catherine  Tsang 
4.7  Conclusion 
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In  summary,  a  moderate  consumption,  over  a  two  week  period,  of  a  red  wine,  rich 
in  gallic  acid,  flavan-3-ols  and  anthocyanins,  significantly  increased  the  concentration 
of  total  phenolics  in  plasma  of  human  volunteers.  This  small  increase  may  be  due  to  the 
trace  levels  of  glucuronide  and  methylated  metabolites  of  flavan-3-ol  monomers  that 
were  detected  in  plasma  post  red  wine  consumption.  There  were  significant  reductions 
in  conjugated  dienes  and  TBARS  and  a  significant  and  modest  increase  in  HDL 
cholesterol  in  the  red  wine  supplemented  group.  The  findings  from  this  study  support 
the  protective  effects  of  red  wine  reported  from  previous  epidemiological  studies  and 
current  medical  opinion  that  moderate  daily  intake  of  red  wine  may  reduce  the  risk  of 
developing  CHD. Catherine  Tsang  131 
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Chapter  5  The  absorption,  metabolism  and  excretion 
of  flavan-3-ols  and  procyanidins  following  the  ingestion 
of  a  tannin-rich  grape  seed  extract  by  rats 
5.1  Introduction 
Flavan-3-ols  are  a  complex  subclass  of  flavonoids  encompassing  the  simple 
monomers  (+)-catechin  and  its  isomer  (-)-epicatechin,  and  the  oligomeric  and  polymeric 
procyanidins,  commonly  known  as  condensed  tannins  (Figure  5.1).  The  procyanidins 
are  formed  from  the  condensation  of  monomeric  units,  between  2-5  units  for  oligomers 
and  over  5  units  for  polymers.  Procyanidins  differ  in  their  position  and  configuration  of 
their  monomeric  linkages,  with  the  dimers  B  1,  B2,  B3  and  B4  being  detected  most 
frequently.  Besides  forming  complexes  with  other  flavan-3-ols,  the  monomeric  flavan- 
3-ols  are  hydroxylated  to  form  the  gallocatechins,  and  also  undergo  esterification  with 
gallic  acid  (Crozier,  2003). 
Flavan-3-ols  are  widely  dispersed  in  the  human  diet  and  are  one  of  the  most  abundant 
dietary  flavonoids  with  red  wine,  tea,  berries,  apples  and  chocolate  providing  the  richest 
food  sources  (Sanoner  et  al.,  1999;  Foo  et  al.,  2000;  Auger  et  al.,  2004;  Del  Rio  et  al., 
2004).  Although  there  are  no  accurate  estimates  of  flavan-3-ol  intake  levels,  it  has  been 
speculated  that  consumption  ranges  between  0.1-0.5  g/d,  (De  Pascual-Teresa  et  al., 
2000a;  Scalbert  &  Williamson,  2000).  The  data  of  Arts  et  al.  (2001  a)  imply  that  flavan- 
3-ols  may  be  one  of  the  more  effective  groups  of  dietary  phenolics  in  reducing  the  risk 
of  coronary  heart  disease.  In  keeping  with  this  possibility  (+)-catechin  and  procyanidins 
have  been  shown  reduce  platelet  aggregation  (Ruf  et  al.,  1995)  and  to  act  as  powerful 
inhibitors  of  low-density  lipoprotein  (LDL)  oxidation  in  vitro  (Teissedre  et  al.,  1996; 
Steinberg  et  al.,  2003)  and  ex  vivo  (Kondo  et  al.,  1996),  events  believed  to  play  a 
crucial  role  in  the  preventing  the  onset  of  atherogenesis  (Steinberg  et  al.,  1989).  It  has 
also  been  demonstrated  that  consumption  of  a  procyanidin-rich  grape  seed  extract 
(GSE)  reduces  the  incidence  of  cataracts  in  the  eyes  of  hereditary  cataractous  (ICR/f) 
rats  (Yamakoshi  et  al.,  2002).  (+)-Catechin  and  (-)-epicatechin  are  absorbed  in  humans 
and  animals  appearing  in  plasma  and  urine  primarily  as  glucuronidated,  methylated  and 
sulphated  metabolites  following  the  ingestion  of  chocolate  (Baba  et  al.,  2001;  Wang  et Catherine  Tsang  133 
al.  2000;  Rein  et  al.,  2000),  black  and  green  tea  (Warden  et  al.,  2001;  Yang  et  al.,  1998; 
Piskula  and  Terao  1998)  and  red  wine  (Bell  et  al.,  2000;  Donovan  et  al.,  1999).  There 
is,  never-the-less,  conflicting  evidence  on  the  absorption  and  metabolism  of  the 
oligomeric  and  polymeric  flavan-3-ols  in  humans  and  animals.  Koga  et  al.  (1999) 
observed  the  presence  of  (+)  catechin  and  (-)-epicatechin  and  an  absence  of  dimers  in 
the  plasma  of  rats  following  ingestion  of  a  GSE.  Extending  this  study,  Donovan  et  al. 
(2002)  fed  rats  a  GSE,  (+)-catechin  and  procyanidin  B3  meals.  While  conjugated 
metabolites  of  (+)-catechin  were  detected  in  plasma  and  urine  after  both  the  (+)-catechin 
and  GSE  meals  there  was  no  evidence  of  absorption  for  the  procyanidins.  However,  in 
another  study  (-)-epicatechin  and  (+)-catechin  and  trace  amounts  of  procyanidin  dimer 
B2  were  detected  in  sulphatase-  and  ß-glucuronidase-treated  human  plasma  collected  30 
min  after  ingestion  of  a  cocoa  beverage  rich  in  flavan-3-ol  monomers  and  procyanidins 
(Holt  et  al.,  2002).  In  keeping  with  this  report,  it  has  been  shown  that  after  oral 
administration  of  B2  to  rats,  the  dimer  is  absorbed  and  excreted  in  urine  with  a  portion 
of  the  procyanidin  being  converted  to  (-)-epicatechin,  which  undergoes  post-ingestion 
conjugation  and  methylation  (Baba  et  al.,  2002). 
This  chapter  reports  on  a  comprehensive  study  of  the  absorption,  excretion  and 
sequestration  in  body  tissues  of  (+)-catechin,  (-)-epicatechin,  their  metabolites  and 
procyanidin  dimers  and  a  trimer  following  the  oral  intake  of  a  GSE  by  rats.  Liver, 
kidney,  brain  and  GI  tract,  together  with  plasma,  urine  and  faeces  were  collected  at 
several  time  points  up  to  24  h  post-ingestion  of  the  extract.  Samples  were  extracted  and 
analysed  by  HPLC-tandem  mass  spectrometry  for  the  identification  of  flavan-3-ols  and 
metabolites. Catherine  Tsang 
OH 
OH 
HO 
,  0"\ü\ 
zb  H  OH 
(-)-Epicatechin 
OH 
ýOH 
HO  ,  O: 
ýI 
OH 
OH 
(+)-Catechin 
OH 
ýOH 
HO,  0,  ý,  ýI 
\  '/O  O 
OH 
HO  OH 
OH 
(-)-Epicatechin  gallate 
OH 
HO 
H 
H  OH 
ö1  OH 
OH 
ÖH  t  1OH  OH 
OH 
00 
H  'OH 
Procyanidin  dimer 
Bt 
Procyanidin  dimer 
B2 
OH 
ýI  OH 
HO  ,O 
ýI 
OH  OH  OH_  OH 
HO  PýZ\  ö 
OH  =  OH  =  OH  OH 
OH 
HO  ,O\ 
"'OH 
OH 
Procyanidin  trimer 
C2 
OH 
ýOH 
HO 
OH  OH  OH 
OI  HO  ýOH 
OH 
134 
OH 
ýOH 
HOIO￿, 
OH 
OH  OH 
ýOH 
HO  ,  ý,  ýý 
OH  OH 
Procyanidin  dimer  Procyanidin  trimer 
B3  B4 
OH 
HOOC  YI 
OH 
HO  ý 
OH  "'/OH 
OH 
(-)-Epicatechin-7-O-glucuronide 
OCH3 
HOOC 
LOH 
HOOý  OO  ,  HO 
OH 
ýý 
"//OH 
OH 
3'-O-Methyl-(-)-epicatechin-7-O-glucuronide 
Figure  5.1  Some  common  flavan-3-ol  structures. Catherine  Tsang 
5.2  Animal  and  sample  preparation 
135 
Sprague-Dawley  male  rats  (n  =  24),  weighing  250  g±5g,  were  housed  in 
metabolic  cages  allowing  the  collection  of  24  h  urine  and  faecal  samples.  Rats  were 
deprived  of  food  for  16  h  before  being  fed  by  gavage  a  GSE  containing  monomers, 
oligomers  and  polymers  of  flavan-3-ols  (1  g/kg  body  weight)  dissolved  in  water  (1  g 
GSE  per  6  ml).  Three  animals  were  terminally  anaesthetised  with  pentobarbital  0,1,2, 
3,4,6,12  and  24  h  after  administration  of  the  GSE.  Blood  was  removed  by  cardiac 
puncture  with  heparin  moistened  syringes  and  plasma  was  obtained  by  centrifugation  at 
2000  g  for  10  min  at  4°C.  Liver,  kidney,  brain,  stomach,  duodenum/jejunum,  ileum, 
caecum,  colon,  urine  and  faeces  were  collected  at  each  time  point.  All  samples  were 
immediately  frozen  in  liquid  N2  and  stored  at  -80°C  prior  to  analysis.  All  animals  were 
maintained  and  handled  according  to  the  guidelines  of  the  Committee  on  Animal  Care 
and  use  at  the  University  of  Montpellier,  France. 
5.3  HPLC  with  diode 
spectrometry 
array  detection  &  tandem  mass 
All  samples  were  analysed  on  a  Surveyor  HPLC  system  comprising  of  a  HPLC 
pump,  diode  array  detector  scanning  from  250  to  700  nm,  and  an  autosampler  set  at  4°C 
as  previously  described  previously  in  Chapter  2  (section  2.6).  Separation  was  carried  out 
using  a  250  x  4.6  mm  i.  d.  4  µm  Synergi  RP-Max  column  (Phenomenex,  Macclesfield, 
UK)  eluted  at  a  flow  rate  of  1  mL/min.  A  mobile  phase  consisting  of  a  5-40  %  gradient 
over  60  min  of  1%  formic  acid  and  acetonitrile  was  used  for  the  analysis  of  all  samples 
except  urine  for  which  a  5-20  %,  60  min  gradient  was  utilised.  After  passing  through  the 
flow  cell  of  the  diode  array  detector  the  column  eluate  was  split  and  0.3  mL  was 
directed  to  a  LCQ  Deca  XP  ion  trap  mass  spectrometer  fitted  with  an  electrospray 
interface  (Thermo  Finnigan,  San  Jose,  USA).  Analysis  was  carried  out  in  negative  ion 
mode  operating  in  full  scan  mode  from  100-2000  amu.  Selective  reaction  monitoring 
(SRM)  was  used  where  compounds  could  not  be  identified  using  the  full  scan  mode. 
With  enhanced  specificity  and  significantly  reduced  chemical  noise  this  method  was 
particularly  useful  for  the  identification  and  quantification  of  trace  levels  of 
procyanidins  in  urine.  The  conditions  used  were  as  outlined  above  except  that  the  mass Catherine  Tsang  136 
spectrometer  was  in  selected  reaction  monitoring  mode.  When  screening  for  the 
presence  of  dimers  the  parent  ion  was  m/z  577,  collison  energy  35  %  and  product  ions 
were  scanned  from  m/z  220-577.  In  the  case  of  trimers,  the  parent  ion  was  m/z  865  and 
product  ions  were  scanned  from  m/z  350-865. 
5.4  Identification  of  grape  seed  phenolics 
In  total  13  phenolic  compounds  were  identified  in  the  GSE  by  HPLC-MS-MS. 
The  data  obtained  are  illustrated  in  Figure  5.2  and  summarized  below  and  in  Table  5.2. 
Where  reference  compounds  were  not  available  identifications  were  facilitated  by 
previous  analyses  of  flavan  3-ols  in  grapes  seeds  and  GSE  (Table  5.1). 
Peak  1  (tR  =  6.2  min,  , max  =  280  nm)  had  a  [M-H]-  at  m/z  865  with  MS2 
yielding  two  major  fragment  ions  at  m/z  695  and  577.  Based  on  the  mass  spectral  data. 
this  compound  is  a  procyanidin  trimer.  Its  elution  prior  to  procyanidin  dimer  B3  (peak  2) 
(Santos-Buelga  et  al.,  1995)  indicates  that  it  is  probably  C2,  a  known  component  of 
grape  seeds  (Romeyer  et  al.,  1986). 
Peak  2  (tR  =  12.1  min,  ?,  max  =  280  nm)  had  a  [M-H]-  at  m/z  577  with  MS2 
yielding  three  fragment  ions  at  m/z  425,407  and  289.  This  mass  spectrum  and  co 
chromatography  with  an  authentic  standard  established  that  peak  2  is  procyanidin  dimer 
B1,  which  has  previously  been  detected  in  grape  seeds  (Ricardo  da  Silva  et  al.,  1991). 
Peak  3  (tR  =  13  min,  2,  max  =  280  nm)  also  had  a  [M-H]-  at  m/z  577  which 
fragmented  to  produce  MS2  ions  at  m/z  425,407  and  289.  Its  elution  prior  to  (+)- 
catechin  (Sun  et  al.,  1999)  and  co-chromatography  with  an  authentic  standard 
demonstrates  that  peak  3  is  procyanidin  dimer  B3. 
Peak  4  (tR  =  14.3  min,  , max  =  280  nm)  had  a  [M-H]-  at  m/z  289  and  MS2 
produced  fragment  ions  at  m/z  245  and  205.  This  mass  spectrum  and  co  chromatography 
with  an  authentic  standard  identifies  peak  4  as  (+)-catechin. 
Peak  5  (tR  =  15  min,  , max  =  280  nm)  produced  a  [M-H]-  at  m/z  1153  which  on 
MS2  yielded  ions  at  m/z  865  and  577.  Although  a  reference  compound  was  not 
available,  the  elution  of  this  peak  close  to  (+)-catechin  and  the  mass  spectral  data Catherine  Tsang  137 
indicate  that  it  may  be  a  non-galloylated  procyanidin  tetramer,  the  presence  of  which 
has  previously  reported  in  a  GSE. 
Peak  6  (tR  =  15.5  min,  , max  =  280  nm)  had  a  [M-H]-  at  m/z  865  with  MS2 
producing  three  fragment  ions  at  m/z  695,577  and  407.  Based  on  the  mass  spectral  data, 
this  compound  is  a  procyanidin  trimer.  Its  elution  between  (+)-catechin  (peak  4)  and  the 
dimer  B4  (peak  7)  indicates  that  it  may  be  epicatechin-(4ß-8)-epic  atechin-(4ß-8)- 
catechin  previously  identified  in  a  GSE  by  Santos-Buelga  et  al.  (1995). 
Peak  7  (tR  =  16.2  min,  , max  =  280  nm)  had  a  [M-H]-  at  m/z  577  which  on  MS2 
yielded  three  ions  at  m/z  425,407  and  289.  This  mass  spectrum  and  co-chromatography 
with  an  authentic  standard  identifies  peak  7  as  procyanidin  dimer  B4,  a  known 
component  of  grape  seeds  (De  Pascual-Teresa  et  al.,  2000b). 
Peak  8  (tR  =  17  min,  , max  =  280  nm)  produced  a  [M-H]-  at  m/z  577  which 
produced  MS2  fragments  at  m/z  425,407  and  289.  The  mass  spectral  data  indicated  the 
presence  of  a  procyanidin  dimer  and  co-chromatography  with  an  authentic  standard 
identified  it  as  the  B2  dimer. 
Peak  9  (tR  =  18.8  min,  2,  max  =  280  nm)  had  a  [M-H]-  at  m/z  289  which  on  MS2 
yielded  two  ions  at  m/z  245  and  205.  This  mass  spectrum  and  co-chromatography  with 
an  authentic  standard  established  that  peak  9  is  (-)-epicatechin. 
Peak  10  (tR  =  20.7  min,  , max  =  280  nm)  produced  a  [M-H]-  at  m/z  865,  which 
yielded  MS2  fragments  at  m/z  695,577  and  407.  Based  on  the  mass  spectral  data  this 
compound  is  procyanidin  trimer. 
Peak  11  (tR  =  21.3  min,  , max  =  275  nm)  had  a  [M-H]-  at  m/z  1153,  and  MS2 
yielded  ions  at  m/z  865  and  577.  This  is  in  keeping  with  peak  11  being  a  procyanidin 
tetramer. 
Peak  12  (tR  =  22.2  min,  , max  =  275  nm)  had  a  [M-H]-  at  m/z  729,  with  MS2 
ions  at  m/z  577,407  and  289.  These  ions  are  similar  to  those  observed  with  the 
procyanidin  dimers  in  peaks  8  and  9  with  the  m/z  577  fragment  resulting  from  a  154 
amu  loss  from  the  [M-H]-  which  is  indicative  of  the  cleavage  of  a  gallate  unit.  On  the 
basis  of  the  MS2  spectrum,  this  compound  is,  therefore,  a  gallated  procyanidin  dimer. 
Although  a  reference  compound  was  not  available,  the  elution  order  of  this  peak  after  (- 
)-epicatechin  (peak  9)  and  a  procyanidin  trimer  (peak  10)  along  with  the  mass  spectral 
data  indicate  that  it  is  either  B1-3-O-gallate  or  B2-3'-O-gallate  both  of  which  have  been 
detected  in  grape  seeds  (Santos-Buelga  et  al.,  1995). Catherine  Tsang  138 
Peak  13  (tR  =  27.2  min,  , max  =  275  nm)  had  a  [M-H]-  at  m/z  441  with  MS2 
producing  a  fragment  at  m/z  289.  This  mass  spectrum  and  co-chromatography  with  an 
authentic  standard  established  that  peak  3  is  (-)-epicatechin-3-O-gallate.  The  levels  of 
the  13  flavan-3-ols  that  were  ingested  when  each  rat  was  fed  the  GSE  are  presented  in 
Table  5.2  together  with  the  summarised  analytical  data.  On  a  per  kg  body  weight  basis 
each  rat  ingested  23.2  mg  of  (+)-catechin,  14.4  mg  of  (-)-epicatechin,  28.4  mg  of 
procyanidin  dimers,  5.2  mg  of  trimers  and  2.8  mg  of  tetramers.  In  addition,  each  rat  also 
ingested  a  substantial  but  undetermined  quantity  of  high  molecular  weight  polymeric 
procyanidins  whose  presence  in  the  GSE  is  evident  from  the  increasing  baseline  and  the 
broad  unresolved  band  of  components  that  elute  across  the  HPLC-A280  chromatogram 
illustrated  in  Figure  5.2. 
Table  5.1  Flavan-3-ols  isolated  from  grape  seeds. 
Peak  order  Compound 
1  Catechin-(4a-8)-catechin-(4a-8)-catechin  (C2) 
2  Catechin-(4a-8)-catechin  (B3) 
3  Epicatechin-(4ß-8)-catechin  (B1) 
4  (+)-Catechin 
5  Epicatechin-(4  f 3-8)-epicatechin-(4ß-8)-catechin 
6  Catechin-(4a-8)-epicatechin  (B4) 
7  Catechin-(4a-8)-catechin-(4a-8)-epicatechin 
8  Epicatechin-(4ß-6)-epicatechin-(4ß-8)-catechin 
9  Catechin-(4a,  6)-catechin  (B6) 
10  Epicatechin-(4ß-6)-epicatechin-(4ß-8)-epicatechin 
11  Epicatechin-(4p-8)-epicatechin  (B2) 
12  Epicatechin-(4p-8)-epicatechin-3-O-gallate-(4ß-8)-catechin 
13  Epicatechin-3-O-gallate-(40-8)-epicatechin  (B2-3-O-gallate) 
14  (-)-Epicatechin 
15  Catechin-(4a-6)-  epicatechin-3-O-gallate  (B4-3'-O-gallate) 
16  Epicatechin-(4ß-8)-epicatechin-(4ß-6)-catechin 
17  Epicatechin-3-O-gallate-(4ß-8)-catechin  (B1-3-O-gallate) 
18  Epicatechin-(4ß-8)-epicatechin-3-0-gal  late  (B2-3'-O-gallate) 
19  Epicatechin-(40-6)-catechin  (B7) 
20  Epicatechin-(4ß-8)-epicatechin-(4ß-8)-epicatechin  (Cl) 
21  Epicatechin-(4ß-8)-epicatechin-(4p-8)-epicatechin-(4ß-8)-epicatechin 
22  (-)-Epicatechin-3  -0-gal  late 
23  Epicatechin-3-0-gallate-(4f3-6)-  catechin  (B7-3-O-gallate) 
24  Epicatechin-3-O-gallate-(4ß-8)-epicatechin-3-O-gallate  (B2-3,3'-O-digallate) 
25  Epicatechin-(4ß-8)-epicatechin-(4ß-8)-epicatechin-3-O-gallate 
26  Epicatechin-(4ß-8)-  epicatechin-3-O-gallate-(4ß-8)-epicatechin-3-O-gallate 
27  Epicatechin-(4p-6)-epicatechin  (B5) 
Adapted  from  Santos-Buelga  et  al.  (1995). oil  '-r7  -.  O  UQ 
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5.5  Identification  of  flavan-3-ol  metabolites  in  body  tissues 
and  fluids 
To  reduce  the  sample  weight  to  manageable  proportions  for  HPLC  analysis  and 
obtain  cleaner  mass  spectra,  samples  from  three  individual  rats  were  combined  and 
extracted  according  to  the  method  of  Mullen  et  al.  (2002b)  described  in  detail  in 
Chapter  2  (section  2.7.2).  The  total  weight  of  each  organ  and  the  amount  of  each  organ 
used  in  the  extraction  method  are  summarised  in  Appendix  II.  Proteins  in  1  mL  volumes 
of  plasma  were  precipitated  and  phenolics  extracted  as  described  in  detail  in  Chapter  2 
(section  2.7.1)  and  in  Mullen  et  al.  (2002b).  Using  a  5-40  %  acetonitrile  gradient  HPLC 
with  MS-MS  in  the  full  scan  mode  four  flavan-3-ol  metabolites  were  detected  in  the  GI 
tract,  plasma,  liver,  and  kidneys.  The  results  of  these  analyses  are  summarized  below 
and  in  Table  5.3. 
Peak  M-1  (tR  =  11.6  min,  , max  =  280  nm)  and  M-2  (tR  =  14.5  min,  , max  =  280 
nm)  both  had  a  [M-H]-  at  m/z  465  which  yielded  MS2  fragments  at  m/z  289  and  245 
corresponding  to  (+)-catechin/(-)-epic  atechin.  The  [M-H]-176  loss  is  in  keeping  with 
the  cleavage  of  a  glucuronyl  unit.  The  MS  fragmentation  pattern,  together  with  the 
HPLC  elution  order,  indicates  that  the  earlier  eluting  M-1  peak  is  a  (+)-catechin 
glucuronide  while  M-2  is  an  (-)-epicatechin  glucuronide. 
Peak  M-3  (tR  =  17.7  min,  , max  =  280  nm)  and  M-4  (tR  =  20.7  min,  , max  =  280 
nm)  also  had  identical  mass  spectra  with  a  [M-H]-  at  m/z  479  which  on  loss  of  176  amu 
(cleavage  of  a  glucuronyl  unit)  yielded  a  MS2  ion  at  m/z  303.  These  fragments  are  14 
amu  higher  than  the  equivalent  ions  in  the  spectra  of  M-1  and  M-2,  indicating  the 
presence  of  methylated  flavan-3-ol  glucuronides.  M-3  is  therefore  probably  a  methyl- 
catechin  glucuronide  and  the  later  eluting  M-4  a  methyl-epicatechin  glucuronide. 
Without  reference  compounds  it  was  not  possible  to  determine  the  positions  on  the 
flavan-3-ol  skeleton  of  the  methyl  and  glucuronic  acid  substituents.  The  most  likely 
candidates  for  M-2  and  M-4  are  (-)-epicatechin-7-O  glucuronide  and  3'-O-methyl-(-)- 
epicatechin-  7-O-glucuronide  which  have  been  identified  in  rat  plasma  and  urine  after 
ingestion  of  (-)-epicatechin  (Natsume  et  al.,  2003).  (+)  Catechin  is  converted  to  3'-O- 
methyl-(+)-catechin  in  rats  (Nakamura  and  Tonogai,  2003),  so  M-3  may  be  a  3'-O- 
methyl-(+)-catechin  glucuronide.  However,  no  (+)-catechin  glucuronides  have  been Catherine  Tsang  142 
structurally  elucidated  so  it  is  not  possible  to  speculate  on  the  position  of  the 
glucuronide  moiety  in  M-1  and  M-3. 
Urine  contained  impurities  that  interfered  with  the  analyses  when  HPLC  was  carried  out 
with  a  5-40  %  gradient  of  acetonitrile.  This  was  overcome  with  the  use  of  a  5-20  % 
gradient  which  enhanced  resolution  and  revealed  the  presence  of  the  four  previously 
detected  metabolites  (M-1,  M-2,  M-3  and  M-4  at  retention  times  of  14.1,19.0,26.0  and 
30.2  min,  respectively)  together  with  four  additional  urinary  metabolites,  U-1,  U-2,  U-3 
and  U-4,  which  were  not  present  in  other  samples  (Table  5.3). 
Peak  U-1  (tR  =  24.6  min,  2,  max  =  280  nm)  and  U-2  (tR  =  27.9  min,  , max  =  280 
nm)  both  had  a  [M-H]-  at  m/z  369  yielding  a  MS2  ion  at  m/z  289.  The  [M-H]-80  loss  is 
in  keeping  with  the  cleavage  of  a  SO3  unit.  The  MS  fragmentation  pattern,  together  with 
the  HPLC  elution  order,  indicates  that  the  earlier  eluting  U-1  peak  is  a  (+)-catechin 
sulphate  while  U-2  is  an  (-)-epicatechin  sulphate. 
Peaks  U-3  (tR  =  29.2  min,  , max  =  280  nm)  and  U-4  (tR  =  38.1,  min,  , max  = 
280  nm)  had  a  [M-H]-  at  m/z  383  which  on  loss  of  80  amu  (cleavage  of  a  S03  unit) 
yielded  a  MS2  ion  at  m/z  303.  These  fragments  are  14  amu  higher  than  the  equivalent 
ions  in  the  spectra  of  U-1  and  U-2,  indicating  the  presence  of  methylated  flavan-3-ol 
glucuronides.  Based  on  the  fact  that  3'-O-methylation  of  flavan-3-ols  predominates  in 
rats  U-3  is  therefore  probably  a  3'-O  methyl-(+)-catechin  sulphate  and  the  later  eluting 
U-4,  a  3'-O-methyl-(-)-epicatechin  sulphate.  This  is  the  first  direct  evidence  for  the 
occurrence  of  sulphated  flavan-3-ol  metabolites  in  rats  and  as  yet  the  position  of  the 
sulphate  moiety  remained  undetermined. O 
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5.5.1  Plasma  flavan-3-ol  metabolites 
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(+)-Catechin  glucuronide  (M-1),  (-)-epicatechin  glucuronide  (M-2),  methyl-(+)-catechin 
glucuronide  (M-3)  and  methyl-(-)-epicatechin  glucuronide  (M-4)  were  detected  in 
plasma  (Table  5.3).  This  is  shown  in  the  HPLC  traces  in  Figure  5.3  which  illustrate  data 
obtained  with  plasma  collected  4h  after  GSE  ingestion.  The  A280  nm  trace  contains  a 
number  of  impurities  in  addition  to  the  four  flavan-3-ol  metabolites  and  it  is  evident  that 
M-3  is  a  shoulder  on  a  contaminant  peak.  None-the-less  full  scan  MS2  spectra,  as 
summarized  in  Table  5.3,  were  obtained  for  all  four  metabolites  which  were  quantified 
by  using  the  enhanced  selectivity  obtained  by  monitoring  the  response  at  m/z  465  for  M- 
1  and  M-2  and  m/z  479  for  M-3  and  M-4  (Figure  5.3).  Unmetabolised  (+)-catechin  and 
(-)-epicatechin  were  not  present  in  the  plasma  samples  in  detectable  quantities  and 
neither  were  procyanidin  dimers,  trimers  and  tetramers.  The  plasma  pharmacokinetic 
profiles  based  on  HPLC-MS-SRM  analyses  are  illustrated  in  Figure  5.4a.  Three  h  after 
GSE  ingestion  (+)-catechin  glucuronide  and  (-)-epicatechin  glucuronide  attained  peak 
plasma  concentration  of  10.3  ±  0.7  and  9.9  ±  0.1  pg/ml,  respectively  which  corresponds 
to  36.0  ±  2.5  and  34.4  ±  0.2  µmoles/L.  The  glucuronide  derivatives  of  methyl-(+)- 
catechin  and  methyl-(-)-epicatechin  also  peaked  after  3h  at  5.5  ±  0.1  and  3.3  ±  0.2 
pg/ml,  14  respectively.  There  was  a  ca.  20  %  reduction  in  the  concentrations  of  all  four 
plasma  flavan-3-ol  metabolites  at  4h  after  which  the  levels  declined  more  rapidly 
(Fig.  5.4a).  Assuming  ca.  12  ml  of  plasma  per  rat,  the  peak  plasma  concentrations  of  the 
two  (+)-catechin  metabolites  corresponds  to  ca.  3%  of  the  (+)-catechin  ingested  and  the 
(-)-epicatechin  metabolites  equate  with  ca.  4%  of  intake. 
5.5.2  Plasma  antioxidant  capacity 
The  antioxidant  capacity  of  plasma  was  measured  in  the  ABTS+  antioxidant  assay 
(Miller  et  al.,  1993)  as  described  previously  in  Chapter  2  (section  2.3.5).  The 
antioxidant  capacity  of  the  plasma  increased  significantly  (P  <  0.05)  from  baseline  0.88 
±  0.0  to  0.97  ±  0.0  (10.4  %)  and  1.06  ±  0.0  (21.5  %)  mmol/L  trolox  equivalents  at  2  and 
4h  post  ingestion  of  the  GSE,  respectively.  Results  are  illustrated  in  Figure  5.4b. Catherine  Tsang 
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Figure  5.3  Reversed  phase  HPLC  analysis,  with  diode  array  and  full  scan  MS2 
detection,  of  the  flavan-3-ol  metabolites  (+)-catechin  glucuronide  (M-1),  (-)-epicatechin 
glucuronide  (M-2),  methyl-(+)-catechin  glucuronide  (M-3),  methyl-(-)-epicatechin 
glucuronide  (M-4)  in  rat  plasma  collected  4h  after  the  ingestion  of  a  GSE  grape  seed 
extract.  Extract  analysed  using  a  60  min  5-40  %  gradient  of  acetonitrile  in  1%  aqueous 
formic  acid  with  detection  at  (A)  280  nm,  (B)  m/z  465  and  (C)  m/z  479.  (For  MS2  data, 
see  Table  5.3). 
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Figure  5.4  (A)  Pharmacokinetic  profile  of  flavan-3-ol  metabolites  detected  in  rat 
plasma  collected  over  a  0-24  h  period  after  the  ingestion  of  a  GSE.  Results  are 
expressed  as  pg  (+)-catechin  equivalents/ml  ±  standard  error,  where  n=3  (triplicate 
analysis  of  same  sample).  In  all  instances  standard  error  bars  are  smaller  than  symbols. 
(B)  Plasma  antioxidant  capacity  expressed  as  mmol/L  trolox  equivalents  ±  standard 
error,  where  n=3  (triplicate  analysis  of  same  sample). 
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5.5.3  Urinary  flavan-3-ol  metabolites 
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A  total  of  eight  flavan-3-ol  metabolites,  methyl-glucuronides,  sulphates  and  methyl- 
sulphates  of  the  monomers  (+)-catechin  and  (-)-epicatechin,  whose  LC-MS-MS 
identifications  are  outlined  in  Table  5.3,  were  detected  in  urine.  HPLC  data  obtained 
with  a  0-24  h  urine  sample  are  illustrated  in  Figure  5.5.  The  A280  nm  trace  contained 
numerous  impurities  (Fig.  5.5A)  so  the  flavan-3-ol  metabolites  were  quantified  by  MS 
with  m/z  383  being  used  to  detect  and  quantify  the  methyl  derivatives  of  (+)-catechin 
sulphate  (M-3)  and  (-)-epicatechin  sulphate  (M-4)  (Fig.  5.5B)  while  m/z  369  was  used  to 
monitor  (+)-catechin  sulphate  (U-1)  and  (-)-epicatechin  sulphate  (U-2)  and  as  illustrated 
in  Figure  5.5  m/z  383  for  their  methyl  derivatives  (U-3  and  U-4).  The  flavan-3-ol 
glucuronide  and  methyl-glucuronide  metabolites,  M-1  to  M-4  were  analysed  at  m/z  465 
and  m/z  479  as  outlined  previously  with  the  plasma  samples.  Information  on  the 
cumulative  excretion  of  the  eight  metabolites  over  0-2,0-4  and  0-24  h  time  periods  is 
presented  in  Table  5.4.  The  levels  of  (+)-catechin  and  (-)-epicatechin  metabolites 
excreted,  relative  to  the  quantity  of  the  monomers  ingested  were  1  and  2%  respectively 
after  2  h,  13  %  after  4h  and  27  and  36  %  after  24  h.  No  (+)-catechin  and  (-)-epicatechin 
were  detected  in  the  urine  samples.  HPLC-MS-MS  in  the  SRM  mode  was  used  to 
analyse  urine  collected  up  to  4h  after  ingestion  of  the  GSE  and  procyanidin  dimers  B  1, 
B2,  B3  and  B4  as  well  as  the  trimer  C2  and  the  unknown  trimer  (that  was  peak  10  in  the 
GSE)  were  identified  (Fig.  5.6).  Also  analysis  at  m/z  865  revealed  the  presence  of  the 
trimer  C1  an  additional  later  eluting  trimer  that  was  also  present  in  the  ingested  GSE.  All 
these  procyanidins  were  detected  in  low  µg  amounts  (Table  5.5)  which  is  much  less 
than  the  levels  of  the  urinary  metabolites  of  (+)-catechin  and  (-)-epicatechin  that  were 
excreted  in  the  first  4h  after  ingestion  of  the  GSE  (Table  5.4). Catherine  Tsang 
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Figure  5.5  Reversed  phase  HPLC  analysis,  with  diode  array  and  full  scan  MS2 
detection,  of  methyl-(+)-catechin  sulphate  (U-3)  and  methyl-(-)-epicatechin  sulphate 
(M-4)  in  rat  urine  collected  4h  after  the  ingestion  of  a  GSE.  Extract  analysed  using  a  60 
min  5-20  %  gradient  of  acetonitrile  in  1%  aqueous  formic  acid  with  detection  at  (A) 
280  nm,  (B)  m/z  383.  (For  MS2  data,  see  Table  5.3). 
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Table  5.4  Cumulative  Excretion  of  Flavan-3-ol  Metabolites  in  Rat  Urine  0-2,0-4  and 
0-24  After  Oral  Ingestion  of  a  Grape  Seed  Extract. 
Peak  Metabolite  0-2  h  0-4  h  0-24  h 
M-1  (+)-catechin  glucuronide  40  ±  0.2  324  +  8.2  814  ±  49 
M-2  (-)-epicatechin  glucuronide  11  ±  2.2  201  ±  1.0  635  ±  23 
M-3  methyl-(+)-catechin  glucuronide  66  ±  7.7  332  ±  9.0  534  +  25 
M-4  methyl-(+)-epicatechin  glucuronide  6.3  +  0.2  193  +  0.7  391  ±  48 
U-1  (+)-catechin  sulphate  2.5  ±  0.1  27  ±  0.4  78  f  6.1 
U-2  (-)-epicatechin  sulphate  n.  d.  39  ±  0.2  139  f  13 
U-3  methyl-(+)-catechin  sulphate  2.3  +  0.2  45  ±  11  120  ±  1.1 
U-4  methyl-(-)-epicatechin  sulphate  1.4  ±  0.1  29  +  1.4  152  ±  1.3 
Results  are  expressed  as  µg  excreted  per  rat  ±  standard  error,  where.  n=3. Catherine  Tsang 
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Figure  5.6  Reversed  phase  HPLC  analysis,  with  diode  array  and  MS2  detection  in  the 
selected  reaction  monitoring  mode,  of  procyanidin  dimers  (A)  and  trimers  (B)  in  rat 
urine  collected  4h  after  the  ingestion  of  a  GSE  grape  seed  extract.  Extract  analysed 
using  a  60  min  5-40  %  gradient  of  acetonitrile  in  1%  aqueous  formic  acid  with  detection 
at  (A)  m/z  577  (B)  m/z  865. 
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Table  5.5  Cumultive  Excretion  of  Procyanidin  Dimers  in  Rat  Urine  0-4  h  After  Oral 
Ingestion  of  a  Grape  Seed  Extract. 
Procyanidin  Amount 
DimerBl  7.5±0.3 
DimerB2  4.2±0.2 
DimerB3  6.4±0.1 
Dimer  B4  3.0  ±  0.4 
Trimer  Cl  13.0  ±  0.1 
Unknown  trimer  5.1  f  0.4 
151 
Results  are  expressed  as  µg  excreted  per  rat  ±  standard  error, where.  n=3. Catherine  Tsang 
5.5.4  Flavan-3-ols  and  metabolites  in  the  GI  tract 
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The  levels  of  flavan-3-ols  and  their  metabolites  that  were  detected  in  the  various 
sections  of  the  GI  tract  are  presented  in  Table  5.6.  Although  the  amounts  fluctuated 
somewhat  from  time  point  to  time  point,  presumably  because  of  rat-to-rat  variations  and 
variable  recoveries,  which,  precludes  a  detailed  analysis  of  the  data,  certain  trends  are 
none-the-less  apparent.  One  hour  after  GSE  supplementation  (+)-catechin,  (-)- 
epicatechin  and  other  flavan-3-ols  were  found  the  GI  tract,  the  highest  quantities  were 
present  in  the  stomach  with  low  levels  in  the  duodenum/jeunum  and  ileum.  Trace 
quantities  of  metabolites,  detected  in  the  duodenum/jejunum  and  ileum  1h  after  the 
ingestion  of  the  GSE,  were  identified  as  glucuronides  of  the  monomers  (+)-catechin  and 
(-)-epicatechin  and  their  methylated  analogs.  The  amounts  present  in  these  organs  at  2h 
corresponded  to  only  1.2  %  and  2  %,  respectively,  of  the  (-)-epicatechin  and  (+)- 
catechin  in  the  ingested  GSE.  Small  amounts  of  flavan-3-ol  metabolites  were  present  in 
the  duodenum/jejunum  and  ileum  up  to  6h  after  ingestion  after  which  they  were  not 
detected.  No  metabolites  were  detected  in  the  stomach,  caecum  and  colon  at  any  time 
point  throughout  the  24  h  collection  period  although  relatively  small  quantities  of 
unmetabolised  flavan-3-ols,  including  the  B1,  B2,  B3  and  B4  dimers,  were  present  up  to 
12  h  after  ingestion  of  the  GSE.  All  the  GSE  flavan-3-ols  were  eliminated  from  the  GI 
tract  24  h  after  ingestion. Uo  *_ 
CCD 
<  CD 
nN 
Oý  WNN  Qý  WNN  Oý  AWNN  Qý  1ý  WNN  Oý  AWNO 
SSSSSSSSSSSSSSSSSSSSSSSSSSSSS  =r  =r 
CD 
n  C_D 
NN  ýl  W  t,  -,  JvÖ  \O 
Ö 
teil  J0-  00 
1Ä=7O  110  JN  0O  =_  00  '--'  .  O\  00  O,  L=  un  =  cý  Oý  W 
t.  A 
°°  FF  Ff  FF  aaaß  FF  IFßna  FF  FF  H-  FF  ßa  FF  H  FF  ii  IFIF  H-  I+  H-  CD 
`C  `ý"7.  WA  pp  wON  0o  NN 
'_  to 
t,  ýD  ýO  A  Ej 
100  O  00  10  ýc  W 
O 
CD 
nC 
__ 
(n 
=  ONO 
- 
coil  __=N  00  N 
p= 
vii 
W=WÖ 
cv'il  ý'  coil  CTi  C00  -  ON  D  I+  I+  FF 
.aa  H-  1-  ýwa. 
ä.  c. 
W  I+  H-  WW  °'  in.  H-  I+  I+  H-  FF  -  ä.  I+  I.  HHwµ  C7  CD 
NG 
Can 
Ö  l'J  v  Oý,  WW  00  JJ  110  Oý 
0O  LA  Cý  ''N  CD 
ý,  O  Oý  O',  vi  Oll  "A  w-N  -l  o  -l  00  110  Jý.  -O2,  oo  wOW 
ß,  W  Oý  Q',  O,  __=JW___  ýO  O"  NN  º-  _  O,  Oý  Oll  N  JI  IC  N  º-  J  Oý  CD 
cý  oa  I+  I+  H  I+  c.  aa  I+  I+  anä  I+  I+  I+  I+  I+  cW  H-  I+  FF  I+ 
. 
FF  `- 
H-HH-  H 
C) 
o 
ww  ..  wýý,  r 
C1.  ýD  Oý  Oý  00  ýD  OP  Oý  JW  -4  ýl  NOJN  -  ""'  =  NýDwO=  ___p.  ZlCD  OO=  _=  O'.  OOw  w=  -P.  -3O\O,  =  W  O11ON11D  O 
CIa  H  F+  I+  I+  aaaa  I+  I+  I+  I+  pcäIFF  +H-  I+  aaHIFIF  Ff  hF  a  FF  HF 
CD 
17,  + 
.yw  ýO  -NWNNNN  ý--O  Oý  NO  O-  O"  --  N  H- 
vý  "  ºý 
C/ý  ýO  Cn  -  -]  N  00 
I^ 
NN-W-W  cn  N-.  W-P  vi  ýD  to  ýl  WÄ  Oo 
- 
ON  CIS  Ll 
-3 
O*,  w  -J  ===--  -a  A  cO  ==  oo  =  00  W  110  Oý  110  N  -1  G  FF  FF  W  I+  ääßH 
H-  H-  H-  IF,  aO.  FF  FF  IFIF  FF  GäöH  H-  IFG  FF  °W°  H-  F-  W  H-  p' 
O  "-  -  v,  --  ,.  W  .-rN  --  oý  a  0- 
,!, 
-a  Q) 
+  C)' 
f-t'  NNÖ=_=  .  41  Oho  ýO  7=_ÖO  -ý  _?  W  to  vý  J=  Oý  00 
N 
CD 
H-  H-  I+  I+  ä.  äa  I+ 
H- 
I+  I+  H-  aac.  I+  I+  I+  I+  t+  n.  n  FF  I+  H-  "H-  I+  äL  I+  I+ 
H° 
I+  H-  ý 
W  "-  ö  `p  WN  .rN  .rNOO  ""  ýp  ö  00  wWo 
, ý" 
rip 
O 
C 
C)  '"C7  "ý  NNNJ  `ý  \1 
Ntj  to  ZO  40  N 
all  m  C) 
c.  ä.  Cl.  c.  c  C.  a.  Cl.  n.  n.  p. 
p. 
ä.  M.  CL.  ä.  H-  I+  H-  a  cý  I+  I+I+c.  ý+  I+  I+  µ  I+  I+  /2)  Cri 
WNA  Cli  00  tN  W  00  W  W-  ýr 
cD  I  p, 
,aW 
00  1.0  00  -l  00  \O  -N  ON1 
Nö(.  A 
w 
Oo  10 
x 
fp 
`ý  _  ý°`v,  o  ==  cný10-=  ==  rn-j  IC  wvo  00  "-=  wem  rn  --  Aý"A  a  ()  O 
M 
203 
CL  H-  H'  H-  ä.  ä.  b  a.  W  H-  +  H-  ä.  n.  p.  I+  H-  H-  H-  H-  P.  ä.  c.  H-  F-  H-  H-  P-  I+  +  F+-  I+  H-  FF  m  CD 
WWNW  --"  W  Jý  W  Oý  /'1  En 
ter  ,ý 
>w  C7 
==______====p=o-  00  00  =___  'o  -w=_____=Gi  (IQ 
äääaääaä  Cl  aac.  äH  l+  I+  I+  p  c.  p.  f+  I+  I+  I+  ßßßacca  c10v  .......  -.  -  C-  -oo 
>O 
N  .S 
öm 
°`°°_____°`_______= 
n 
-  aaa  as  aanaääääa  cL  cä  n  ä.  ý  c.  in.  ä  ac.  ä.  ä.  n.  c.  C.  ä.  Cl.  n. 
10' 
C  C)  C0 
^  ?WNWW  4k  WN  ýO 
__=____=_______=  Oý  cnW  "-  O==OO,  _______`J 
aä  ä  ý.  ä  ää  aaaaaä.  ä.  a.  ä.  FF  H-  H-  wwc,  o.  W  FF  FF  WWc.  c.  ä.  n.  ä.  ä.,  >C  11-1  ?NN  N-  O  O, 
-N 
II 
+CW 
O  ýp  NwNWNN  rQ  z  HO  C"  rTI 
_k  p.  =,  a  ß.  p.  asa.  aaa  Cl.  aa  Cl.  a  as  I+a  I+  W  H-  as  H-  Ef  I+  I+  ääaääää  >  C) 
CD  .ýN  NO-  y  _r  r^W  4nJ Catherine  Tsang  154 
5.5.5  Analysis  of  flavan-3-ol  metabolites  in  the  the  liver,  kidneys 
and  brain 
HPLC-MS-MS  analyses,  as  described  above,  identified  glucuronidated  and  methylated 
metabolites  of  (-)-epicatechin  and  (+)-catechin  in  liver  extracts  collected  1  and  4h  after 
ingestion  of  the  GSE.  The  methylated  conjugates  were  the  major  metabolites  (Table 
5.7).  None  of  the  metabolites  were  present  in  subsequent  liver  samples  collected  6,12 
and  24  after  ingestion.  The  levels  of  metabolites  detected  in  the  kidney  were  low 
reaching  a  maximum  by  4h  post-ingestion  with  134  and  28  µg  per  total  catechin  and 
epicatechin  ingested,  respectively.  In  the  liver,  a  number  of  compounds  were  present 
from  1h  after  the  grape  seed  extract.  In  the  present  study  no  metabolites  could  be 
detected  in  the  brain  using  either  full  scan  MS  or  SRM  for  glucuronides,  methyl 
glucuronides  or  sulphates  at  any  time  point  following  ingestion  of  the  GSE. 
5.5.6  Metabolites  identified  in  the  faeces 
HPLC-MS-MS  with  SRM  detected  trace  non-quantifiable  amounts  of  (+)-catechin 
glucuronide,  (-)-epicatechin  glucuronide  and  their  methyl  derivatives  in  the  occasional 
faecal  sample  collected  over  a  24  h  period  after  GSE  ingestion.  They  were,  however, 
not  detected  in  the  majority  of  samples  that  were  analysed. Catherine  Tsang  155 
Table  5.7  Levels  of  flavan-3-ol  metabolites  in  liver  and  kidney  of  rats  over  a  24  h 
period  after  the  ingestion  of  a  GSE. 
Organ  Time  (h)  CGIcUA  ECGIcUA  McCG1acUA  McECG1cUA 
Liver  1  4.3±01  2.5±2.0  57±  1.3  21±  0.1 
2  n.  a.  n.  a.  n.  a.  n.  a 
3  n.  a.  n.  a.  n.  a.  n.  a 
4  2.3±0.1  1.3±  1.0  45±  10  20±0.9 
6  n.  d.  n.  d.  n.  d.  n.  d. 
12  n.  d.  n.  d.  n.  d.  n.  d. 
24  n.  d.  n.  d.  n.  d.  n.  d. 
Kidney  1  n.  d.  n.  d.  n.  d.  n.  d. 
2  7.6  ±  0.1  4.1  ±  0.2  87  ±  0.1  9.1  ±  0.3 
3  2.7  ±  0.2  1.2  ±  0.3  8.4  ±  0.4  2.7  ±  0.4 
4  3.1±0.2  2.1±0  131±1.0  26.3±2.5 
6  2.7±0.6  2.3±0.1  58±0.3  8.2±0.3 
12  n.  d.  n.  d.  n.  d.  n.  d. 
24  n.  d.  n.  d.  n.  d.  n.  d. 
Results  are  expressed  a  µg  per  organ  ±  standard  error,  where  n=3.  CG1cUA-(+) 
catechin  glucurnide;  ECG1cUA-(-)-epicatechin  glucuronide:  McCG1cUA-methyl 
catechin  glucuronide:  McECG1cUA-methyl-epicatechin  glucurnide;  n.  a.  -not  analysed; 
n.  d.  -  not  detected. Catherine  Tsang 
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In  the  present  study  rats  were  fed  a  single  acute  dose  of  a  flavan-3-ol  rich  USE.  The 
mean  amounts  fed  to  each  rat  by  gavage  were  5.8  mg  of  (+)-catechin,  3.6  mg  of  (-)- 
epicatechin,  4.3  mg  of  procyanidin  dimers,  1.3  mg  of  trimers  and  0.7  mg  of  tetramers 
(Table  5.2).  This  dose  is  equivalent  to  ca.  700  mg  GSE  based  on  a  19/kg  body  weight 
basis  for  a  70  kg  human.  In  terms  of  obtaining  this  amount  in  the  diet,  three  glasses  of 
the  red  wine  used  in  this  study  (Chapter  4)  would  provide  ca.  600-700  mg  of  grape 
derived  polyphenols.  This  amount  is  unlikely  to  be  consumed  in  a  typical  diet  and  other 
dietary  sources  are  likely  to  provide  additional  sources.  In  addition,  the  GSE  contained 
a  substantial,  but  undetermined,  quantity  of  high  molecular  weight  polymeric 
procyanidins.  Relatively  high  levels  of  the  various  components  in  the  GSE  remained  in 
the  stomach  for  6  h,  declined  by  12  h  and  had  disappeared  after  24  h.  Small  amounts  of 
GSE  phenolics  appeared  in  the  duodenum/jejunum  and  to  a  greater  extent  the  ileum 
after  1h  and  in  both  instances  had  disappeared  by  12  h.  The  phenolics  were  detected  in 
the  caecum  2h  after  ingestion  and  only  trace  amounts  remained  after  12  h.  Smaller 
amounts  were  found  in  the  colon  3-12  h  after  gavage.  The  vast  majority  of  compounds 
detected  in  the  GI  tract  were  the  original  GSE  flavan-3-ols  with  only  trace  levels  of  four 
metabolites  occurring  in  the  duodenum/jejunum  and  ileum.  The  data  presented  in  Table 
5.6  do  not  show  either  a  sizable  increase  in  either  (+)-catechin  or  (-)-epicatchin  or  a 
concomitant  decrease  in  the  relative  amounts  of  dimers  which  supports  the  view  that 
oligomeric  proanthocyanidins  are  not  depolymerised  into  monomeric  flavan-3-ols  to 
any  extent,  if  at  all,  during  passage  through  the  stomach  and  GI  tract  (Donovan  et  al., 
2002;  Rios  et  al.,  2002;  Nakamura  and  Tonogai,  2003).  HPLC  retention  data  and  MS2 
fragmentation  patterns  indicated  that  the  trace  levels  of  flavan-3-ol  metabolites 
appearing  in  the  GI  tract  were  a  (+)-catechin  glucuronide  and  a  methyl-(+)-catechin 
glucuronide  together  with  the  corresponding  (-)-epicatechin  derivatives  which  in  view 
of  earlier  studies  with  rats  (Natsume  et  al.,  2003)  were  tentatively  identified  as  (-)- 
epicatechin-7-O-glucuronide  and  3'-O-methyl-(-)-epicatechin-7-O-glucuronide  (Table 
5.3).  The  fate  of  the  GSE  flavan-3-ols  in  the  GI  tract  of  rats  is,  therefore,  very  different 
to  that  of  quercetin-4'-glucoside  which  undergoes  very  rapid  conversion  to  a  mixture  of 
glucuronide,  methyl  and  sulphated  metabolites  with  only  25  %  of  the  parent  glycoside 
remaining  after  one  hour  (Mullen  et  al.,  2002b).  In  marked  contrast  to  the  GI  tract Catherine  Tsang  157 
where  the  parent  GSE  flavan-3-ols  were  the  major  components,  the  circulatory  system 
contained  only  the  four  previously  mentioned  flavan-3-ol  metabolites  in  detectable 
quantities.  Three  hours  after  ingestion  a  peak  plasma  concentration  of  ca.  35  µmole/L 
was  attained  with  the  (+)-catechin  and  (-)-epicatechin  glucuronides  with  their 
methylated  derivatives  present  at  2-3  fold  lower  levels  (Figure  5.4).  The  peak  plasma 
concentrations  of  the  two  (+)-catechin  metabolites  corresponds  to  ca.  3%  of  the  (+)- 
catechin  ingested  and  the  (-)-epicatechin  metabolites  equate  with  ca.  4%  of  intake. 
There  was  a  statistically  significant  increase  in  the  plasma  antioxidant  capacity  at  2  and 
4h  post-ingestion  of  the  GSE  (Fig.  5.4b).  However,  this  increase  did  not  coincide  with 
the  peak  plasma  concentration  of  metabolites  at  3  h.  A  previous  study  with  rats  has 
shown  an  increase  in  the  plasma  antioxidant  capacity  following  ingestion  of  (-)- 
epicatechin  and  quercetin.  The  major  circulatory  compounds  in  the  plasma  were 
conjugated  derivatives  indicating  that  they  may  play  a  role  in  the  antioxidant  defences 
of  plasma  (Terao,  1999).  The  apparent  discrepancy  observed  in  the  present  study  may 
simply  have  been  due  to  inter-individual  differences  between  each  rat.  The  levels  of  the 
metabolites  in  the  bloodstream  were  far  greater  than  the  amounts  present  in  GI  tract. 
This  is  in  keeping  with  the  methylation  and  glucuronidation  of  (+)-catechin  and  (-)- 
epicatechin  occurring  on  the  luminal  side  of  the  endoplasmic  reticulum  of  the  small 
intestine  during  transport  into  the  blood  stream  (Kuhnle  et  al.,  2000;  Donovan  et  al., 
2001).  The  small  quantities  of  metabolites  in  the  GI  tract  could  be  due  to  either  low 
level  efflux  back  into  the  lumen  of  the  intestine  or  enterohepatic  recirculation  via  the 
bile.  Trace  levels  of  the  methylated  and  glucuronidated  flavon-3-ol  metabolites  were 
also  detected  in  liver  and  kidney  extracts  (Table  5.3)  but  they  were  excreted  in  much 
higher  amounts  in  urine  along  with  four  sulphated  metabolites,  namely  (+)-catechin 
sulphate,  that  were  not  present  in  either  the  GI  tract,  the  liver  and  kidneys  or  the 
circulatory  system.  In  contrast  to  other  studies,  no  free  (+)-catechin  or  (-)-epicatechin 
were  detected  outside  the  GI  tract,  although  trace  quantities  of  the  procyandin  B1,  B29 
B3  and  B4  dimers  and  the  C2  trimer  were  detected  in  urine  (Figure  5.6,  Table  5.5).  The 
levels  of  (+)-catechin  and  (-)-epicatechin  metabolites  excreted  relative  to  the  quantity  of 
the  monomers  ingested  were  27  and  36  %,  respectively,  after  24  h.  This  is  similar  to  the 
37  %  urinary  excretion  reported  to  occur  after  feeding  (-)-epicatechin  to  rats  (Donovan 
et  al.,  2002).  This  provides  further,  albeit  indirect,  evidence  that  the  procyanidin 
oligomers  in  the  GSE  were  not  depolymerised  to  monomers  to  any  extent  after Catherine  Tsang  158 
ingestion.  If  this  had  occurred  the  level  of  recovery  of  the  monomeric  metabolites  in 
urine  is  likely  to  have  been  substantially  higher  than  the  37  %  obtained  by  Donovan  et 
al.  (2002)  after  feeding  rats  with  (-)-epicatechin.  The  ca.  30  %  recovery  of  the  ingested 
(+)-catechin  and  (-)-epicatechin  as  metabolites  in  urine  is  well  in  excess  of  comparable 
figures  of  ca.  2-3  %  and  0.1  %  that  are  typically  obtained  with  flavonols  and 
anthocyanins,  respectively  (Prior  et  al.,  2003).  However,  this  still  leaves  70  %  of  the 
ingested  monomer  unaccounted  for  and  although  seemingly  not  absorbed  to  any  extent, 
only  miniscule  small  amounts  of  the  procyanidins  in  the  GSE  reach  the  colon  (Table 
5.6)  and  are  excreted  in  faeces.  The  most  likely  fate  of  these  compounds  is  that  they  are 
converted  to  low  molecular  weight  phenolic  acids  (Deprez  et  al.,  2000;  Gonthier  et  al., 
2003a)  most  notably  3-hydroxyphenylpropionic  acid  (Ward  et  al.,  2004).  These 
compounds  were  not  analysed  in  the  current  study.  They  have  a  low  extinction  co- 
efficient  and  a  , max  below  250  nm  and  as  a  result  are  not  readily  detected  with  a  diode 
array  detector  and,  in  addition,  they  do  not  ionize  readily  when  subjected  to  MS  with  an 
electrospray  interface.  Although  HPLC-MS  with  an  electrospray  interface  has  been 
used  to  analyse  phenolic  acid  (Gonthier  et  al.,  2003b)  the  method  lacks  the  sensitivity  it 
exhibits  with  many  flavonoids  so  quantitative  analyses  has  to  be  based  on  selected 
reaction  monitoring  rather  than  full  scan  MS  (Gonthier  et  al.,  2003c).  The  method  of 
choice  of  many  investigators  when  analyzing  putative  phenolic  acid  catabolites  is  gas 
chromatography-mass  spectrometry  with  electron  impact  ionization  (Rechner  et  al., 
2002;  Olthof  et  al.,  2003).  Moreover,  despite  a  thorough  search  by  HPLC-MS-MS  no 
metabolites  could  be  identified  in  the  brain  in  either  full  scan  or  SRM.  El  Mohsen  et  al. 
(2002)  reported  the  presence  of  (-)-epicatechin  glucuronide  and  3-0-methyl  epicatechin 
glucuronide  in  rat  brain  extracts  following  the  ingestion  of  (-)-epicatechin.  In  this  study 
rats  were  fed  by  gavage  a  dose  of  100  mg/per  kg  body  weight,  which  is  ca.  20  mg  (-)- 
epicatechin  ingested  per  rat.  This  is  vastly  higher  (ca.  5-fold)  than  the  dose  of  3.6  mg  (- 
)-epicatechin  ingested  by  each  rat  in  the  present  study,  and  therefore  it  is  likely  that  the 
reason  we  failed  to  detect  any  such  metabolites  in  the  brain  was  simply  due  to  the 
differences  in  the  dose  supplemented. Catherine  Tsang  159 
5.7  Conclusion 
In  summary,  the  present  investigation  indicates  that  flavan-3-ol  monomers, 
oligomers  and  polymers  can  be  directly  absorbed  into  the  bloodstream  while  the 
monomers  are  metabolised  into  glucuronidated  and  methylated  conjugates,  which  may 
contribute  to  an  increase  in  the  antioxidant  capacity  of  plasma.  This  study  provides 
further,  albeit  indirect,  evidence  that  the  procyanidin  oligomers  in  the  GSE  were  not 
depolymerised  to  monomers  to  any  extent  after  ingestion.  Their  cardioprotective  effects 
stem  from  the  ability  to  inhibit  lipid  peroxidation,  chelate  redox-active  metals,  and 
attenuate  other  processes  involving  reactive  oxygen  species.  Further  investigation  of  the 
metabolism  of  these  phytochemicals  is  justified  to  extend  structure-activity  relationships 
to  preventive  and  therapeutic  nutritional  strategies. Catherine  Tsang  160 
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The  research  presented  in  this  thesis  has  reported  on  a  series  of  investigations 
undertaken  in  an  effort  to  determine  the  antioxidant  activity,  protective  effects  and 
absorption  of  phenolic  and  polyphenolic  compounds  in  red  wine.  This  work  has 
identified  and  quantified  the  major  antioxidant  phenolics  in  red  wine  and  has  shown  that 
some  of  these  phenolics,  namely  the  flavan-3-ols  are  bioavailable  in  humans  following  a 
moderate  and  regular  consumption  of  red  wine  which  may  contribute  to  some  of  the 
protective  effects  observed.  (+)-Catechin,  (-)-epicatechin,  procyanidin  dimers  (B  i,  B29 
B3  and  B4)  and  trimers  (C2  and  an  unknown  trimer)  are  directly  absorbed  into  the 
bloodstream  from  the  GI  tract  in  rats.  Conjugated  derivatives  of  the  monomers  are 
present  in  detectable  amounts  in  the  plasma,  urine,  liver  and  kidney  and  to  a  lesser 
extent  in  the  proximal  small  intestine.  The  oligomers  do  not  appear  to  be  depolymerised 
in  the  GI  tract  releasing  monomers  however  their  metabolic  fate  remains  undetermined. 
6.1  Identification  of  the  major  antioxidants  in  red  wine 
In  the  present  investigation  red  wines  were  analysed  for  their  phenolic  content  and 
antioxidant  activity.  The  combination  of  three  different  techniques  HPLC,  MS2  and 
HPLC  with  on-line  detection  of  antioxidant  activity  enabled  the  identification  of  the 
major  phenolics  in  red  wines  together  with  their  individual  contribution  to  the  total 
antioxidant  activity  (Chapter  3).  Extensive  research  has  focused  on  the  identification  of 
the  active  components  in  red  wine;  however  the  isolation  of  these  compounds  has  been 
met  with  little  success  as  existing  techniques  have  been  unable  to  fully  separate  and 
isolate  single  phenolic  compounds  in  such  complex  mixtures.  Many  studies  have 
focused  on  separating  phenolics  in  red  wine  using  solid  phase  and  liquid-liquid 
extraction  procedures.  However,  this  approach  lacks  specificity  due  to  the  differences  in 
polarity  between  different  phenolics  within  a  group  and  as  such  previous  studies  have 
reported  inconsistent  findings.  Large-scale  preparative  HPLC  was  initially  used  to 
separate  wine  into  60  aliquots,  although  it  did  now  allow  for  the  complete  separation  of 
red  wine  components  the  results  indicate  that  increasing  antioxidant  activity  was  highly 
and  significantly  correlated  with  increasing  total  phenolic  and  catechin  content  of  each Catherine  Tsang  162 
wine  fraction.  Recently  sensitive  and  reliable  on-line  methods  of  analysing  radical 
scavenging  activity  have  been  developed  (Dapkevicius  et  al.,  2001,  Koleva  et  al.,  2001). 
Such  methods  require  a  stable  model  free  radical  system  such  as  2,2-azinobis  (3- 
ethylbenzothiazoline-6-sulfonic  acid)  radical  cation  (ABTS)  with  radical  scavenging 
activity  assessed  in  comparison  to  the  water-soluble  synthetic  vitamin  E  derivative 
Trolox.  On-line  assessment  of  antioxidant  activity  allows  complex  mixtures  to  be 
separated  by  HPLC  and  the  antioxidant  contribution  of  individual  components  can  be 
evaluated.  In  summary  the  present  study  has  demonstrated  for  the  first  time  the 
identification  and  quantification  of  the  major  phenolic  contributors  to  the  total 
antioxidant  activity  in  red  wine.  Red  wine  is  a  rich  source  of  antioxidants  and  gallic 
acid,  (+)-catechin,  (-)-epicatechin  and  procyanidin  dimers  B1  and  B2  contributed  to  the 
antioxidant  potential.  The  findings,  however,  should  be  taken  within  the  context  of  this 
study  and  are  not  representative  of  red  wines  in  general  as  variations  in  grape  type, 
vintage  and  vinification  methods  are  known  to  influence  the  levels  of  phenolics. 
6.2  Protective  effects  of  red  wine 
In  this  study  daily  moderate  consumption  of  an  antioxidant  rich  red  wine  for  2- 
weeks  in  healthy  volunteers  was  associated  with  a  small  but  significant  increase  in  the 
plasma  total  phenolic  concentration.  Trace  levels  of  flavan-3-ol  metabolites,  mainly 
glucuronides  and  methyl  glucuronides  of  (+)-catechin  and  (-)-epicatechin  were  detected 
in  the  plasma  of  the  red  wine  group  indicating  that  these  phenolics  are  absorbed  from 
the  GI  tract  (Chapter  4).  The  flavan-3-ols;  (+)-catechin,  (-)-epicatechin,  procyanidin 
dimers  131  and  B2  were  identified  as  the  major  in  vitro  antioxidants  in  this  red  wine 
(Chapter  3).  The  findings  from  the  present  study  confirm  and  extend  previous  reports 
that  some  phenolic  compounds  in  red  wine  are  absorbed  and  metabolised  in  the  human 
body.  These  metabolites  may  contribute  to  protective  effects  such  as  raising  HDL 
cholesterol  concentrations  and  enhancing  the  resistance  of  LDL  to  withstand  oxidative 
modification.  It  is  possible  that  other  phenolics  and/or  metabolites  were  present  in  the 
plasma  that  were  undetected  or  may  have  been  present  in  levels  which  were  below  the 
limits  of  detection.  The  possible  health  effects  of  red  wine  are  therefore  likely  to  be  due Catherine  Tsang  163 
to  the  cumulative  effects  of  phenolic  compounds  (Serafini  et  al.,  1998)  and  alcohol 
working  in  synergy  (Duthie  et  al.,  1998). 
6.3  Absorption,  metabolism  &  excretion  of  flavan-3-ols  in 
rats 
In  the  present  investigation  glucuronidated,  methylated  and  sulphated  metabolites 
of  (+)-catechin  and  (-)-epicatechin  were  exclusively  detected  in  the  plasma  and  urine, 
with  only  trace  amounts  of  metabolites  occurring  in  the  duodenum/jejunum  and  ileum 
of  rats  following  the  ingestion  of  a  GSE.  (-)-Epicatechin  has  been  shown  to  be  modified 
on  absorption  during  transfer  across  the  small  intestine  (Kuhnle  et  al.,  2000).  UDP- 
glucuronosyl  transferase  has  been  found  in  the  mucosa  of  the  upper  half  of  the  small 
intestine,  caecum  and  upper  half  of  the  large  intestine  (Piskula  &  Terao,  1998) 
confirming  that  conjugation  of  flavan-3-ols  can  take  place  in  the  intestine.  The  fate  of 
GSE  flavan-3-ols  in  the  GI  tract  are  in  contrast  with  the  findings  of  Mullen  et  al.  (2002), 
whereby  quercetin-4'-glucoside  was  very  rapidly  converted  to  a  mixture  of  glucuronide, 
methyl  and  sulphated  metabolites  with  only  25  %  of  the  parent  glycoside  remaining 
after  one  hour.  Methylation  and  glucuronidation  of  (+)-catechin  and  (-)-epicatechin 
occurs  on  the  luminal  side  of  the  endoplasmic  reticulum  of  the  small  intestine  during 
transport  into  the  blood  stream  (Donovan  et  al.,  2001).  Therefore  the  small  quantities  of 
metabolites  in  the  GI  tract  in  the  present  study  indicate  either  low  level  efflux  back  into 
the  lumen  of  the  intestine  or  enterohepatic  recirculation  via  the  bile.  Trace  quantities  of 
the  procyandin  B  1,  B2,  B3  and  B4  dimers  and  the  C2  trimer  were  detected  in  urine 
suggesting  that  these  compounds  have  limited  bioavailability.  The  levels  of  (+)-catechin 
and  (-)-epicatechin  metabolites,  excreted  relative  to  the  quantity  of  the  monomers 
ingested,  were  27  and  36  %,  respectively  after  24  h  in  agreement  with  Donovan  et  al. 
(2002).  This  provides  further,  albeit  indirect,  evidence  that  the  procyanidin  oligomers  in 
the  GSE  were  not  depolymerised  to  monomeric  flavan-3-ols  to  any  extent,  if  at  all, 
during  passage  through  the  stomach  and  GI  tract. Catherine  Tsang 
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Research  into  the  alleged  health  benefits  of  phenolic  and  polyphenolic  compounds 
continues  to  have  considerable  potential  however  many  questions  remain  to  be 
answered.  Extending  the  work  in  this  thesis  ileostomy  studies  would  provide  valuable 
information  on  the  absorption  and/or  modification  of  phenolics  occurring  in  the  small 
intestine  following  red  wine  consumption.  This  information  could  then  be  related  to  the 
levels  of  phenolics  detected  in  plasma  and  urine  giving  an  indication  of  the  extent  of 
metabolism  and  sequestration  within  the  human  body.  The  fate  of  compounds  escaping 
digestion  in  the  stomach  and  small  intestine  is  little  understood  and  future  work  should 
investigate  the  role  of  colonic  bacteria  in  this  regard.  Incubation  of  red  wine  phenolics 
with  human  faecal  samples  and  subsequent  analysis  of  the  metabolites  by  LC-MS2 
would  provide  further  insight  into  the  nature  of  these  compounds.  Moreover,  the 
biological  importance  of  the  conjugated  derivatives  and  microbial  metabolites  of 
polyphenols  should  be  evaluated  and  future  in  vitro  studies  should  focus  on  the  activity 
of  these  compounds  instead  of  the  parent  compound. 
Finally,  any  health  benefit  arising  from  red  wine  must  be  considered  within  the 
context  of  the  adverse  effects  of  excessive  alcohol  consumption,  and  should  not  be 
actively  promoted.  A  balanced  diet  rich  in  fruits  and  vegetables  and  low  in  saturated  fat 
is  recommended  for  good  health  supplemented  by  moderate  consumption  of  red  wine, 
green  tea  and  dark  chocolate,  according  to  taste. Catherine  Tsang 
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Title  of  study: 
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The  effect  of  red  wine  consumption  on  the  susceptibility  of  plasma  and  low-density 
lipoprotein  (LDL)  to  oxidative  modification  in  healthy  volunteers. 
You  are  being  invited  to  take  part  in  a  research  study.  Before  you  decide  it  is  important 
for  you  to  understand  why  the  research  is  being  done  and  what  it  will  involve.  Please 
take  time  to  read  this  information  very  carefully  and  discuss  with  friends  and  family  if 
you  wish.  Ask  us  if  there  is  anything  that  is  not  clear  or  if  you  would  like  more 
information.  Take  time  to  decide  whether  or  not  you  wish  to  take  part.  If  you  decide  to 
take  part  in  this  research  study,  you  should  understand  enough  about  the  risks  and 
benefits  to  make  an  informed  judgement.  This  process  is  known  as  informed  consent. 
Once  you  understand  about  the  study,  you  will  be  asked  to  sign  a  consent  form  if  you 
wish  to  participate. 
What  is  the  purpose  of  this  study? 
A  number  of  large  studies  have  shown  that  a  moderate  alcohol  intake  may  be  protective 
against  the  death  from  coronary  heart  disease  (CHD).  There  is  evidence  that  red  wine 
can  offer  a  greater  protection  than  white  wine,  beer  or  spirits.  The  protective  effects 
have  been  attributed  to  substances  known  as  phenolic  compounds  contained  in  red  wine. 
It  is  believed  that  compounds  in  red  wine  act  as  antioxidants.  Antioxidants  protect  the 
body  from  damaging  oxidation  reactions  caused  by  `free  radicals'.  The  oxidation  of 
low-density  lipoproteins  (a  protein  which  carries  cholesterol  in  the  blood)  is  one  such 
damaging  reaction.  When  LDL  becomes  oxidised  or  damaged  by  `free  radicals'  it  can 
result  in  a  series  of  steps  that  are  believed  to  be  involved  in  the  development  of 
atherosclerosis  which  can  lead  to  CHD.  Phenolic  compounds  in  red  wine  are  mainly 
from  grapes  and,  in  particular,  the  skins  and  seeds  which  are  removed  during  the 
procedure  to  make  white  wine.  There  are  large  variations  in  the  phenolic  contents  of Catherine  Tsang  205 
different  wines  depending  on  the  grape,  variety,  climatic  conditions  in  which  the  grapes 
are  grown  and  the  wine-making  techniques. 
The  purpose  of  this  study  is  to  find  out  if  the  consumption  of  red  wines  that  have  been 
shown  to  be  rich  in  antioxidant  phenolic  compounds  can  influence  indicators  of 
oxidation  in  the  blood. 
What  will  it  involve? 
You  will  be  involved  in  the  study  for  approximately  4  weeks  and  we  hope  to  start  the 
study  in  June  2001.  Prior  to  starting  the  study  we  will  ask  you  to  complete  a 
questionnaire  called  a  food  frequency  questionnaire  so  we  can  assess  your  usual  intake 
of  antioxidant  rich  foods  such  as  fruits,  vegetables,  tea  and  wine.  During  the  study  you 
will  be  asked  to  follow  your  usual  eating  habits  but  to  avoid  phenolic  rich 
foods/beverages  and  all  alcohol.  You  will  be  required  to  give  fasting  blood  samples 
before  and  after  the  wine-drinking  period.  You  will  also  be  required  to  fast  overnight 
before  giving  blood.  This  means  not  having  anything  to  eat  or  drink  from  about  8  pm 
the  evening  before.  The  blood  samples  will  be  taken  by  a  qualified  nurse  in  the 
morning. 
Can  you  tell  me  more  about  the  wine? 
Moderate  intake  of  wine  has  been  shown  in  a  number  of  large  studies  to  be  protective 
against  CHD.  In  fact,  a  consumption  of  a  moderate  amount  of  wine  is  recommended  as 
part  of  a  healthy,  balanced  diet.  In  this  study,  volunteers  will  be  asked  to  drink  2-3 
glasses  of  red  wine  every  day  for  two  weeks.  The  wine  used  in  this  study  will  be 
commercially  available. 
What  are  the  benefits  in  taking  part  in  this  study? 
CHD  is  a  major  cause  of  death  in  Scotland.  Diet  is  believed  to  play  an  important  role  in 
the  development  of  this  disease.  This  study  aims  to  increase  understanding  of  the 
manner  in  which  dietary  constituents  affects  our  overall  dietary  intake  in  relation  to 
heart  disease  risk.  The  findings  of  the  study  will  be  published  in  the  scientific  and 
medical  literature  so  that  understanding  of  the  ways  in  which  diet  can  influence  the  risk 
of  CHD  can  be  increased. Catherine  Tsang 
Are  there  any  risks  involved? 
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Taking  blood  samples  can  cause  minor  bruising.  Very  rarely  it  may  cause  inflammation 
of  the  vein  and  possible  infection.  A  qualified  and  experienced  nurse  will  be  employed 
to  take  the  blood  samples  and  they  will  make  every  effort  to  avoid  this  happening. 
Drinking  2-3  glasses  of  wine  will  cause  drowsiness  and  may  impair  your  judgement  and 
therefore,  you  should  not  drive,  cycle  or  operate  mechanical  instruments  afterwards.  To 
take  part  in  this  study,  it  is  important  that  you  are  healthy  and  not  suffering  from  any 
illnesses  such  as  CHD,  cancer  or  diabetes  or  not  taking  any  medication  (other  than  the 
contraceptive  pill).  As  alcohol  consumption  is  not  recommended  for  pregnant  women, 
you  should  not  take  part  in  the  study  if  you  are  pregnant.  Other  exclusion  criteria  for  the 
study  are:  taking  antioxidant/nutrition  supplements  and  excessive  alcohol  consumption 
which  means  drinking  more  than  21  unites  of  alcohol  per  week  for  men  and  drinking 
more  than  14  units  for  women  (1  unit=half  pint  beer,  small  glass  of  wine/sherry,  one 
pub  measure  of  spirits). 
How  inconvenient  will  the  study  be  to  me? 
Giving  blood  samples  may  be  inconvenient  to  you.  You  will  be  required  to  come  to  the 
Department  of  Human  Nutrition  on  two  occasions  to  give  a  blood  sample.  You  will  also 
be  required  to  fast  overnight  before  giving  blood.  This  means  not  having  anything  to  eat 
or  drink  from  about  8  pm  the  evening  before.  The  blood  sample  will  be  taken  by  a 
qualified  nurse  in  the  morning. 
Confidentiality 
Although  information  will  be  stored  by  computer,  each  subject  will  be  entered  as  a 
number  rather  than  by  name  and  will  not  be  identifiable.  This  is  in  accordance  with  the 
data  protection  act. Catherine  Tsang 
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Your  decision  to  take  part  in  this  study  is  entirely  voluntary.  You  may  leave  the  study  at 
any  time.  If  you  have  any  questions  about  the  study  you  may  contact  Dr  Siobhan 
Higgins,  University  Department  of  Human  Nutrition,  University  of  Glasgow,  Yorkhill 
NHS  Trust  Hospital  on:  (0141)  201  0768. Catherine  Tsang 
Statement  of  Informed  Consent 
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The  effect  of  red  wine  consumption  on  the  susceptibility  of  plasma  and  low-density 
lipoprotein  to  (LDL)  oxidative  modification  in  healthy  volunteers. 
I,  (Name) 
...................................................................................... 
Of  (Address) 
.................................................................................. 
agree  to  take  part  in  this  research  project  described  above. 
Dr/Mr/Mrs/Miss/Ms 
........................................... 
has  explained  to  me  what  I  have 
to  do,  how  it  might  affect  me  and  the  purpose  of  the  research  project. 
Signature  of  subject:  ......................................... 
Date:............................ 
Signature  of  witness:  ........................................ 
Date:........................... 0 
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